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ABSTRACT OF DISSERTATION 
Two types of placentitis were studied: ascending and nocardioform placentitis.  
Although the first diagnosis of nocardioform placentitis was made three decades ago, little 
is known about the disease, due to the lack of an experimental model. In attempt to develop 
a research model, Crossiella equi was inoculated through intrauterine, intravenous, 
intrapharyngeal, and oral routes, but none of the routes resulted in nocardioform placentitis. 
This may indicate that unidentified factors may play a role in disease pathogenesis and that 
simple presence of bacteria is not sufficient to induce nocardioform placentitis. The second 
and major component of this dissertation involved the identification of diagnostic markers 
for placentitis. Because ascending bacterial placentitis is readily and predictably induced 
using existing experimental models, this model was used to identify diagnostic markers for 
placentitis in maternal plasma and fetal fluids.  Three potential biomarkers were examined: 
acute phase inflammatory proteins, steroid hormones produced by the fetoplacental unit, 
and protein composition of the fetal fluids. Of the three acute phase proteins investigated, 
serum amyloid A and haptoglobin but not fibrinogen increased in association with 
experimentally induced ascending placentitis. Androgens and progestins appear to be poor 
markers for placentitis. Serum estradiol 17β concentrations were reduced in mares with 
experimentally induced placentitis and appear to be a good marker for placentitis in mares.  
Different methods were used to study the protein composition of the fetal fluids. Alpha-
fetoprotein was characterized as a major protein present in the equine fetal fluids, and this 
protein was elevated in plasma of mares with placentitis. In another study, using a high-
throughput proteomic technique several new proteins were characterized in the amniotic 
and allantoic fluids of mares carrying normal pregnancies, and several previously 
uncharacterized proteins were detected in the allantoic fluid of mares with placentitis. 
Three secreting proteins were elevated in allantoic fluid of mares with experimentally 
induced ascending placentitis. 
Key-words: ascending placentitis, nocardioform placentitis, pregnancy loss, premature 
delivery, abortion 
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Chapter 1 
Review of the Literature 
 
1.1.  Introduction 
Late-term pregnancy wastage generates several million dollars of losses to horse 
owners each year due to the costs of producing a pregnancy (i.e. breeding fees, semen 
transport, feed, vaccinations, veterinary services, etc.).  Additionally, late term pregnancy 
loss may also cause significant emotional stress to the owner that might have high 
expectations for the foal from a particular mating.  Placentitis, an important cause of late-
term pregnancy wastage, is estimated to affect 3 to 5% of pregnancies in Thoroughbred 
mares (Troedsson & Zent 2004). Therefore, means to prevent pregnancy loss are 
warranted.  
Placental pathology/insufficiency was identified in a large retrospective study as 
being responsible for greater than 60% of pregnancy losses (i.e. abortions, stillbirths and 
neonatal deaths up to 24 hours post-delivery) in central Kentucky (Giles et al. 1993). Two 
additional retrospective studies carried several years apart by the same referral diagnostic 
laboratory supported the finding that placentitis was the most common cause of late 
pregnancy loss in mares (Hong et al. 1993, Williams et al. 2004).  Outside North America, 
placentitis has also been indicated as an important cause of pregnancy loss in mares in 
Brazil (Moreira et al. 1998, Marcolongo-Pereira et al. 2012), France (Laugier et al. 2011), 
and Australia (Carrick et al. 2014). However, in the United Kingdom umbilical cord 
pathology (e.g. torsion and entrapments) was the leading cause of pregnancy loss in 
submissions received by a referral diagnostic laboratory (Smith et al. 2003).  These 
differences between the United Kingdom and the rest of the world can probably be 
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accounted for the methodology applied to diagnose placentitis, type of placentas presenting 
lesions which are submitted for pathologic examination, presence of certain 
microorganisms (e.g. nocardioform organisms) as well as potential differences in the true 
incidence of diseases. 
  
1.2. Overview of Etiopathogenesis and Epidemiology of Placentitis 
 
Several infectious agents have been commonly recovered from placentitis cases; 
bacteria are responsible for the large majority of cases and fungi for the minority (Table 
1.1).  Bacterial agents commonly associated with the occurrence of placentitis include 
Streptococcus equi subspecies zooepidemicus, Escherichia coli, Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Leptospira sp, Crossiella equi (C. equi) and Amycolatopsis 
species (Amycolatopsis kentuckyensis, Amycolatopsis lexingtonensis and Amycolatopsis 
pretoriensis) (Hong et al. 1993, Giles et al. 1993, Moreira et al. 1998, Williams et al. 2004) 
(Table 1.1).  Fungi associated with equine placentitis primarily include Aspergillus ssp and 
Candida albicans (Hong et al. 1993).  
Leptospiral infection causing abortions are highly variable across the years in 
central Kentucky (Williams et al. 2004, Erol et al. 2014).  In North America, the serovar 
Pomona type Kennewicki is the most important type associated with Leptospiral abortions 
in mares (Sheorian et al. 2000, Timoney et al. 2011, Erol et al. 2014); however, in other 
parts of the world, the serovars Bratislava, Grippotyphosa, Copenhageni, Autumnalis, 
Hebdomadis, Arborea and Icterohaemorrhagiae are more commonly associated with 
abortions in mares (for review, Erol et al. 2014).  Environmental conditions (e.g. 
precipitation and flooding) are alleged to be important in the dissemination of the bacteria 
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from wildlife to horses (which are considered incidental hosts). Wild animals (e.g. 
raccoons, white tailed deer, striped skunks, opossums, and red grey foxes) have been shown 
to harbor the serovar Pomona and are thought to play a role as source of infection for 
pregnant mares (Timoney et al. 2011). 
 
Table 1.1: Ten most commonly isolated microorganisms in 236 equine placentitis cases in 
central Kentucky. Adapted from Hong et al. (1993). 
 
Microorganisms 
Frequency 
Number of cases % 
Streptococcus equi subspecies zooepidemicus 39 16.5 
Leptospira ssp. 37 15.7 
Escherichia coli 33 14.0 
Fungi 16 6.7 
Pseudomonas aeruginosa 11 4.7 
Streptococcus equisimilis 11 4.7 
Enterobacter agglomerans 5 2.1 
Klebsiella pneumonia 5 2.1 
α-hemolytic Streptococcus 5 2.1 
Staphylococcus aureus  2 0.9 
 
Based upon morphologic lesions and suggested pathogenesis, there are four 
different types of equine placentitis: ascending, focal mucoid (nocardioform), diffuse 
(hematogenous), and multifocal (Williams et al. 2004) (Figure 1.1).  Ascending placentitis, 
the most frequent type of placentitis, is commonly associated with beta hemolytic 
streptococci and coliforms (Hong et al. 1993) (Table 1.1). Nocardioform placentitis is 
commonly associated with Gram-positive branching bacilli, C. equi and Amycolatopsis 
species (Figure 1.2) (Donahue & Williams 2000). In certain years, nocardioform placentitis 
is the predominant type of equine placentitis in central Kentucky (Williams et al. 2004, 
Carter et al. 2012) (Figure 1.3).  A multifocal distribution is a rare type of placentitis and 
has been sporadically seen in isolated cases in association with fungi or bacteria (Hong et 
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al. 1993, Williams et al. 2004).  Diffuse placentitis can be diagnosed as isolated cases in 
association with bacteria or fungi or during outbreaks mainly in association with 
Leptospirosis (Figure 1.3). 
Figure 1.1: Representative photographs of the four morphologic types of equine placentitis. 
(A) ascending placentitis (focal extensive lesion in the chorionic surface of the 
chorioallantois); arrows indicate extensive funisitis, while the asterisk indicates the 
chorionic surface affected by placentititis, #: indicates aminiotinitis (B) Nocardioform 
(focal mucoid lesion in the chorionic surface) ** extensive chorionic surfrace covered by 
mucus; (C) hematogenous (Diffuse erosive lesions present in the allantoic surface of the 
chorioallantois); (D) multifocal, in the allantoic surface view, multifoci areas of infection 
can be observed in this placenta.  Courtesy Dr. Neil Williams (photo B) and Dr. Rafaela 
De Negri (photo C). 
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Figure 1.2: Morphologic aspects of nocardioform microorganisms in culture and 
photomicrographs of Gram-stained microorganisms. (A) Amycolatopsis ssp. Three species 
of Amycolatopsis have been identified in association with nocardioform placentitis: A. 
kentuckyensis, A. lexingtonensis, and A. pretoriensis. (B) Gram staining of Amycolatopsis 
ssp, note the Gram + and branching aspect of the organisms. (C) Crossiella equi culture 
morphology, note the “donut-shape” of each colony. (D) Gram staining of Crossiella equi, 
note the Gram + and branching aspect of the organisms. Courtesy Dr. Erdal Erol.  
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Figure 1.3:  Confirmed placentitis cases in cases submitted to the University of Kentucky 
Veterinary Diagnostic Laboratory during the 2010, 2011 and 2012 foaling seasons. 
Courtesy Dr. Craig Carter. The graphic below is divided in three groups, other types of 
placentitis including multifocal, ascending; nocardioform placentitis and leptospiral 
abortions. 
 
In ascending placentitis, it has been suggested that infectious agents (i.e. bacteria 
and fungi) enter the uterus via the vagina/cervix and then colonize the caudal pole of the 
chorioallantois (LeBlanc 2010, Troedsson & Macpherson 2011) (Figure 1.4). Once the 
infection has been established, clinical signs such premature udder development (± 
streaming of pre-foaling mammary gland secretions), and vulvar discharge may become 
noticeable.  Normal mammary gland development starts about 4 weeks (2 to 6 weeks) from 
the foaling, with more pronounced development in the week of parturition.  Premature 
Other types of placentitis  
Nocardioform placentitis  
Leptospiral abortions  
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mammary gland development is not a pathognomonic sign of placentitis, but rather a non-
specific sign of pending late-term pregnancy loss which can be associated with different 
conditions, such as twin pregnancy, umbilical cord torsion, and idiopathic imminent 
abortion (Macpherson 2006, Troedsson & Macpherson 2011). Enlargement of the 
mammary gland may be observed in mares suffering with hydrops, pre-pubic tendon 
rupture (mammary gland may be filled with serosanguineous/bloody material and cranially 
displaced), and normal pre-foaling ventral edema (Lofstedt 2011). In mares with 
placentitis, premature mammary development might not be present until the placental 
lesions are well advanced. Vulvar discharge is highly variable, as the discharge can be 
smeared by and under the mare’s tail and easily missed, unless frequent monitoring is 
applied. If early treatment is not applied, the lesions will progress, and then the infectious 
agent(s) may gain access to the fetus through the placental vessels and umbilical cord 
(Figure 1.4). 
Figure 1.4: Representative diagram of the suggested pathogenesis of ascending placentitis 
in mares. Adapted from LeBlanc et al. (2012) 
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Infection of the chorioallantois is associated with inflammation which results in 
elevation of prostaglandins (i.e. PGE2 and PGF2α) in the fetal fluids and increased 
expression of pro-inflammatory cytokines (e.g. IL-6 and IL-8) (LeBlanc et al. 2002, 2012). 
Lesions in mares with ascending placentitis are not restricted to the chorioallantois but in 
certain cases of ascending placentitis, funisitis and amnionitis are also present (Hong et al. 
1993, Williams et al. 2004). Ultimately, prostaglandin release has been suggested to lead 
to abortion or delivery of a premature foal (LeBlanc et al. 2002, 2012) (Figure 1.4).  
Chronic placentitis leads to placental insufficiency, which may result in growth retardation 
and delivery of nonviable or weak foals. Foals born alive from mares with placentitis may 
be born septic and may demand intensive veterinary critical care. In addition, despite 
treatment pre-partum or and post-delivery there is no guarantee that the foal will be 
athletically sound.  Thus, early diagnosis and subsequent treatment are likely to improve 
the possibility of delivering a live foal. 
Placentitis accelerates the hypothalamic-pituitary adrenal axis (HPA) maturation 
(Lyle et al. 2006, Troedsson & Macpherson, 2011).  Mares with placentitis may deliver 
live and viable foals by 310 days of gestation (Christensen et al. 2006, Troedsson & 
Macpherson 2011), while  dead foals often will be delivered, if pregnancies of comparable 
gestational age of mares without placentitis are interrupted.  The mechanisms associated 
with survival of preterm foals from mares with placentitis are unclear, but it has been 
suggested that it is related to a premature rise in fetal ACTH and cortisol.  Different than 
other species, final maturation of the equine fetal HPA occurs in the few days preceding 
normal parturition and continues during the first several weeks after birth (for review, Hart 
& Barton 2012). Foals born prematurely presented lower cortisol concentrations (<3µg/dL) 
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within 2 hours post-delivery compared to normal full-term foals (12-14 µg/dl) (Rossdale 
et al. 1991).  In addition, premature foals showed remarkably higher ACTH concentrations 
in comparison to normal full-term foals (650 pg/mL vs 300 pg/mL within the first 30 
minutes post-delivery).  In mares with placentitis, treatment strategies to prevent premature 
delivery should be applied, thus prolonging fetal time in utero which may allow more fetal 
maturation and as consequence improve the outcome for neonatal survival.  
Nocardioform placentitis was first recognized ~20 years ago in central Kentucky 
(Giles et al. 1986); however, little is known about the pathogenesis of this disease.  Lesions 
in this type of placentitis are located in the uterine body and base of the uterine horns with 
no association with the cervical star (Hong et al. 1993). As a consequence, vulvar discharge 
is not commonly observed in the mare with nocardioform placentitis unless the mare is 
about to abort.  Based upon submissions to a referral laboratory in central Kentucky, C. 
equi appear to be more pathogenic than Amycolatopsis species, as more mares infected 
with C. equi tend to abort, while more mares infected with Amycolatopsis ssp tend to 
delivery live, premature foals.  Because nocardioform infection is restricted to the 
chorioallantois (i.e. amnion, umbilical cord and fetus are not affected) (Hong et al. 1993), 
chorionitis is believed to accelerate fetal maturation and to induce placental insufficiency 
(i.e.  In-utero growth retardation). 
Little is known about the pathogenesis of diffuse or multifocal placentitis, it is 
suggested that the microorganisms reach the uterus hematogenously; however, there has 
been speculation that multifocal placentitis is the result of a dormant chronic infection of 
the uterus that became active later in pregnancy.  In multifocal placentitis, lesions can be 
confined to the chorion and may also be present on the allantoic surface (Hong et al. 1993, 
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Williams et al. 2004). Leptospira, the most important cause of hematogenous (or diffuse) 
placentitis, is believed to gain access to the uterus through the systemic circulation.  
Leptospiral lesions include amnionitis, funisitis and acute inflammatory changes in the 
chorioallantois (Hong et al. 1993, Donahue & Williams 2000). Interestingly, leptospiral 
abortions are associated with high immunoglobulin titers in maternal plasma, different than 
other types of placentitis (Donahue & Williams 2000, Erdal et al. 2014).  Leptospira is 
believed to cause abortion directly by infection of the fetoplacental unit, but it appears that 
systemic inflammation in association with hyperthermia and prostaglandin production may 
contribute to the pregnancy loss.  
 
 
1.3. Diagnosis of Placentitis 
 
Currently the diagnosis of placentitis is based on ultrasonography and clinical signs 
(i.e. premature lactation and/or vulvar discharge) (LeBlanc 2010, Troedsson & 
Macpherson 2011). Transrectal ultrasonography of the caudal placental pole is commonly 
used to diagnose ascending placentitis (Renaudin et al. 1997, Troedsson & Zent 2004, 
Bucca et al. 2005, Troedsson & Macpherson 2011) (Figure 1.5).  While performing this 
technique, the operator should make a perfect midline alignment of the transducer with the 
cervix and ventral aspect of the caudal pole, to assure that a branch of uterine artery/cranial 
vaginal artery is imaged. Three measurements are usually taken of the combined thickness 
of uterus and placenta (CTUP) and the values can be compared to reported normal ranges 
(Renaudin et al. 1997, Troedsson & Zent 2004, Coutinho da Silva et al. 2013).  Increased 
CTUP associated with clinical signs and areas of placental separation are suggestive of 
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ascending placentitis (Troedsson & Macpherson 2011). Interestingly, there appears to be 
small variations in normal CTUP between horse breeds (Renaudin et al. 1997, Troedsson 
& Zent 2004, Bucca et al. 2005, Hendricks et al. 2009, Coutinho da Silva et al. 2013). In 
a Dutch study, parity was reported to have effects on values of CTUP, i.e. nulliparous mares 
presented higher values compared to multiparous mares (Hendricks et al. 2009).  Despite 
the widespread use of transrectal ultrasonography to diagnose ascending placentitis, data 
on sensitivity and specificity are scant.  
Transabdominal ultrasonographic examination of the fetus and placenta has been 
commonly used as a tool to assess fetal and placental health (Bucca et al. 2005, Bucca 
2011). This approach is a particularly useful clinical tool in suspected nocardioform 
placentitis (Wolfsdorf et al. 2000, Troedsson & Macpherson 2011).  However, since a very 
limited area of the uterus is accurately visualized by transabdominal ultrasonographic 
examination, the lack of apparent lesions in the chorioallantois does not exclude the 
possibility of disease. Areas of placental separation with hyperechoic exudate between the 
chorioallantois and the uterus are suggestive of nocardioform placentitis (Wolfsdorf et al. 
2000, Troedsson & Macpherson 2011). Presumptive diagnosis of nocardioform placentitis 
can be challenging, especially if only a small area is affected. Therefore, the development 
of an experimental model for this disease would help investigators to better understand its 
pathogenesis, diagnosis and treatment. 
Fetal heart rate monitoring and ultrasonographic character of the fetal fluids can 
also be evaluated by transrectal and transabdominal ultrasonography (Reef et al. 1996, 
Bucca 2011, Coutinho da Silva et al. 2013). Reduced or increased fetal heart rates (i.e. 
normal heart rates ~80 beats per minute during late pregnancy) are associated with poor 
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pregnancy outcome (Reef et al. 1996, Troedsson & Macpherson 2011). Increased 
echogenicity of the fetal fluids are associated with imminent abortion (Troedsson & 
Macpherson 2011). It is worth noting that the echogenicity of the amniotic fluid increases 
with gestational age (Coutinho da Silva et al. 2013), probably related to the vernix being 
released by the fetus. However, fetal stress (e.g. colic surgery, fetal hypoxia by different 
reasons) may result in fetal diarrhea, and echogenicity of the amniotic fluid may increase 
remarkably as consequence of solid particles floating in the amniotic fluid.  The normal 
amnion appears as a thin membrane surrounding the fetus; amnionitis can be observed by 
ultrasonography as a thickened and irregular amniotic membrane (Troedsson & 
Macpherson 2011). 
Figure 1.5: Transrectal ultrasonography of the caudal pole of the chorioallantois. (A) 
Normal ultrasonographic appearance of the chorioallantois and combined thickness of 
uterus and placenta (i.e. <8mm) in a mare at 270 days of gestation (--); (B) Note fluid 
accumulation and separation of the chorioallantois from the uterus (*), this finding is 
consistent with early signs of placentitis. 
 
Cytology and culture swabs obtained from the external cervical os in pregnant 
mares can be beneficial in cases of ascending placentitis, when the cervix is open and 
12 
 
discharge is present (Figure 1.6) (LeBlanc 2010).  Samples for culture and cytology can be 
collected with the use of a double-guarded cytobrush/swab via vaginoscopy or manually 
with a sterile sleeve. The presence of neutrophils, bacteria, and/or fungal hyphae will aid 
the presumptive diagnosis and give some clues about the type infection (i.e. Gram 
positive/negative and shape, or presence of hyphae) while waiting for further laboratorial 
diagnostic tests. 
The definitive diagnosis of placentitis is attained by pathologic and microbiologic 
examination of the placenta (Hong et al. 1993, Giles et al. 1993, Donahue & Williams 
2000).  Ordinarily, the placenta should be laid out in an “F” or “Y” shape, thereafter the 
chorionic surface of the chorioallantois is examined and sampled (Hong et al. 1993, 
Schlafer 2004). Macroscopic examination of the placenta allows determination of the 
affected areas, classification of the lesions and sampling for further examinations (i.e. 
histopathology and microbiologic evaluations). The placenta should be inverted to expose 
the allantoic surface of the chorioallantois, similarly the placenta should be laid out in an 
“F” shape, the amnion and umbilical cord should be spread out, examined and sampled for 
pathologic examination (Schlafer 2004).  Affected areas, normal tissues, and areas of 
transition between the normal and affected tissues should be sampled from the 
chorioallantois, amnion and umbilical cord (Hong et al. 1993, Schlafer 2004). 
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Figure 1.6: Cervical cytology collected from a mare with ascending placentitis. Note the 
presence of several segmented neutrophils (example indicated by an asterisk) and several 
bacterial colonies (Streptocccus species indicated by the arrow). Courtesy Dr. Barry Ball. 
 
Swabs collected from affected placental tissues can be used for bacterial culture 
and PCR testing for abortigenic infectious agents (e.g. Leptospira, equine herpesvirus type 
1, equine arteritis virus) (Schlafer 2004, Williams et al. 2004, Erdal et al. 2014). Fetal 
tissues (e.g. brain, liver, spleen, kidney, heart and lungs) and fetal body fluids (e.g. heart 
blood, thoracic and abdominal fluids) can be used for diagnostic testing. Fragments of 
placenta and fetal tissues can be collected, macerated, and be used for culture and PCR 
testing (Hong et al. 1993, Schlafer 2004, Williams et al. 2004, Erol et al. 2014).  A 
combination of different diagnostic methods will improve the diagnostic accuracy (Hong 
et al. 1993, Schlafer 2004, Erol et al. 2012, Erol et al. 2014). However, despite extensive 
testing, in about 20% of abortions submitted to a referral laboratory in central Kentucky, 
the cause of abortion could not be determined (Williams et al. 2004). 
Lesions detected upon histopathologic examination of the placenta vary with the 
infectious agent involved and chronicity of the infection (Hong et al. 1993). Acute bacterial 
placentitis is characterized by neutrophilic infiltration of the inter-villous space and/or 
necrosis of the chorionic villae (Hong et al. 1993, Williams et al. 2004). Chronic placentitis 
is associated with necrosis of the chorionic villi, presence of eosinophilic amorphous 
*
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material in the chorion, and/or infiltration of mononuclear cells in the intervillous spaces 
(Hong et al. 1993).  Other lesions reported in association with chronic placentitis include 
chorioangiosis, hyperplasia with or without squamous metaplasia of the chorionic 
epithelium, and adenomatous hyperplasia of the allantois (Hong et al. 1993). Leptospiral 
placentitis is characterized by edema, placental hemorrhage, brown mucoid material, green 
discoloration, cystic adenomatous hyperplasia of the allantois, vasculitis, amnionitis and 
funisitis as well as by the presence of spirochetes (Hong et al. 1993, Donahue & Williams, 
2000) (Figure 1.7). Severe fetal lesions are also a remarkable feature of leptospiral 
abortion; the aborted fetus may be emaciated and icteric, present generalized edema and 
fluid accumulation and severe degenerative inflammatory lesions of lungs, liver, kidneys 
(Hong et al. 1993, Donahue & Williams, 2000, Williams et al. 2004). 
In nocardioform placentitis, the macroscopic lesions are focal-extensive at the base 
of the uterine horn(s) and cranial uterine body on the chorionic surface of the 
chorioallantois, without involvement of the cervical star (Hong et al. 1993; Donahue & 
Williams 2000). A brown tenacious, mucoid material is found overlying white granular 
punctuate lesions (Hong et al. 1993).  Histopathologic lesions are described as chronic-
active; severely affected villi are often necrotic and coated with an extensive layer of 
eosinophilic amorphous material mixed with neutrophils and colonies of long filamentous 
branching bacteria (Hong et al. 1993, Donahue & Williams 2000). In less severely affected 
areas the same type of exudate is present in the crypts and mononuclear cells are present 
in the villous stroma and chorionic stroma.  Endometritis is a common finding in mares 
presenting with placentitis. Adenomatous hyperplasia of the allantoic epithelium and 
hyperplasia with or without squamous metaplasia of the chorionic epithelium is frequently 
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observed (Hong et al. 1993, Donahue & Williams 2000). Bacterial cultures of the affected 
areas are routinely used as part of the necropsy diagnostic testing in pregnancy loss cases 
(i.e. abortion cases, premature delivery and suspicious placentitis cases). Methods and 
procedures for bacterial culture for nocardioform actinomycetes have been recently 
improved (Labeda et al. 2003, Donahue & Williams 2000, Erol et al. 2012a). Analyses by 
PCR analysis for actinomycetes (i.e. C. equi and Amycolatopsis ssp) has been incorporated 
as a routine test for the diagnosis of nocardioform placentitis in central Kentucky (Erol et 
al. 2012). The perceived advantage of PCR in comparison to other diagnostic tools includes 
a rapid turnaround time; however, the specificity and sensitivity for PCR detection have 
not been reported. At present, as for other abortigenic diseases, the combination of the 
different diagnostic methods is highly recommended to maximize diagnostic accuracy. 
Fungal placentitis is commonly associated with chronic extensive placentitis at the 
cervical star. Similar to chronic bacterial placentitis, some fungi induce multifocal 
granulomatous placentitis (Hong et al. 1993).  Adenomatous hyperplasia of the allantoic 
epithelium, with or without squamous metaplasia can be commonly observed in chronic 
placentitis (e.g. fungal placentitis, E. coli and nocardioform placentitis) (Hong et al. 1993, 
Shivaprasad et al. 1994). Fungal placentitis can be found in association with bacterial 
placentitis. Anecdotally, treatment for bacterial placentitis may be associated with a 
secondary fungal infection; however, such associations have not been studied.  
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Figure 1.7: Leptospiral abortion. (A) Chorionitis, note large area of mottling and extensive 
placental edema. (B) Severely emaciated fetus aborted in a mare affected with Leptospira. 
(C) Severe amnionitis in a mare aborting due to Leptospira infection. Grossly, the amnion 
was hemorrhagic and necrotic (indicated by asterisks). (D) Icteric fetal carcass (serosa), 
note the rib impression on the liver as a consequence of the hepatic edema. Courtesy Dr. 
Rafaela De Negri.  
 
 
1.3.1 Diagnostic Markers for Equine Placentitis 
Several molecules have been measured in blood from pregnant mares to evaluate 
fetoplacental well-being. Over the last three decades, steroids produced by the fetoplacental 
unit have received the most attention (Rossdale et al. 1991, Ousey et al. 2004, Douglas 
2004, Morris et al. 2007, LeBlanc 2010). Other molecules including relaxin and “equine 
* 
* 
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feto-protein” have also been investigated in mares with pregnancy loss (Sorensen et al. 
1990, Ryan et al. 2001, Ryan et al. 2009). Recently, serum amyloid A (SAA) has been 
investigated as a prognostic marker for mares with experimentally induced ascending 
placentitis (Coutinho da Silva et al. 2013). Therefore, different diagnostic markers for 
placental health in mares will be discussed herein. 
 
Fetoplacental steroids 
During pregnancy several steroids (i.e. estrogens, progestins and androgens) are 
produced and metabolized by the fetoplacental unit (Cox et al. 1975, Raeside et al. 1979, 
Pashen and Allen 1979, Raeside 2004, Ousey 2011).  These steroids achieve extremely 
high concentrations in the maternal and fetoplacental circulation (Ousey et al. 2003, Ousey 
2011). At the present, we have very limited understanding of the function of the different 
steroids during pregnancy, particularly within the fetoplacental unit.  Progestins are 
responsible for maintaining pregnancy (Ginther, 1992, Scholtz et al. 2014); however, it is 
unclear what functions estrogens and androgens have during pregnancy in mares.  Removal 
of fetal gonads did not affect pregnancy maintenance; however, concentrations of PGFM, 
a metabolite of PGF2α, was remarkably reduced, and as a consequence, the second stage 
of labor was delayed (Pashen & Allen 1979, 1982).   
Progestins can be subclassified as pregnenes and 5α pregnanes. Pregnenes include 
pregnenolone, progesterone and 5-pregnene-3β,20β–diol (P5ββ); 5α-pregnanes include 5α 
hydroxyprogesterone (5α-DHP), 3β5P, 20α-5P, ββdiol, 5-pregnene-3β,20α–diol (βαdiol), 
however, 5αDHP, 20α5P, and βα-diol predominate (Chavatte-Palmer et al. 1997, Ousey et 
al. 2003). During the first 100 days of pregnancy, progesterone is the main progestin, with 
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5αDHP also being also present in high proportion starting from ovulation (Scholtz et al. 
2014).  It is produced by the primary corpus luteum, and secondary and accessory corpora 
lutea (Ginther 1992). Starting by 70-100 days of gestation the main source of progestins is 
the equine placenta (Holtan et al. 1978, Hinrichs et al. 1987), in fact removal of the 
maternal ovaries by 100 days of gestation did not affect the pregnancy maintenance 
(Hinrichs et al. 1987), however, removal of maternal ovaries by 70 days of pregnancy was 
associated with pregnancy loss in 50% of the mares (Holtan et al. 1978). It is worth noting 
that in addition to progesterone, 5α-DHP is also present in the maternal circulation during 
early pregnancy and has been recently confirmed as a potent, bioactive progestin (Scholtz 
et al. 2014). Interestingly, from approximately 150 days of pregnancy, progesterone is 
present in very low concentrations in the maternal plasma (Short 1950), and it appears that 
other progestins (e.g. 5α-DHP) are responsible for pregnancy maintenance. During the last 
30 days of gestation, maternal concentrations of progesterone rise until immediately prior 
to parturition (Holtan et al. 1975). 
Measurement of progestins has been used to monitor placental health in 
spontaneous and experimental cases of placentitis (Rossdale et al. 1991, Douglas 2004, 
Ousey et al. 2007, Morris et al. 2007). Chronic placentitis (>7 days post-inoculation) in 
experimentally induced mares was associated with increased plasma progestin 
concentrations (Morris et al. 2007); however, in the same study, mares that developed acute 
placentitis (abortion <4 days post inoculation) experienced a rapid decline in plasma 
progestin concentrations. Spontaneous cases of placentitis have been reported to cause 
elevation in total progestin concentrations (Douglas 2004, Ousey et al. 2007). This increase 
in concentration of progestins is thought to be linked to the accelerated adrenal gland 
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maturation in the fetus of pregnant mares experiencing chronic placentitis (Rossdale et al. 
1991, Lyle et al. 2006). The adrenal gland is thought to produce pregnenolone, and this 
molecule is used as a precursor for progesterone in the equine placenta.  It is assumed that 
placentitis increases the substrate (i.e. pregnenolone) which leads to an increased peripheral 
progestin concentration in mares with chronic placentitis. It has also been suggested that 
placentitis affects the ability of the placenta to metabolize progesterone into other 
progestins, thus progesterone will appear in higher concentration in plasma. Repeated 
measurements of plasma progestins in mares with placentitis have been proposed as a 
useful method to identify mares that may abort or deliver prematurely (Douglas 2004, 
Morris et al. 2007, Ousey et al. 2007). 
During pregnancy, the equine fetal gonads of both male and female fetuses undergo 
marked hypertrophy and secrete large quantities of androgens, particularly 
dehydroepiandrosterone (DHEA) and 7-dehydro DHEA  (Raeside et al. 1973, Pashen et 
al. 1979, Raeside et al. 1997). Dehydroepiandrosterone serves as a precursor for classic 
phenolic estrogens (i.e. estrone, estradiol-17β, estradiol-17α, and their sulfoconjugates), 
and 7-dehydro-DHEA serves as a precursor for ring B unsaturated estrogens (i.e. equilin, 
equilenin and their hydroxyderivatives 17α-dihydroequilin, 17α-dihydroequilenin, 17β-
dihydroequilin, and 17β-dihydroequilenin) by the equine placenta (Raeside et al. 1979, 
Pashen & Allen 1979, Bhavnani 1988, Raeside et al. 1997, Ousey 2011). In addition to 
DHEA, circulating testosterone is elevated in plasma of pregnant mares (Silberzahn et al. 
1984, Daels et al. 1996).  To date, determination of fetoplacental androgens have not been 
critically assessed in mares experiencing pregnancy losses. Because androgens serve as 
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precursors of estrogens, it seems logical that placentitis affects androgen concentrations in 
the maternal circulation. 
The equine blastocyst begins to secrete estrogens about 10 days post ovulation 
(Zavy et al. 1984, Ginther 1993); thereafter, estrogens are produced by the corpora lutea 
starting by 40 days of pregnancy (Daels et al. 1991). This ovarian secretion of estrogen is 
believed to be mediated by eCG and will last until the demise of the corpora lutea around 
150 days of gestation (Ginther 1992, Ousey 2011).  Concomitant with ovarian secretion of 
estrogens (i.e. by day 40 of gestation), the fetoplacental unit also starts to secrete estrogens.  
Concentrations of estrogens in maternal circulation will increase remarkably through the 
second trimester of pregnancy, and maximal concentrations are achieved by 210-240 days 
of gestation. From the peak of estrogen concentrations in maternal circulation, there is a 
progressive reduction in estrogen concentrations through the end of pregnancy with 
minimal estrogen concentrations at parturition, which is contrary to reports in domestic 
ruminants (Cox 1975, Ginther, 1992, Raeside 2004, Ousey 2011).  The estrogen production 
parallels the enlargement of the fetal gonads (Schlafer 2011, Ousey 2011).  Since estrogens 
are a final product of the fetoplacental unit, determination of peripheral estrogen 
concentrations in pregnant mares may provide utility in the diagnosis of equine placentitis. 
Determination of estrone sulfate concentrations in maternal circulation has been 
suggested as a useful marker for fetal wellbeing during early pregnancy (Kashman et al. 
1988, Jeffcott et al. 1987 Stabenfeldt et al. 1991); however, studies involving estrone 
sulfate in advanced pregnancy are scant (Ousey et al. 1987, Santschi et al. 1991). There 
are no controlled studies assessing estrone sulfate in mares experiencing placentitis, despite 
its high popularity among practitioners which frequently use estrone sulfate as a test to 
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assess fetal-wellbeing and placental health. Field observations carried by a commercial 
laboratory, reported that aborting mares present significantly lower “total estrogen” 
(unreported crossreactivity) concentrations than do mares maintaining pregnancy (Douglas 
2004). Controlled studies are warranted to confirm field observations concerning the utility 
of conjugated and unconjugated estrogen concentrations in pregnant mares as markers for 
placentitis. 
Acute phase proteins 
Acute phase proteins (APP) are elevated when inflammation is present (Pepsy et 
al. 1989, Peterson et al. 2004).  This group of proteins is mainly produced by the liver in 
response to an inflammatory stimulus (i.e. cytokines) (Husebeck et al. 1986, Nunokawa et 
al. 1993, Jacobsen & Andersen 2007, Cray 2012).  Acute phase proteins are classified as 
minor, moderate and major; minor and moderate (i.e. constantly present in the plasma and 
concentration increases 1 to 5 and 5 to 10 fold upon inflammation, respectively) and major 
(i.e. low or undetectable concentrations in the blood circulation and upon inflammatory 
stimulus increases >10 and often 100 to 1000 times) (Chrisman et al. 2006, Jacobsen & 
Andersen 2007).  The main acute phase protein in the horse is serum amyloid A, whereas 
the moderate acute phase proteins include haptoglobin (Hp) and fibrinogen (Fb), and minor 
C-reactive protein (CRP) and α1-acid glycoprotein (Jacobsen & Andersen 2007, Belgrave 
et al. 2013, Cray & Belgrave 2014). As a moderate APP, Hp is constantly present in plasma 
of health horses and concentrations are elevated upon inflammation (Jacobsen & Andersen, 
2007, Cray, 2012).  
In horses, Hp has recently been shown to be a useful marker for a variety of acute-
chronic clinical conditions (i.e. >4 days duration) (Cray & Belgrave 2014). Recently, 
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increases in peripheral blood concentrations of SAA have been reported in mares with 
experimentally induced bacterial endometritis (Christoffersen et al. 2010) and ascending 
placentitis (Coutinho da Silva et al. 2013). In healthy pregnant mares, SAA concentrations 
remained low throughout the last half of gestation while showing a significant increase 
beginning approximately 12 hours post-partum.  Maternal SAA concentrations then return 
to baseline within approximately 60 hours postpartum (Coutinho da Silva et al. 2013). 
Interestingly, levels of SAA in peripheral blood have been reported to increase in mares 
affected by placentitis and decrease again in response to treatment (Coutinho da Silva et 
al. 2013).  Fibrinogen, the most widely used APP in the horse, is commonly used in 
association with white blood cell counts (WBC) as means to assess inflammation in the 
horse (Chrisman et al. 2006, Belgrave et al. 2013); however, anecdotally it has been 
suggested that neither WBC nor Fb change in mares with placentitis.  To date SAA or Hp 
have not been critically evaluated as diagnostic tool for mares with spontaneous and or 
with experimentally induced ascending placentitis.  
 
Relaxin 
Relaxin, a hydrophilic polypeptide hormone, is a member of the insulin-like peptide 
superfamily.  Equine relaxin, which is the smallest relaxin among mammals, is composed 
of two subunits (i.e. A: alpha 20-residue; and B: beta 28-residue) which are connected by 
disulfide bonds similar to insulin (Ginther 1992, Hossain et al. 2006).  It has been suggested 
that relaxin plays an important role during pregnancy, and the proposed functions include 
uterine growth, distensibility of uterus, cervix and pelvic ligaments (Ginther 1992). To date 
the role of relaxin during equine pregnancy is not fully understood.  
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Relaxin is produced by the equine placenta and can be detected in high 
concentrations in the peripheral blood from day 80 of gestation until term (Stewart et al. 
1982, Stewart et al. 1992).  It has been reported that relaxin is a useful biomarker assess 
placental health (Ryan et al. 1999, 2001). Ryan et al. (2009) reported that there was a 
positive relationship between circulating levels of relaxin and poor outcomes in high risk 
pregnancies. These investigators suggested that because the placenta is the sole source of 
relaxin, blood concentrations could be used as a biomarker of placental function (Ryan et 
al. 1999). It is worth noting that relaxin concentrations vary greatly among different breeds 
(e.g. Thoroughbred vs Standardbreds) and horse types (pony vs standard size horse mares) 
(Stewart et al. 1992, Ryan et al. 2001). In addition, the lack of a commercially available 
test at present precludes the use of relaxin clinically in mares. 
 
1.3.2 Biomarkers for Chorioamnionitis in Humans 
In recent years, microRNAs (miRNA), small non-coding ribonucleic acids (~22 
nucleotides) have been the focus of human studies as potential biomarkers for diseases (e.g. 
cancer, inflammatory and cardiovascular pathologies). MicroRNAs are associated with a 
wide range of biological functions through regulation of gene expression either by 
degrading or transcriptionally repressing messenger RNA (Ladomery et al. 2011). 
MicroRNAs are relatively stable in the systemic circulation and represent a source of cell-
free nucleic acid (Chim et al. 2008).  In plasma, miRNAs are stable because they are 
transported within exosomes (non-cellular vesicles), and recent findings have shown that 
miRNAs present in these vesicles control immune response mediated by T-cells 
(Mittelbrun et al. 2011). A number of studies have characterized pregnancy-associated 
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miRNAs in women (Ladomery et al. 2011 Chim et al. 2008, Kotlabova et al. 2011) and 
some have indicated changes in expression of miRNAs associated with abnormal or 
preterm labor, therefore indicating their potential diagnostic application (Kotlabova et al. 
2011, Mayor-Lynn et al. 2011). To date miRNAs have been received limited attention 
during equine pregnancy, a recent study demonstrated changes in miRNAs in the dam’s 
circulation during maternal recognition of pregnancy (Cameron 2012).  Since miRNA (i.e. 
miR223 and miR 338) change in the placenta of pregnant women suffering with 
chorioamnionitis (Montenegro et al. 2007), it is reasonable to hypothesize that these or 
other miRNA may change in mares with placentitis.   
Proteomics of the amniotic fluid and fetal circulation has been used in women to 
identify biomarkers for chorioamnionitis (intra-amniotic infection/inflammation) 
(Ruetschi et al. 2005, Romero et al. 2008, Buhimschi et al. 2007, Buhimschi et al. 2008, 
Buhimschi & Buhimschi 2010,  Buhimschi et al. 2011). Ruetschi and collaborators (2005) 
identified seventeen proteins that were overexpressed in amniotic fluid samples of women 
with chorioamnionitis. Among these proteins, three proteins were further identified as 
human neutrophil protein 1-3 as well as calgranulin A and B. Another study identified 39 
proteins that are differentially expressed in amniotic fluid samples obtained from patients 
with intra-amniotic infections (Romero et al. 2008). To date proteomics of the equine fetal 
fluids have not been described; thus characterization of the protein composition of fetal 
fluids would be a useful to identify potential new markers for equine placentitis.  Recently 
a study involving proteomics of human neonates demonstrated that Hp and haptoglobin-
related protein immunoreactivity (Hp-RP) are useful markers for neonatal sepsis 
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(Buhimschi et al. 2011). Proteomics of the fetal fluids and the newborn foal may aid in 
identifying new diagnostic markers for placentitis and neonatal sepsis.  
Macrophage migration inhibitory factor (MIF), an inflammatory marker, is 
elevated in amniotic fluid in chorioamnionitis (Chaiworapongsa et al. 2005). Interestingly, 
during early pregnancy, non-infectious early pregnancy losses in women were associated 
with reduced serum levels of MIF (Yamada et al. 2003).  Macrophage migration inhibitory 
factor is expressed in high levels by the embryo and endometrium during early pregnancy 
in horses (Klein & Troedsson 2013). Unfortunately, our preliminary results measuring MIF 
in plasma of mares with placentitis showed that MIF is highly variable across days and 
mares, and there were no associations between placentitis and concentrations of MIF 
(Canisso et al. 2012), therefore, measuring MIF does not appear useful as a diagnostic 
marker for placentitis. 
  In human medicine, CRP has been the most widely studied APP, as a non-specific 
biomarker for placental and fetal health (Wu et al. 2009, Popowski et al. 2011, Lee et al. 
2012). Changes in concentrations of CRP in the systemic circulation of women suffering 
with chorioamnionitis have been demonstrated by several authors (Popowski et al. 2011, 
Smith et al. 2012, Lee et al. 2012). In horses, CRP is a minor APP and has received limited 
attention (Nunokawa et al. 1993, Lavoie-Lamoureux et al. 2012), likely due to the lack of 
remarkable changes in different diseases evaluated to date.  
In mammals, infection of the placenta triggers the local innate immune response 
through activation of Toll-like receptors (TRL), a group of receptors responsible for 
recognition of pathogen patterns and tissue damage (Kim et al. 2004, Romero et al. 2007). 
Activation of TLR (e.g. TRL-2 and TRL-4) initiates a cascade of events of the innate 
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immune response that results in migration of phagocytic cells to infected/damaged tissues 
and production of inflammatory mediators (e.g. cytokines, prostaglandins, and many others 
mediators) (Kim et al. 2004; Romero et al. 2007). Cytokines are small molecules (peptides, 
proteins, glycoproteins) that modulate the immune system/response, either by promoting 
or suppressing inflammation (Oppenheim 2001, Dinarello 2007). Dozens of cytokines are 
known, and there are several cell-types that produce (e.g. macrophages, monocytes, 
fibroblasts, dendritic cells, B lymphocytes, NK cells and epithelial cells) and secrete these 
molecules (Oppenheim 2001, Dinarello 2007).  Normal placental tissues of mammals 
including the mare and women constitutively express pro-inflammatory cytokines (Jana et 
al. 2008; LeBlanc et al. 2012, Palm et al. 2013, Pitman et al. 2013). However, placental 
infection in women is associated with an increased production of several pro-inflammatory 
cytokines (e.g. IL-6, IL-8 and TNF- α) not only in placental tissues, but also in the fetal 
and maternal blood (Vogel et al. 2005, Romero et al. 2007). Pro-inflammatory cytokines 
have been shown to be useful markers for placental infection, and valuable prognosticators 
to determine whether a pregnancy will be carried to term in humans (El-Bastawissi et al. 
2000, Gervasi et al. 2012, Cobo et al. 2012, La-Sala et al. 2012, Cobo et al. 2013). 
However, there have been few studies evaluating pro and anti-inflammatory cytokines in 
mares with experimentally induced ascending placentitis (LeBlanc et al. 2002, 2012).  It is 
unlikely that measuring cytokines in plasma will be widely used tool in veterinary medicine 
due to the limited clinical availability of assays for equine cytokines. 
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1.4.Treatment of Placentitis 
 
Bacterial infection of the equine pregnant uterus in the middle of gestation can 
result in acute abortions with no lesions in the fetal membranes and minimal to no outward 
clinical signs (e.g. vulvar discharge, premature mammary gland development) (Hong et al. 
1993, Giles et al. 1993). Therefore, treatment is often not an option to prevent this type of 
abortion. On the other hand, bacterial infections of the uterus late in pregnancy tend to be 
associated with chronic placentitis (Hong et al. 1993); these mares will usually show the 
clinical signs as described above, thus if a diagnosis is made early enough, treatment can 
be applied and pregnancies can be potentially rescued (Troedsson & Zent 2004).  
Primarily, treatment for placentitis should be aimed to prolong maintenance of a 
viable fetus in utero to allow time for fetal development and maturation. To achieve this 
goal, therapy should: 1) control bacterial infection of placenta and fetus, 2) maintain the 
myometrial quiescence and 3) block the production of pro-inflammatory cytokines 
(LeBlanc 2010, Troedsson & Macpherson 2011).  To date, there are few evidence-based 
therapies for mares with placentitis. The limited evidence-based treatment strategies come 
from mares with experimentally induced placentitis. Unfortunately, as noted above, 
experimentally induced placentitis does not necessarily mirror spontaneous infections; 
thus, data generated from experimentally induced placentitis should be interpreted with 
caution.  
Treatment for placentitis is commonly based on a combination of antibiotics, anti-
inflammatories, and progestins (LeBlanc 2010, Bailey et al. 2010 Troedsson & 
Macpherson 2011) (Table 1.2).  The rationale to use anti-inflammatories is based on the 
finding that mares with experimentally induced placentitis have increased uterine 
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contractility (McGlothlin et al. 2004) as a consequence of the prostaglandin production 
(LeBlanc et al. 2002) and increased expression of pro-inflammatory cytokines (LeBlanc et 
al. 2012). Similarly, progestin therapy for mares with placentitis is used to block 
myometrial contractions (Bailey et al. 2010). The evidence-based for the use of anti-
inflammatories and progestins is based on studies with cloprostenol-induced abortion 
during early pregnancy. In these studies, all mares receiving cloprostenol but also treated 
with altrenogest (a progestin) maintained the pregnancy (8/8); however, mares given 
cloprostenol and also treated with progesterone resulted in 5 of 8 pregnancies maintained, 
as expected all mares receiving cloprostenol (n=5) but no other treatment aborted (Daels 
et al. 1996). From this study, it has been assumed that mares with placentitis during late 
pregnancy will behave in a similar manner although this has not been critically evaluated. 
Antibiotics are included as part of the therapy for the bacterial infection of the fetal 
membranes and to treat and/or prevent bacteria reaching the fetus (LeBlanc 2010, 
Troedsson & Macpherson, 2011). To date, few antimicrobials have been shown to cross 
the placental barrier and to achieve effective minimal inhibitory concentrations (MICs) in 
the fetal fluids and fetus against common bacteria causing placentitis (LeBlanc 2010, 
Troedsson & Macpherson, 2011).   
Antimicrobials that have been shown to cross the placenta include sulfa-
trimethoprim, penicillin and gentamicin (Murchie et al. 2006, Rebello et al. 2006). 
Ceftiofur crystalline free acid, a drug that has effective in vitro antimicrobial activity 
against many bacteria causing placentitis was recently tested (Macpherson et al. 2013).  
Unfortunately, administration of ceftiofur crystalline free acid to pony mares did not result 
in concentrations of desfuroylceftiofur acetamide (i.e. the active metabolite) needed to 
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effectively treat bacterial placentitis, and it did not improve survival of foals born from 
mares with experimentally induced ascending placentitis (Macpherson et al. 2013). These 
findings discourage the use of this antibiotic to treat placentitis in mares.  
Controversy exists regarding the duration of antimicrobial therapy once a diagnosis 
of placentitis is made. Anecdotally, short antimicrobial treatment (i.e. 10-15 days) has been 
advocated to be an effective and a thoughtful approach to treat placentitis as well as an 
approach to avoid bacterial resistance associated with prolonged antimicrobial therapy 
(LeBlanc 2010). However, evidence-based findings in mares with experimentally induced 
placentitis do not support the claim for effectiveness of short-term antimicrobial therapy. 
In fact, mares with experimentally induced ascending placentitis did not carry foals to term 
when treatment was discontinued after 2 weeks; however, an apparent increase in survival 
rates was observed when mares were kept on antimicrobials for a prolonged period of time 
(Rebello et al. 2006, Bailey et al. 2010).  Another interesting finding about antimicrobial 
therapy from the same group demonstrated that mares kept on a prolonged treatment with 
antibiotics, present positive endometrial bacterial culture within 6 hours post abortion or 
delivery of a viable foal (Diaw et al. 2010).  These findings suggest that antimicrobials 
administered to mares with experimentally induced placentitis may suppress bacterial 
growth, but do not achieve complete bacterial elimination.   
Empirically, estrogen supplementation has been advocated to treat mares with 
placentitis (Douglas 2004). As aforementioned, this author reported that mares with 
placentitis that subsequently aborted had remarkably lower “total estrogen” concentrations 
than mares of the same gestational age that maintained pregnancy. As estrogens are 
produced in high concentrations during the second and third trimesters of pregnancy, it is 
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unlikely that estrogen supplementation will be able to restore normal estrogen 
concentrations.  For example, it required continuous intravenous infusion of 126-231 mg 
of estrone sulfate per hour to achieve peripheral pregnancy levels of estrone sulfate 
(Raeside & Rosskopf 1980). Therefore, to date, estrogen therapy has not been critically 
assessed by controlled studies or prospectively assigned field studies.  
Other drugs that have been added to the treatment of equine placentitis include 
acetylsalicylic acid, pentoxifylline, and dexamethasone (LeBlanc 2010) (Table 1.2). 
Acetylsalicylic acid has been given to mares with placentitis under the impression that this 
drug would improve the blood flow to the mare’s uterus; however, there is no evidence-
basis in the literature to support this practice. In human medicine, low dose of 
acetylsalicylic acid has been shown to reduce the risks of preeclampsia in women 
(Henderson et al. 2014). Similarly, pentoxifylline has been included as part of the treatment 
for mares with placentitis with the idea that this drug possesses antinflammatory and 
rheolytic properties (Macpherson 2006, Bailey et al. 2010) which might improve the 
oxygenation of the pregnant uterus. Pentoxifylline was found to be present in the fetal 
fluids of pregnant mares treated with the standard dose (Rebello et al. 2006) and has been 
added to the treatment of mares with experimentally induced placentitis (Bailey et al. 
2010). However, it is unclear whether this drug has any beneficial effect on the treatment 
of placentitis. In addition, uterine artery blood flow remained unchanged when 
pentoxifylline was given to early pregnant mares during a short treatment period (Bailey 
et al. 2012). Dexamethasone has been suggested to be useful for the treatment of placentitis 
(LeBlanc 2010); however, it is uncertain whether administering this drug improves 
pregnancy outcome in mares with placentitis.  At best, very limited to no evidence-basis 
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exists to support the practice to include these drugs (i.e. acetylsalicylic acid, pentoxifylline, 
and dexamethasone) in the treatment of placentitis.  
Since the pathogenesis of nocardioform placentitis is unknown, and there are no 
established experimental models to the study this type of placentitis, treatment for 
nocardioform placentitis has been empirically applied and based on treatments used for 
other types of equine placentitis. To date there are no evidence-based reports supporting 
the treatment of nocardioform placentitis in mares. A recent retrospective study 
demonstrated in vitro antimicrobial sensitivity for Amycolatopsis ssp and C. equi (Erol et 
al. 2012b) (Table 1.3). However, it is unclear whether these antimicrobials are effective in 
vivo. It is also unclear whether addition of antinflammatories is effective or necessary for 
the treatment of nocardioform placentitis.  
Tocolytic agents such as clenbuterol and isoxsuprine have also been used in 
practice as part of the treatment of mares with placentitis (LeBlanc 2010); however, there 
is no evidence-basis to support such practice. In fact, in a study carried out with normal 
pre-foaling mares clenbuterol was not effective in delaying parturition, and treated mares 
foaled earlier than control mares (Palmer et al. 2002). The lack of efficacy of clenbuterol 
to delay parturition should discourage the practice to give this drug to mares with 
placentitis.  
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Table 1.2: Therapeutic agents commonly used to treat placentitis in mares 
Therapeutic agent Dose Proposed effect in mares with 
placentitis 
Potassium Penicillin 
G 
22,000 IU/kg, IV, 
QID 
Antimicrobial,  
Gentamicin  6.6 mg/kg, IV, SID Antimicrobial 
Trimethoprim 
sulpamethoxazole  
15-30mg/kg, PO, BID Antimicrobial 
Altrenogest 0.088 mg/kg, PO, SID Tocolytic, suggested to prevent 
prostaglandin mediated abortion 
Pentoxifylline  8.5 mg/kg, PO, BID Anti-pro-inflammatory cytokines, 
rheolytic 
Flunixin meglumine 1.1 mg/kg, PO/IV, 
SID, or BID 
Anti-inflammatory, not detected in the 
fetal fluids  
Acetylsalicylic acid  
 
50 mg/kg, PO, BID Suggested to improve blood flow to the 
uterus by inducing thrombocytopenia, 
this has not been critically tested 
Dexamethasone 40, 35, 25 mg, SID 
24h, IV for 6 days, 
decreasing dose every 
2 days 
 
This treatment has not been critically 
tested in mares with placentitis. Clinical 
experiences and published studies 
suggested to be useful approach for 
other complications during pregnancy 
(e.g. body wall ruptures) 
Adapted from: Rebello et al. (2006), Murchie et al. (2006), LeBlanc (2010), Troedsson & 
MacPherson (2011). 
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Table 1.3: In vitro anti-microbial sensitivity for Amycolatopsis ssp (n=38) and Crossiella 
equi (n=22) isolated from placentas in mares aborting in central Kentucky.  The minimum 
inhibitory concentrations required to inhibit the growth of 50% and 90% of organisms 
(MIC50/MIC90) (Adapted from Erol et al. 2012b). 
 
Lately a new practice of antimicrobial therapy has been introduced, without a 
clinical diagnosis of placentitis; mares are administered antimicrobials for 10 days of the 
month throughout pregnancy (LeBlanc 2010). The idea of such practice would be that 
antimicrobial treatment would treat-subclinical/undiagnosed placental infection. This 
practice not only should be discouraged to the lack of proven efficacy, but also because it 
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favors bacterial resistant. Thus there is an enormous risk to create super resistant bacteria 
which may become a major threat not only to the horses but to public health.  
 
1.5 Experimental Models of Bacterial Placental Disease in Large Animals  
 
Experimental models for abortigenic diseases in domestic animals vary according 
to the animal species, infectious agent, natural route of infection, as well as the ability of 
the organism to survive in the environment. Different routes of infection have been used to 
induce disease experimentally; some models involve a vector that is important in the 
natural infection (e.g. Foot Hill Abortion in cattle), in other models, macerated tissues 
obtained from aborted materials are directly administered to susceptible animals. In the 
present review, only ruminant, porcine, and equine models will be briefly reviewed.  
Induction of abortigenic diseases with different bacterial species (e.g. Brucella ovis, 
Brucella abortus, Brucella melitensis, Brucella suis, Chlamydophila abortus) in several 
species of ruminants (i.e. goats, sheep, bison and cattle) and pigs have been achieved by 
intravenous or subconjuntival inoculation (Meador & Deyoe 1986, Anderson et al. 1986, 
Palmer et al. 1996, El Idrissi et al. 2001, Jungersen et al. 2006, Marques et al. 2010, Olsen 
& Johnson 2011, McCollum et al. 2013). Other routes, such as to the nasal and rectal mucus 
membranes through the inoculation of infected semen with Brucella ovis have also been 
described in sheep (Ridler et al. 2014). Oral administration of Chlamydophila abortus 
(Tsakos et al. 2001) have been recently described in sheep. These routes probably mimic 
the natural infection, while others such as intravenous and subconjunctival by pass the 
means of natural infection. Once inoculated through either route noted above, bacteria gain 
access to the pregnant uterus and then cause severe necrotizing placentitis (Meador & 
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Deyoe 1986, Anderson et al. 1986, Palmer et al. 1996, El Idrissi et al. 2001, Tsakos et al. 
2001, Jungersen et al. 2006, Marques et al. 2010, Olsen & Johnson 2011, McCollum et al. 
2013, Poester et al. 2013).  
It is likely that Brucella species migrate through the systemic circulation in immune 
cells (i.e. monocytes). Similar mechanisms are thought to occur for other bacterial species. 
Classically, Brucella ssp present tropism for trophoblastic cells, testes and mammary gland 
(Poester et al. 2013). Even though experimental inoculation of Brucella ssp through 
intravenous and subconjunctival routes induces abortion, oral transmission appears to be 
the most important route, except for Brucella ovis and Brucella suis where venereal 
transmission appears to be most relevant.  Most species of Brucella can infect any mammal, 
including horses. In horses, “fistulous withers” is the most common clinical presentation 
in animals exposed to Brucella abortus; however, sporadic abortions have also been 
described (Denny 1973, Robertson et al. 1973, Hinton et al. 1977). Brucellosis in horses 
occurs where horses are kept with a herd of cattle where Brucella abortus is endemic. 
Epizootic bovine abortion (i.e. Foothill abortion) can be induced by administration 
of macerated products of the aborted fetus (e.g. thymus) subcutaneously or through tick 
vector (i.e. Ornithodoros coriaceus) (Stott et al. 2002, Coker et al. 2012). From the 
subcutaneous tissue, the microorganism (an unidentified Deltaproteobacterium member of 
the order Myxococcales) (King et al. 2005), reaches the maternal circulation and the 
pregnant uterus and fetus. Placental lesions are not commonly present, but severe chronic 
inflammatory lesions are present in the fetus thymic atrophy, hepatomegaly, ascites, and 
generalized lymphomegaly (Hall et al. 2002). 
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Models to study Leptospirosis in cattle include inoculation through subconjunctival 
route, inoculation of bacteria into the central area of a placentome (through laparotomy), 
and intravenous inoculation (Aycardi et al. 1982, Ellis et al. 1986, Smith et al. 1994).  The 
bacteria enter the systemic circulation and pregnant uterus and then cause placentitis, fetal 
lesions, abortion, stillbirths and weak neonates (Aycardi et al. 1982, Ellis et al. 1986, Smith 
et al. 1994, Donahue & Williams 2000).  Different serovars of Leptospira affect cattle and 
horses, the subtype Pomona concentrates most of the serovars that affect both species 
(Schlafer & Palmer 2007).  
Experimental induction and challenges with Campylobacter fetus subspecies fetus 
in sheep involves oral administration of the bacteria, which is the natural route of infection 
(Grogono-Thomas & Woodland 1996). Interestingly, a different subspecies of this genera, 
causes a different disease (i.e. early embryonic death and abortion is less commonly 
observed) in cattle, thus experimental infection of Campylobacter fetus subspecies 
venereallis infection in cows  is achieved through intracervical inoculation of the bacteria 
in non-pregnant cows or intra-preputial inoculation in bulls (Ardila et al. 2012). 
To date there is only one effective model to induce experimentally bacterial 
placentitis in mares. The model was initially described by Dr. Michelle LeBlanc’s group 
at the University of Florida (Mays et al. 2002, LeBlanc et al. 2002). The model involves 
the inoculation of a pathogenic strain of Streptococcus equi subspecies zooepidemicus (107 
to 109 cfu), into the cervix of mares during the 3rd trimester of pregnancy. Since the original 
description of the model, it has been used by other researchers with very predictable 
outcomes (Christensen et al. 2009, Bailey et al. 2010, Macpherson et al. 2013, Finger et 
al. 2014). One of the limitations of this research model is that a large inoculum is 
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administered to mares intracervically, with a resulting acute ascending placentitis and rapid 
abortion. This clinical presentation appears much more rapid that seen in spontaneous 
placentitis which tends to be insidious and chronic. Therefore, studies to address diagnostic 
makers and treatments strategies should be interpreted with caution regarding the clinical 
presentation of spontaneous and experimental placentitis.   
 
1.6. Conclusions 
 
Placental disease is an important cause of pregnancy wastage in broodmares.  
Bacterial infections are responsible for a large portion of abortion cases.  There are four 
different morphologic types of placentitis: ascending, focal mucoid (nocardioform), diffuse 
(hematogenous), and multifocal, whereas, ascending is the most frequent type of 
placentitis, whereby beta-hemolytic streptococci predominate.  The diagnosis of equine 
placentitis is based on clinical signs (i.e. vulvar discharge, premature udder developing and 
lactation) and ultrasonography.  While transrectal ultrasonography has been shown to be a 
valuable clinical tool to diagnose and manage cases of placentitis; the technique is prone 
to false positive diagnosis and early cases of the disease can be missed. Treatment of 
placentitis should be aimed on prolonging the permanence of the foal in uterus, to achieve 
this goal; control of placental and fetal infection, maintaining of the uterus quiescent and 
by blocking the production of pro-inflammatory cytokines. Few antibiotics (i.e. Penicillin, 
gentamycin, and sulfa-trimethoprim) have been shown to cross the placenta and achieve 
satisfactory inhibitory concentrations. 
 
Copyright © Igor Frederico Canisso 2014 
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2.1. Summary: 
 
Reasons for performing study: Nocardioform placentitis in horses is poorly understood, 
and the development of an experimental horse model would be of help in understanding 
the pathogenesis of the disease.  
Objectives: To investigate whether (1) intrauterine inoculation of C. equi during the 
periovulatory period or (2) i.v., oral or intranasopharyngeal inoculation of C. equi during 
mid-gestation would result in nocardioform placentitis, and (3) before and after mating 
endometrial swabs present evidence of nocardioform-associated organisms (C. equi or 
Amycolatopsis ssp).   
Methods: Study I, mares (n=20) received an intrauterine inoculation of C. equi 24h after 
artificial insemination. Endometrial swabs were obtained 24h post-inoculation for PCR 
analysis for C. equi. In Study II, pregnant mares (at 180 and 240 days of gestation) were 
inoculated with C. equi by intranasopharyngeal (n=5), oral (n=4) or i.v. (n=4) routes. Sixty 
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contemporaneous pregnant mares maintained on the same farm served as controls animals. 
In Study III, privately-owned Thoroughbred mares (n=200) had endometrial swabs 
collected before and within 24-48h post-mating for detection of nocardioform 
microorganisms.   
Results: In Study I, C.equi was identified by PCR in 3/20 mares following intrauterine 
inoculation. Pregnancy was established in 19 of 20 treated mares. There were 2 embryonic 
losses and one abortion at 177d of gestation (undetermined cause). Sixteen mares delivered 
a normal foal and placenta. In Study II, one mare (oral inoculation) aborted at 200 days of 
gestation (unidentified cause). The remaining mares delivered a normal foal and placenta.  
In Study III, none of the mares yielded positive endometrial PCR for nocardioform 
microorganisms.   
Conclusions: We were unable to induce nocardioform placentitis, and there was no 
evidence of nocardioform microorganisms in endometrial swabs of broodmares before or 
after mating. These findings suggest that nocardioform placentitis is not induced simply 
via the presence of nocardioform actinomycetes, and that route, insufficient duration of 
exposure and dose may play a role in the development of disease. Additional 
predispositions may be involved in the development of nocardioform placentitis. 
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2.2. Introduction 
Placentitis is an important cause of pregnancy wastage in mares. In the USA, 
placental pathology accounts for the majority of late-term pregnancy losses and neonatal 
deaths in the first 24h of life (Giles et al. 1993, Hong et al. 1993, Williams et al. 2004). 
Four different types of equine placentitis have been described according to the 
morphological lesions and suggested pathogenesis, namely ascending, focal mucoid 
(nocardioform), diffuse (hematogenous), and multifocal (Williams et al. 2004). Overall, 
ascending placentitis is the most prevalent type of placentitis (Giles et al. 1993, Hong et 
al. 1993).  
Nocardioform placentitis was first diagnosed in 1985 in central Kentucky by the 
University of Kentucky Veterinary Diagnostic Laboratory (UKVDL) (Giles et al. 1988). 
Since its initial description, the number of mares suffering from this disease has fluctuated 
across years in the region (Giles et al. 1993, Hong et al. 1993, Giles et al. 1988, Williams 
et al. 2004, Donahue & Williams 2000, Carter et al. 2012, Erol et al. 2012a), and 
nocardioform placentitis has also been diagnosed in other areas of the United States 
(Christensen et al. 2006). Additionally, isolated cases of nocardioform placentitis have 
been reported in other parts of the world, including South Africa (Volkmann et al. 2001) 
and Italy (Cartoli et al. 2004). During the 2002 and 2003 foaling seasons, a total of 128 
cases of nocardioform placentitis were diagnosed by the UKVDL (Williams et al. 2004).  
Most recently, during the 2011 foaling season, the UKVDL registered 390 confirmed cases 
of nocardioform placentitis (N.M. Williams, unpublished data).  
Microorganisms associated with nocardioform placentitis include Amycolatopsis 
species (Amycolatopsis kentuckyensis, Amycolatopsis lexingtonensis and Amycolatopsis 
pretoriensis) and Crossiella equi (C. equi) (Donahue et al. 2002, Labeda et al. 2003, 
42 
 
Christensen et al. 2006, Labeda et al. 2009, Erol et al. 2012ab). In 2009, two new species 
of Streptomyces (Streptomyces atriruber and Streptomyces silaceus) were isolated from 
nocardioform placentitis cases (Labeda et al. 2009). Historically, these bacterial agents 
have been denominated as nocardioform actinomycetes or more recently as gram-positive 
branching bacilli based on PCR and 16S ribosomal RNA analyses (Erol et al. 2012a). In 
the 2010-2011 foaling season in central Kentucky, C. equi and Amycolatopsis ssp were 
responsible for 85% of the cases submitted to the UKVDL. In the remaining cases lesions 
were present but the bacterial species were not identified (Erol et al. 2012a). Based upon 
observations of cases submitted to the UKVDL, it appears that mares affected with C. equi 
are more prone to abortion, whereas mares infected with other actinomycetes tend to 
deliver live premature foals (unpublished observations, UKVDL). In addition, it is worth 
noting that to date the causative organisms have only been cultured from clinical placentitis 
cases and not from the environment. 
A specific distinction between bacteria causing nocardioform placentitis (i.e. C. 
equi and Amycolatopsis ssp) and other actinomycetes that affect horses is related to the 
propensity to infect not only the fetal membranes but also the offspring in utero.  For 
example, mares affected by Cellulosimicrobium cellulans in Kentucky presented mucoid 
placentitis associated with fetal lesions (Bolin et al. 2004). Similarly, a group of 
actinomycetes (e.g. Cellulosimicrobium sp, Cellulomonas sp) and other nonspecific 
bacterial species have been associated with mucoid placentitis and fetal lesions in a 
condition known as equine amnionitis and fetal loss (EAFL) that is associated with 
ingestion of processionary caterpillars in Australia (Todhunter et al. 2013).  On the other 
hand, the actinomycetes causing nocardioform placentitis do not infect the fetus in utero as 
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is commonly seen in other types of placentitis. In other words, the bacterial infection in 
NPL is limited to the chorionic surface of the placenta (Hong et al. 1993, Williams et al. 
2004, Donahue & Williams 2000). 
The definitive diagnosis of nocardioform placentitis is based on the presence of 
macroscopic and microscopic lesions, bacterial culture and identification of bacterial DNA 
by polymerase chain reaction (PCR) of samples from the chorioallantois (Hong et al. 1993, 
Donahue & Williams 2000, Erol et al. 2012ab). A presumptive clinical diagnosis can be 
attained through clinical examination and ventral transabdominal ultrasonography 
(Christensen et al. 2006, Wolfsdorf et al. 2000). Mares suffering from nocardioform 
placentitis present areas of placental separation with accumulation of hyperechoic exudate 
in the ventral uterine body and/or base of the horns (Christensen et al. 2006, Wolfsdorf et 
al. 2000, Troedsson & Macpherson 2011).  Because the cervical star region is not involved, 
no vulvar discharge or cervical softening is observed unless the mare is very close to 
abortion or parturition. Premature mammary gland development, which is the first common 
sign observed in mares with ascending placentitis, is not always observed in mares during 
initial stages of nocardioform placentitis. The absence of outward clinical signs (i.e. vulvar 
discharge and premature mammary development) makes the presumptive diagnosis of 
nocardioform placentitis challenging for the clinician.  
The pathogenesis of nocardioform placentitis is unknown, and a reliable model to 
reproduce the disease would therefore be useful.  The objective of these studies was to 
develop an experimental model for induction of clinical nocardioform placentitis in mares. 
Specifically, we investigated (1) whether intrauterine inoculation of C. equi during the 
periovulatory period or (2) intravenous, oral or intranasopharyngeal inoculation of C. equi 
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between 180 and 240d of gestation would result in nocardioform placentitis, and (3) 
whether endometrial swabs obtained from Thoroughbred mares before and after mating 
would provide evidence for the presence of C. equi or Amycolatopsis ssp.  
2.3. Material and methods 
All the experimental animal work in this research project was carried out at the 
University of Kentucky, Lexington, KY, USA, from September of 2011 to November of 
2012 (Studies I&II) with approval from the Institutional Animal Care and Use Committee 
(Protocol # 2011-0840). The endometrial swabs (Study III) were collected during the 2012 
breeding season at commercial Thoroughbred farms in central Kentucky. In Studies I&II, 
all the animals were kept in paddocks and supplemented with hay, grain, water, and trace 
minerals ad libitum. In Study II, during more intensive handling procedures and 
immediately pre-foaling, the mares were kept in individual stalls during the night and 
turned out on pasture during the day. The C. equi strain used in this study was a reference 
strain, originally isolated from an equine abortion case submitted to the UKVDL 
(Reference number: LDDC 22291-98T, NRRLB-24105).  This isolate was stored at -80oC 
and had a very low passage number (passage 3).  
 
Study I: Intrauterine inoculation of C. equi in estrous mares 24h after artificial insemination 
Twenty mares of different light horse breeds and with a mean age of 10.5 years 
(range: 5-20 years) were used in this study. Detailed breeding management is described in 
the appendices. Estrous mares were bred with ≥ 500 million progressively motile sperm in 
fresh semen pooled from three fertile stallions and diluted using a commercial extender 
(without antibiotics).   
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At 24h post breeding, each mare received an intrauterine inoculation of C. equi 
(1x104 colony-forming-unit in 1mL of skimmed milk). Bacteria were kept at 37oC in 
enriched TGY (tryptone-glucose-yeast) broth medium, and then plated onto minimal agar 
(Czapek’s agar) plates for 2-3 days.  Bacterial cultures were prepared and preserved in 2 
mL cryovials at -80oC until inoculation. Serial dilution and plating were used to determine 
cfu. Immediately before inoculation, the samples were thawed at room temperature. After 
inoculation, bacterial culture was performed from each cryovial to confirm viability of the 
inoculum. At 24h post-inoculation, each mare had an endometrial swab collected for PCR 
testing for C. equi (Sells 1996, Tan et al. 2006, Erol et al. 2012a). 
Pregnancy diagnosis was performed by transrectal ultrasound at 15, 25, 35, 60, 90 
and 120 days post-ovulation. From 150 days to term, the mares were examined monthly by 
transabdominal ultrasonography (transducer 2–6 MHz) to confirm normal pregnancy and 
to evaluate the fetal membranes (Troedsson & Macpherson 2011).  
All the placentas from inoculated mares in Study I were submitted to the UKVDL 
for pathological evaluation, culture (i.e. for C.equi and Amycolatopsis ssp) and PCR for 
both organisms.  A swab from each chorioallantois was collected and cultured according 
to Erol et al. (2012ab). PCRs for C.equi and Amycolatopsis ssp were performed according 
to established protocols (Sells 1996, Tan et al. 2006, Erol et al. 2012a) at the UKVDL, an 
accredited veterinary diagnostic laboratory by American Association of Veterinary 
Laboratory Diagnosticians. As part of the quality control and assurance cycle, a negative 
amplification control, a negative extraction control and a positive extraction control (C. 
equi or Amycolatopsis reference strains) were performed in each PCR run. 
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Sixty contemporaneous pregnant mares of various light breeds and ages (mean 
10.5yrs; range 4-20yrs) kept at the same farm were used as controls. All placentas were 
examined by two veterinarians and, if signs of placentitis were observed, the placenta was 
submitted to the UKVDL for full pathological examination (Hong et al. 1993, Williams et 
al. 2004, Donahue & Williams 2000). Unlike mares in the inoculated groups, control mares 
were not regularly monitored by ultrasonography. Therefore, the experimental end point 
for the control mares was the presence of nocardioform placentitis lesions after foaling. 
None of the mares received antibiotics during pregnancy or any type of treatment for 
placentitis or other clinical problems. Additionally, 10 placentas from control mares were 
submitted for full pathological examination. 
 
Study II: Intravenous, Intranasopharyngeal and Oral Inoculation of C. equi to Pregnant 
Mares 
Thirteen mares of various light breeds and ages (mean 13.2 years; range 8-19 years) 
were used in this experiment. Mares were bred with fresh extended semen and ovulation 
was confirmed by ultrasound performed every other day. Before the beginning of the 
experiment, each mare was examined by transabdominal ultrasonography to confirm 
normal pregnancy. Mares were randomly allocated into three treatment groups, and 
inoculated with C. equi as follows: nasopharyngeal (n=5), oral (n=4), and intravenous 
(n=4). The inoculations were performed from 180 to 240d of pregnancy; mares in the 
intravenous route group received the inoculum once at 180d of gestation, whereas mares 
in the oral and nasopharyngeal route groups received the bacteria four times at two week 
intervals (i.e. 180 to 240d of gestation). In this experiment, each inoculum contained 1x109 
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cfu of C. equi. Detailed explanation of the bacterial culture is described elsewhere (Erol et 
al. 2012ab) and in the supplemental information.  
For all the different routes of inoculation, mares were restrained in stocks and when 
necessary sedated with xylazine hydrochloride (0.2-0.4 mg/kg intravenously) immediately 
pre-inoculation. Inoculating doses were prepared at a final concentration of 1x109 cfu/mL 
of C. equi, and were transported refrigerated to the farm (<5 min). Immediately before 
inoculation, the inoculum was thoroughly mixed and diluted 1:4 with sterile Dulbecco’s 
phosphate buffer solution. For respiratory route administration, the inoculum was loaded 
into a 20 mL sterile syringe and administered deep into the nasopharayngeal cavity using 
an AI pipette. For oral administrations, the mare’s oral cavity was thoroughly flushed with 
water to remove any residual feedstuff. Thereafter the inoculum (i.e. 5 mL solution) was 
deposited deep into the mare’s mouth. After inoculation through the nasopharyngeal and 
oral routes the mare’s head was held up for 5 min. 
Intravenous inoculation was performed through a jugular catheter (14G; 3 inches 
long). The inoculum was administered slowly (>2 min), and the catheter was then flushed 
thoroughly with sterile Dulbecco’s phosphate buffer solution (100 mL) to avoid bacterial 
retention on the catheter or in the subcutaneous tissues.  
Immediately before inoculation and thereafter for the first 72h, all mares were 
examined clinically at 12h intervals for evidence of sepsis. At 24h post inoculation, CBC, 
fibrinogen and serum amyloid A analyses were determined for the mares receiving the 
bacteria via the i.v. route. Concentrations of serum amyloid A were determined (at 12, 24, 
48 and 72h after inoculation for mares receiving the bacteria intravenously) by 
immunoturbimetric assay (Jacobsen et al. 2006) at the University of Miami.  
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All mares were thoroughly examined every 2 weeks by transabdominal 
ultrasonography with a curvilinear transducer 2–6 MHz, from 24h before inoculation until 
parturition. The control mares described in Study I also served as controls for Study II. All 
placentas from inoculated mares were submitted for full pathological examination as 
described for Study I.  
 
Study III: Endometrial PCR for C. equi and Amycolatopsis ssp in Mares 
 
A total of 200 commercial Thoroughbred mares had an endometrial swab collected 
immediately before and within 24-48h after natural mating. Mares had the perineal area 
thoroughly prepared in a standard manner. Swabs were submitted to the UKVDL for PCR 
analysis for C. equi and Amycolatopsis ssp as described above.  
 
2.4. Results 
Study I 
The overall pregnancy rate was 95% (19 of 20 mares). One mare was bred during only 
one cycle and did not become pregnant. This mare went into seasonal reproductive 
transition after the first estrous cycle and was not rebred. Fifteen mares became pregnant 
on the first cycle. Three mares became pregnant on the second estrous cycle; one mare 
became pregnant after 3 cycles.  There were 2 embryonic losses (between 25-35d and 35-
60d); it is worth noting that both mares had unremarkable ultrasonographic examinations 
and negative PCR for C.equi and bacterial culture upon diagnosis of pregnancy loss. One 
mare aborted at 177d of gestation. Unfortunately, the placenta and part of the fetus were 
taken by wild scavengers. Therefore, the cause of abortion could not be determined. Nine 
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days pre-abortion, transabdominal ultrasonography was unremarkable and the fetus was 
alive. Fetal material and a nasal swab from the dam were PCR negative for EHV-1. Paired 
serology taken at three week intervals presented low titers for Lepstopira species (data not 
shown).  
Out of 25 inoculations, only three mares had a positive endometrial PCR result for 
C. equi at 24h post inoculation. Two of the mares with positive PCR delivered a normal 
foal and placenta, and the remaining mare aborted (as noted above). All ultrasonographic 
examinations were unremarkable during the entire experiment (data not shown). None of 
the mares presented clinical or pathological (i.e. macroscopic or histopathological lesions) 
or microbiological (culture and PCR) evidence of nocardioform placentitis. 
All mares in the control group delivered normal foals and fetal membranes, 
although one of these mares had a small (~12cm2) lesion on the chorion that was grossly 
consistent with nocardioform placentitis. Macroscopically there was loss of villi and 
increased pallor centrally with raised tan thickenings peripherally. Histopathology 
confirmed signs consistent with placentitis including necrotic villi with accumulation of 
eosinophilic debris on the chorionic surface that contained long filamentous bacteria. The 
villi were infiltrated by moderate numbers of macrophages, neutrophils and lymphocytes 
and the stroma contained large infiltrates of lymphocytes. The remainder of the placenta 
was unremarkable. Macroscopic and microscopic findings were consistent with 
nocardioform placentitis (Donahue & Williams 2000, Williams et al. 2004). However, 
PCR was negative for C. equi and Amycolatopsis ssp, aerobic culture yielded saprophytic 
bacteria but no nocardioform organisms were isolated. 
Study II 
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All mares remained healthy after inoculation and physical exam parameters 
remained within normal ranges (data not shown). Blood PCR at 12 and 24h post IV 
inoculation were negative for C. equi and Amycolatopsis ssp. Concentrations of SAA 
remained baseline (i.e. <20mg/L) from immediately before to 72h after intravenous 
inoculation (i.e. 12, 24, 48 and 72h, data not shown). Fibrinogen and CBC analyses for the 
group receiving the bacteria intravenously were within normal ranges by 24h after 
inoculation.  
Twelve mares delivered a normal foal and placenta with no clinical, 
microbiological or pathological evidence of nocardioform placentitis.  One mare aborted 
at 200d of gestation after two inoculations through the oral route. The cause of abortion 
was not established but there was no pathological evidence of nocardioform placentitis.  
Study III 
All the PCR analyses on samples collected shortly before and post-mating were 
negative for C. equi and Amycolatopsis ssp. 
 
2.5. Discussion 
This is the first report to attempt experimental induction of nocardioform 
placentitis. None of the experimental approaches in the present study resulted in clinical, 
pathological or microbiological evidence of nocardioform placentitis. Additionally, none 
of the uterine swabs recovered from 200 commercial broodmares before or post-mating 
yielded a positive PCR for actinomycetes nocardioform species.  
As there are no established experimental models for nocardioform placentitis, there 
are no data regarding infective dose, culture conditions or route of inoculation for these 
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organisms required to induce the disease in horses; therefore the infective dose in this study 
was determined empirically and general route of inoculations (i.v., intranasopharyngeal 
and oral routes) were tried in order to address whether the transmission occurs 
hematogenously.  Possible explanations for the inability to induce nocardioform placentitis 
in the current experimental model include: inadequate infective dose, low pathogenicity of 
the bacteria, improper route of exposure, insufficient duration of exposure, and absence of 
host immunosuppression of unknown origin that may make some pregnant mares prone to 
developing nocardioform placentitis. In Studies I & II the inoculating doses were 
empirically chosen because there is no basis in the literature for determining the dose of C. 
equi required to establish infection.  
Although the source of actinomycetes responsible for nocardioform placentitis 
remains undetermined, there are some associations which suggest an environmental source 
for these pathogens. In a retrospective analysis of the weather conditions in central 
Kentucky, we found a strong negative correlation (r=-0.7) between rainfall in August and 
September and the number of nocardioform placentitis cases during the subsequent winter 
and spring (unpublished data). In central Kentucky, most Thoroughbred mares will be at 
6-8 months of gestation by August-September; therefore in Study II, pregnant mares were 
inoculated at this stage of gestation in an attempt to mimic supposed natural exposure. 
Indeed, if the nocardioform actinomycetes are found in the environment (i.e. soil), the oral 
and nasopharyngeal routes would likely allow prolonged exposure to the environmental 
source of pathogen, thus, these two routes were evaluated here using multiple inoculations. 
However,  multiple attempts to isolate C. equi from the environment (stalls, soil, water, 
hay, grass)  were unsuccessful (Erol E, unpublished observation), either due to  low number 
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of microorganisms in the environment or the presence of these organisms in other areas of 
the environment.  In addition, UKVDL performs thousands of fecal culture from mares 
yearly; however, these organisms have not been isolated from fecal samples (Erol E, 
unpublished observation), suggesting that C. equi is not shed in feces.  
The lesions observed in spontaneously occurring nocardioform placentitis suggest 
that the bacteria either enter the uterus either hematogenously or during gynecological 
intrauterine interventions (e.g. uterine lavage, endometrial swabbing, etc) or at mating. 
Mares in Study I, received the bacteria 24h post-breeding as we considered that this would 
increase the persistence of the inoculum in the uterus, since mixing the inoculum with the 
semen would potentially result in rapid drainage of the fluid through the cervix after 
breeding. It is worth noting that previous attempts, carried out at our facilities in 1998-
2000, using intrauterine inoculation (n=5 mares C. equi; 106 cfu) post-ovulation failed to 
induce nocardioform placentitis. All mares became pregnant and four mares delivered live 
normal foals. A normally developed foal from the 5th mare was found suffocated in the 
placenta. No abnormalities were found in any of the placentas (unpublished data, 
K.J.McDowell). Additionally, every-other-day intrauterine inoculation (inoculum 106 cfu 
C. equi) of five non-bred mares (supplemented with progesterone 150mg/IM) for 10 days 
post ovulation failed to yield a C. equi positive endometrial culture (swabs collected 24h 
after each of the 5 inoculations) (K.J.McDowell, unpublished data).These results and our 
findings (Study I) support the concept that C. equi grows poorly in the uterine lumen of the 
non-pregnant mare. 
The bacteria appear not to be transmitted during mating, since the 200 mares 
sampled here had negative PCR for C. equi and Amycolatopsis ssp (Study III), and mares 
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receiving the bacteria by the intrauterine route after insemination (Study I) did not develop 
clinical or pathological evidence of nocardioform placentitis. These experiments do not 
completely exclude the possibility that nocardioform organisms are acquired during 
breeding, as the sample size was too small to detect a low rate of infection at mating. If, in 
fact, nocardioform transmission occurs during mating, using 200 mares with an alpha error 
of 0.05 and power of 0.8 and based on a one-tailed test, we would have been able to detect 
an incidence of 2.1% of positive PCR; however, with the estimated incidence of 0.1% 
nocardioform placentitis in Central Kentucky, >4000 mares would need to be sampled to 
be sure of detecting infection.  
Data presented here support the hypothesis that C. equi has low pathogenicity, 
because bacteria administered intravenously neither induced changes in peripheral 
leukocyte counts nor resulted in positive blood culture 24h post inoculation or positive 
PCR at 12, 24, 48 or 72h post inoculation, and intravenous inoculation did not cause 
elevations in the concentrations of SAA (i.e. 12, 24, 48 and 72h post inoculation), a 
sensitive marker of inflammation (Jacobsen et al. 2006). Absence of clinical signs after 
intravenous inoculation further corroborates the hypothesis of the lack of pathogenicity of 
this organism and that the bacteria appear to replicate poorly in the systemic circulation 
under normal conditions. 
In the present Studies (I & II), we hypothesized that different routes of transmission 
(i.e. intrauterine, oral and intranasopharyngeal) were important in the pathogenesis of 
nocardioform placentitis, but we were unable to reproduce the disease through any tested 
route of inoculation.  It is possible that the bacteria can be acquired by other routes of 
transmission not tested here (e.g. ocular, mucosal or dermal); however, this remains 
54 
 
speculative until the route of transmission is established. Another possible explanation for 
the lack of success in reproducing the disease includes insufficient time or duration of 
exposure to the actinomycetes. Some of the routes (intrauterine and intravenous) involved 
a single administration.  Perhaps, to become infected a mare needs prolonged exposure to 
the bacteria (e.g. continual environmental exposure). Anecdotally, it has been suggested 
that the mechanism leading to uterine nocardioform infections is likely to be related to a 
deficient immune response of the prospective host (perhaps mediated by progesterone); to 
date, this hypothesis has not been tested. In a preliminary study, two pregnant mares (240d 
of gestation) were intracervically inoculated with 1x109 cfu of C. equi, both mares 
developed ascending placentitis due to secondary beta hemolytic streptococci (Canisso et 
al. 2013).  These findings support the concept that C. equi grows poorly in the uterine 
lumen of normal pregnant mares. 
Interestingly, field and experimental cases of EAFL in Australia also present 
mucoid placentitis (Todhunter et al. 2013, Cawell-Smith et al. 2013) similar to 
nocardioform placentitis; however, EAFL is associated with additional placental and fetal 
lesions. To our knowledge, neither C.equi nor Amycolatopsis ssp have been associated with 
EAFL. Researchers believe that intestinal lesions caused by processionary (Todhunter et 
al. 2013, Cawell-Smith et al. 2013) and eastern tent (McDowell et al. 2010) caterpillars 
are involved in the pathogenesis of EAFL and mare reproductive loss syndrome (MRLS). 
However, field and experimental cases of MRLS are not associated with nocardioform 
placentitis (McDowell et al. 2010), instead during the 2001 MRLS outbreak in Kentucky 
(>3000 pregnancy losses) the UKVDL registered one of lowest incidences of nocardioform 
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placentitis cases in almost 30 years. Thus at this time there is no evidence linking MRLS 
and nocardioform placentitis in central Kentucky.  
In conclusion, intrauterine inoculation of C. equi after ovulation did not result in 
clinical or pathological evidence of nocardioform placentitis in mares.  Intravenous, oral 
or pharyngeal inoculation of C. equi between 180 and 240d of gestation also failed to 
induce clinical or pathological evidence of nocardioform placentitis in mares. None of the 
endometrial swabs recovered shortly before or after mating of 200 commercial 
Thoroughbred broodmares tested positive for C. equi or Amycolatopsis ssp by PCR. The 
route of transmission and pathogenesis of equine nocardioform placentitis therefore 
remains undetermined. Alternative routes of inoculation, using different bacterial isolates 
and species, doses and intervals should be tested.  
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 Chapter 3: 
Serum amyloid A and Haptoglobin Concentrations are Increased in Plasma of 
Mares with Ascending Placentitis in the Absence of Changes in Peripheral 
Leukocyte Counts or Fibrinogen Concentration 
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3.1. Summary  
Currently placentitis, an important cause of late pregnancy loss, is diagnosed by 
clinical signs and ultrasonography. Acute phase proteins (APP) are mainly produced and 
secreted by the liver in response to acute inflammatory stimuli, and we hypothesized that 
APP are elevated in mares with placentitis.  Concentrations of serum amyloid A (SAA), 
haptoglobin (Hp), fibrinogen (Fb) and white blood cell counts (WBC) were determined in 
plasma of mares with experimentally induced placentitis and gestationally aged-matched 
control mares. Placentitis was induced via intracervical inoculation of Streptococcus equi 
subspecies zooepidemicus, a common isolate from clinical cases of bacterial placentitis. 
Concentrations of SAA and Hp were also determined in 10 days pre-partum in normal 
57 
 
mares. Mares with placentitis aborted within 5-25 days after inoculation. Concentrations 
of SAA and Hp rapidly increase subsequent to experimental induction of placentitis and 
remain elevated until abortion. Neither Fb nor WBC appeared to be useful markers for 
placentitis. Parturition did not trigger an increase in either SAA or Hp in normal foaling 
mares.  
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3.2. Introduction 
Ascending placentitis is a common cause of late-term abortion and premature 
delivery in mares (Giles et al. 1993, Troedsson & Zent 2004, Williams et al. 2004, LeBlanc 
2010, Laugier et al. 2011); it can be caused by fungal or bacterial agents with bacteria 
being responsible for about 90% of clinical cases (Hong et al. 1993). Bacterial agents 
commonly associated with the occurrence of ascending placentitis include Streptococcus 
equi subspecies zooepidemicus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas 
aeruginosa, of which beta-hemolytic streptococci predominate (Hong et al. 1993, Williams 
et al. 2004, LeBlanc 2010).  Generally, only one or eventually two species of bacteria are 
isolated from most clinical cases (Hong et al. 1993). The incidence of placentitis in well-
managed Thoroughbred farms has been estimated as 3-5% (Troedsson & Zent 2004). The 
pathogenesis of ascending placentitis in mares is not well established; however, it is 
believed that bacterial agents enter the uterus via the cervix (LeBlanc 2010). Placental 
infection/inflammation leads to abortion or delivery of a pre-mature foal (LeBlanc et al. 
2012). Chronic placentitis may also lead to placental insufficiency, which may result in the 
delivery of a nonviable foal. Foals born alive from mares suffering placentitis are often 
septic and demand intensive care and are not necessarily viable athletes (Barr 2005). 
Mares with ascending placentitis present premature mammary development and 
purulent vulvar discharge, and if not treated, mares will delivery prematurely (i.e. abortion, 
stillbirth, or have septic foals) (LeBlanc 2010, Troedsson & Macpherson 2011). 
Manifestation of such clinical signs warrant immediate veterinary attention; thus the 
clinical diagnosis can be confirmed based upon clinical signs and transrectal 
ultrasonography of the placenta near the cervix (Troedsson & Macpherson 2011). While 
later stages of placentitis are easily diagnosed via ultrasonography, earlier stages and 
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subclinical cases of placentitis can be missed.  Therefore, improved and earlier diagnostic 
methods may improve treatment outcomes in some of these cases.  
Ascending placentitis is widely associated with focal extensive inflammatory and 
necrotic changes of the chorioallantois near the cervical star (Hong et al. 1993). Mares with 
experimentally induced ascending placentitis present increased concentration of PGE2 and 
PGF2α in the fetal fluids and increased transcripts for IL-6 and IL-8 in the chorioallantois 
(LeBlanc et al. 2002).  Unlike placentitis in women (i.e. chorioamnionitis), where the 
disease can be life-threating (Fahey 2008, Tita 2010), equine ascending placentitis is 
thought to be a local inflammatory disease of the pregnant uterus with little or no systemic 
inflammatory response. Mares with spontaneous or experimentally induced ascending 
placentitis do not present systemic clinical signs (e.g. sepsis, life threating complications). 
A growing body of literature has been dedicated to use acute phase inflammatory proteins 
(APP) to diagnose placental disease (i.e. chorioamnionitis, funisitis and early-onset of 
neonatal sepsis) in humans (Wu et al. 2009, Popowski et al. 2011, Lee et al. 2012).  A 
recent study conducted to address the usefulness of serum amyloid A (SAA) determination 
as prognostic marker for mares with placentitis indicated that mares with experimentally 
induced ascending placentitis present an increase in SAA concentrations when they did not 
receive a common treatment (i.e. antibiotics, anti-inflammatories and progestins) for 
ascending placentitis (Coutinho da Silva et al. 2013). In addition to changes associated 
with placentitis, Coutinho da Silva et al. (2013) suggested that parturition was associated 
with an increase in SAA concentration in normal periparturient mares.  Because sample 
frequency prior to parturition was limited, results from this report were equivocal 
concerning a pre-partum rise in SAA in the normal mare at parturition.   
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Haptoglobin (Hp), a moderate APP, is constantly present in plasma of healthy 
horses, and concentrations are increased upon inflammation (Jacobsen et al. 2007, Cray & 
Belgrave 2014). Recent studies, involving human neonates, suggested that Hp is a useful 
marker for neonatal sepsis (Buhimschi et al. 2011, Ferrazzi et al. 2012). In horses, Hp 
appeared to be a useful marker to evaluate acute-chronic conditions (i.e. >4-day duration) 
(Cray & Belgrave 2014). To date, there have been no studies assessing Hp in mares with 
placentitis. 
Fibrinogen (Fb) is the APP used most frequently in the horse to evaluate 
inflammation; however, to the best of our knowledge, there are no published reports in the 
literature evaluating this APP in equine placentitis. Total white blood cell counts (WBC) 
are widely used in human and veterinary medicine as a routine screening test for disease 
and as a method to monitor treatment response. In women, WBC in peripheral blood has 
been used as an indicator of chorioamnionitis (Sereepapong et al. 2001), although other 
reports do not support such an assertion (Cray & Belgrave 2014). Other authors found that 
WBC in fetal fluids along with bacterial culture appears to be superior for the diagnosis of 
chorioamnionitis compared to peripheral leukocyte counts (Buhimschi et al. 2011). To the 
best of our knowledge there are no controlled studies or randomized trials addressing 
changes in peripheral WBC counts in equine placentitis.   
The objectives of the current study were to: (i) compare plasma concentrations of 
APP and the WBC in mares with experimentally induced ascending placentitis and 
gestationally aged-matched control mares carrying normal pregnancies, and (ii) describe 
SAA (serum amyloid A) and Hp (haptoglobin) concentrations in normal pre-foaling mares.  
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3.3. Material and Methods 
Animal Husbandry  
Clinically healthy adult horse mares of different ages were enrolled in these 
experiments. Mares were maintained at the Maine Chance Farm, Department of Veterinary 
Science, University of Kentucky, Lexington, KY. All the experimental protocols were 
approved by the Institutional Animal Use and Care committee at the University of 
Kentucky (Project #2010-0769). All the animals were kept in paddocks and supplemented 
with hay, grain and water ad libitum along with trace minerals. Immediately pre-abortion 
or prior to normal parturition; the mares were kept in individual stalls (16 x 16 feet) during 
the night and turned out in pasture during the day.  
Study I: Serum Amyloid A, Haptoglobin, Fibrinogen and WBC in Mares with Ascending 
Placentitis 
Experimental design 
Mares carrying normal pregnancies (260-280 days of gestation) were assigned to 
(i) a control group with (n= 7) or without trans-abdominal ultrasound-guided fetal fluid 
sampling (FFS; n=10) and (ii) a treatment group with experimentally induced ascending 
placentitis with (n =7) or without FFS (n=10). Fetal fluid sampling was performed at 0, 5 
and 12 days post inoculation (DPI) or until abortion. Similar methodology has been 
described elsewhere (Canisso et al. 2014). Here briefly, the mare was sedated, placed in 
stocks and fetal fluids were collected with transabdominal ultrasound and an echotip spinal 
needle (18Gx6”; 30o short bevel, Chiba-Type spinal needle, with stylet, Echo Block PTC 
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Havel’s Cincinnati, OH, USA) (Canisso et al. 2014).  Fetal fluid sampling was performed 
in a subset of mares as part of another study. 
Experimental Induction of Ascending Placentitis  
Ascending placentitis was induced via intracervical inoculation of Streptococcus 
equi ssp. zooepidemicus. The experimental model for induction of bacterial placentitis in 
the mare was modified from that previously described (LeBlanc et al. 2002) and has been 
successfully used by different laboratories as a reliable and predictable model to induce 
ascending bacterial placentitis in the mare (Coutinho da Silva et al. 2013, Morris et al. 
2007).  Sham inoculation of control mares was not performed in the present study as this 
procedure may induce placentitis in an unpredictable manner; as noted by previous 
publications.  The bacterial inoculum was deposited midway intracervically with the usage 
of a semi-flexible artificial insemination pipette. The inoculum was contained in a 0.5-mL 
straw and was deposited with the use of a stylet. The bacterial strain used was isolated from 
a placenta from a mare diagnosed with spontaneously ascending placentitis by the 
Veterinary Diagnostic Laboratory at the University of Kentucky.  The bacterial isolate was 
preserved in cryovials containing skim milk at -80oC until use.  Prior to inoculation, 
bacterial cultures were prepared and bacterial counts performed in standard fashion using 
blood Agar plates (incubated at 37oC), serial dilution and plating were used to determine 
the number of colony-forming units. The bacterial inoculum, containing 5 million colony 
forming units (cfu), was suspended in 0.5 mL of phosphate buffered saline. Once 
inoculation was carried out, a swab was obtained from the leftover in the cryovial and 
cultured in similar conditions to assure that the bacteria inoculum was still viable. 
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Transrectal Ultrasonography 
Before the beginning of the experiment, mares underwent transrectal 
ultrasonography to assess the caudal placental pole to assure that all mares were carrying 
normal pregnancies. Three measurements of the combined thickness of uterus and placenta 
(CTUP) were taken and compared with previously established normal ranges (Renaudin et 
al. 1997, Coutinho da Silva et al. 2013). All mares had CTUP values within previously 
reported normal ranges and presented normal ultrasonographic appearance of the caudal 
pole of the placenta (data not shown); therefore all mares were enrolled in this study.  
Thereafter, all mares had transrectal ultrasonography performed every other day for 12 
days or until abortion. Transrectal ultrasonography examinations were performed to follow 
ultrasonographic changes in inoculated mares and to confirm the lack of changes in mares 
in the control group.  Particularly, we assessed for changes that are highly indicative of 
placentitis such as areas of placental separation and fluid accumulation between the uterus 
and chorioallantois. 
Blood Sampling and Determination of Serum Amyloid A and Haptoglobin 
Blood samples were obtained immediately before inoculation/initial fetal fluid 
sampling (d=0), and then daily for 12 days or until abortion. Blood was attained by jugular 
venipuncture into heparinized 10-mL tubes. Immediately after collection, the blood was 
centrifuged at 600 xg for 10 min at 5o C. Plasma was harvested and preserved at -20o C 
until further analysis. Concentration of SAA was analyzed by a turbidometric 
immunoassay. The assay was developed for humans (LZ test SAA, Eiken Chemical© 
Tokyo, Japan) and has been validated for horses (Jacobsen et al. 2006, Belgrave et al. 
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2013). Concentrations of Hp were determined by the use of a commercial colorimetric 
assay (Phase™, Tri-Delta Diagnostics Inc., Boonton Township, NJ) (Cray & Belgrave 
2014).  Both SAA and Hp were analyzed at the Acute Phase Proteins Laboratory (Miller 
School of Medicine, University of Miami, Miami, FL, USA). 
Determination of WBC and Fibrinogen  
A subset of mares carrying normal pregnancies [(n=9), without (n=3) and with 
(n=6) FFS] and with experimentally induced placentitis [(n=8), without (n=5) and with 
(n=3) FFS] were examined to determine leukocyte counts and circulating fibrinogen.  
Blood was collected daily from inoculation until abortion or for 12 days for control mares.  
Fibrinogen was determined by comparing total plasma and serum protein. For WBC, an 
EDTA-anticoagulated blood sample was collected, and analyzed on an automated platform 
(Genesis, Oxford Science, Oxford CT, USA).   
Placental and Fetal Pathology 
Placentas from control and inoculated mares, and all aborted fetuses underwent 
complete pathological (macroscopic and histopathologic examination) and microbiological 
evaluation (Hong et al. 1993).  Here briefly, the placenta was laid out and the 
chorioallantois, amnion, and umbilical cord were examined. Areas with no apparent lesions 
and areas presenting macroscopic lesions were sampled and preserved in buffered formalin 
for further histopathologic evaluation. Swabs were collected from the chorioallantois and 
used to perform aerobic bacterial culture (Hong et al. 1993). Fetuses were necropsied in 
routine fashion and internal organs (liver, spleen, stomach content, lung, heart, and trachea) 
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were macroscopically examined and sampled for histopathologic evaluations and aerobic 
bacterial culture (Hong et al. 1993). 
Study II: Pre-Partum Plasma Concentrations of Serum Amyloid A and Haptoglobin in 
Mares Carrying Normal Pregnancies 
To address the question of whether normal parturition is associated with an increase 
in plasma concentrations of SAA and Hp, healthy pregnant mares (n=7) were sampled daily 
beginning between 310 and 320 days of gestations through parturition. Jugular 
venipunctures were performed daily. Immediately after collection, blood was centrifuged 
at 600xg for 10 min, and the plasma was harvested and stored at -20o C until further 
analyses. Concentrations of SAA and Hp in plasma samples were analyzed as 
aforementioned for days -10, -8, -6, -4, -2, -1, and 0 (the day of parturition).  All placentas 
underwent complete pathologic and microbiologic evaluations as in Study I. 
Statistical Analyses  
All the data analyses were carried out with JMP 10 (SAS Institute Cary NC). 
Changes in SAA, Hp and Fb concentrations as well as WBC were analyzed relative to  days 
post-inoculation (DPI, 0 to 7 days) as well as relative to days from abortion (DFA,-7 days 
to 0) in separate mixed models. Mare was accounted as random effect and treatment; DPI 
(or DFA) were fixed effects. Fetal fluid sampling was nested within group. As we were 
interested to evaluate the acute changes in APP and WBC following inoculation, the data 
were analyzed for changes up to 7 DPI. On the other hand, as the interval from inoculation 
to abortion was variable, we were interested to examine the changes in the seven days prior 
to abortion.  Two and three way interactions were also included in the different models for 
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DPI and DFA. Prior to analyses, the data were log transformed. Post-hoc comparisons 
across days were analyzed by Fisher’s Least Significant Difference Test.  In study II, 
changes in SAA and Hp for normal pre-foaling mares were analyzed by mixed model with 
mare as random effect and days pre-foaling as a fixed effect. Significance was set at p<0.05, 
statistical tendency was defined as 0.05 ≤ p <0.10. Data are presented as mean ± S.E.M.   
3.4. Results 
Overall, mares with experimentally induced ascending placentitis aborted within 5-
25 DPI with a mean of 9.4 ± 1.3 DPI. Only one mare in the control group (subgroup FFS) 
aborted 8 days after the last sampling; pathological and microbiological examination of the 
placenta and fetus revealed no lesions and culture yielded saprophytic non-pathogenic 
bacteria and negative virus isolation (data not shown); thus the cause of abortion was not 
determined. Three mares (17.6% of the mares that were inoculated) failed to develop 
placentitis after a single inoculation. One mare with experimentally induced placentitis 
(subgroup without FFS) did not develop placentitis; she delivered a normal foal and 
placenta with no pathological or microbiological evidence of placentitis. Two mares in the 
group with experimentally induced placentitis (one with and another without FFS) did not 
develop placentitis and were re-inoculated 14 days after the first inoculation. The mare 
without FFS aborted 20 days after re-inoculation and the other mare with FFS aborted 9 
days after re-inoculation. All four of these mares were excluded from the analyses for DPI 
or DFA for APP or WBC; however, their SAA and Hp concentrations are presented in the 
supplement (appendices Fig. 3.1 to 3.4).  One mare in the control group developed 
extensive cellulitis at the Viborg’s triangle secondary to venipuncture, thus she was 
excluded from the analysis and her WBC, and APP concentrations are presented separately 
in the appendices (Fig. 3.5). 
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Streptococcus equi ssp. zooepidemicus was the single bacteria cultured from 12 
fetuses and placentas from inoculated mares; however, in other 3 fetuses and placentas 
from inoculated mares, Escherichia coli was also cultured in association with the 
Streptococcus equi ssp. zooepidemicus. Actinobacillus equuli was isolated in association 
with Streptococcus equi ssp. zooepidemicus of one fetus and its placenta. All inoculated 
mares, but one mare, developed ultrasonographic changes consistent with ascending 
placentitis (i.e. placental separation, fluid accumulation between uterus and the 
chorioallantois) (data not shown). All mares in the control group presented normal 
ultrasonographic findings (data not shown). With the exception of one mare that failed to 
develop placentitis after experimental induction (noted above) and the control mare with 
FFS that aborted, all the remaining mares that aborted with experimentally induced 
ascending placentitis developed gross and histopathologic lesions consistent with 
ascending placentitis (i.e. neutrophilic infiltration in the intervillous spaces, necrosis of 
chorionic villi, infiltration of mononuclear inflammatory cells in the intervillous spaces, 
villous stroma, chorionic stroma, endothelium and allantois) (Hong et al. 1993) (data not 
shown). All mares in the control group delivered macroscopically and microscopically 
normal placentas. Bacterial culture yielded non-pathogenic saprophytic bacteria (data not 
shown).   
All but two foals from mares with experimentally induced ascending placentitis 
were dead at delivery.  One foal was spontaneously delivered alive and one foal was 
delivered upon induction of parturition because of sepsis in the mare. Both of these foals 
had clinical evidence of sepsis and were euthanized immediately post-delivery. 
Streptococcus equi ssp. zooepidemicus was isolated in all of their internal organs. 
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Unexpectedly, one mare with experimentally induced ascending placentitis developed 
systemic clinical signs of sepsis (hyperthermia (40oC, reference 37-38.8oC); 
hyperfibrinogenemia (900 mg/dL, reference 200-400 mg/dL); leukocytosis (15.1x103 
WBCs/µL, reference 7-12 x103 WBCs/µL); dehydration (normal PCV, 42.4%, reference 
30-44%, and  slightly elevated total proteins 8 g/dL, reference 5.4-7.6 g/dL); neutrophilia 
(88%, reference 50-70%); lymphopenia (6%, reference 22-40%); and left shift (4%, 
reference 0-2%)) 14 days post inoculation. The mare received treatment for sepsis 
including intravenous fluids for approximately 3h and then parturition was induced with 
oxytocin continuous rate infusion (approximately 1 unit/minute). A live foal was delivered 
≤20min of the treatment commence. Intravenous oxytocin treatment was continued and the 
placenta was delivered in ~30min (Canisso et al. 2013). The foal was euthanized 
immediately and submitted accompanied by its placenta for full pathologic and 
microbiologic evaluation as aforementioned. 
SAA, Hp, Fb and WBC in Mares with Ascending Placentitis 
Overall, there were significant effects of time and time x group interaction on 
concentrations of SAA based upon either DPI (p<0.0001) or DFA (p=0.01) (Fig. 3.1). 
Concentrations of SAA were significantly elevated from 2 DPI and from -6 DFA until 
abortion in inoculated mares compared to control mares (Fig. 3.1) (p<0.05). For Hp 
concentrations, there were significant effects of time and a time x group interaction, based 
upon DPI (p<0.0001) or DFA (p=0.001) (Fig. 3.2). Concentrations of Hp were elevated 
from 3 DPI and -3 DFA in inoculated mares compared to control mares (Fig. 3.2) (p<0.05). 
There was a significant interaction between FFS and group on the concentration of Hp 
(p<0.0001). 
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There were effects of DPI (p=0.03) and a group by DPI interaction (P=0.02) on 
WBC. However, there were no effects on WBC in the previous 7 DFA (p=0.26) and no 
interaction between group and WBC (DFA, p=0.98) (Fig. 3.3).  On Fb analyses, there was 
an effect of time for DPI (p=0.002); however, there was no effect on DFA (p=0.27).  There 
were no time interactions between group and DPI (p=0.83) or DFA (p=0.61) (Fig. 3.4) and 
between group and FFS (p=0.65). However, there were significant three way interactions 
among FFS, group and time (p=0.02). 
Figure. 3.1 Serum amyloid A concentrations in mares with experimentally induced 
ascending placentitis and gestationally age-matched control mares carrying normal 
pregnancies. (a) 0 to 7 DPI; 0 = the day of inoculation or commence of sampling for mares 
in the control group. (b) -7 to 0 (i.e. day of abortion) DFA. There were no significant 
differences between mares in the control group and mares with placentitis (DPI p=0.25; 
DFA p=0.06). Concentrations of SAA were elevated from 2 DPI and -6 DFA (p<0.05). 
There were significant time and group interactions (DPI p<0.0001; and DFA p=0.01). 
*Within day denotes significant statistical difference p<0.05.  
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Figure. 3.2 Haptoglobin concentrations in mares with experimentally induced ascending 
placentitis and gestationally age-matched control mares carrying normal pregnancies. (a) 
0 to 7 DPI; 0= the day of inoculation or commence of sampling for mares in the control 
group). (b) -7 to 0 (i.e. day of abortion) DFA.  There were no significant differences 
between mares in the control group and mares with placentitis (DPI p=0.61; DFA p=0.9). 
Concentrations of Hp were elevated by 3 DPI and -3 DFA (p<0.05), and there were 
significant time x group interactions (DPI p<0.0001; and DFA p=0.001). *Within day 
denotes significant statistical difference p<0.05. 
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 Figure 3.3 White blood cell counts (WBC) in mares with experimentally induced ascending 
placentitis and gestationally age-matched control mares carrying normal pregnancies. (a) 
0 to 7 DPI; 0= the day of inoculation or commence of sampling for mares in the control 
group. (b) -7 to 0 (i.e. day of abortion) DFA. There were no significant differences between 
mares in the control group and mares with placentitis (DPI p=0.76; DFA 0.70). There were 
effects of DPI (p=0.03) and interaction between group and time (DPI, p=0.02). There were 
no effects on WBC in the previous 7 DFA (p=0.26) and no interaction between group and 
WBC (DFA, p=0.98). *Within day denotes significant statistical difference p<0.05. 
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Figure 3.4: Fibrinogen concentrations in mares with experimentally induced ascending 
placentitis and gestationally age-matched control mares carrying normal pregnancies. (a) 
0 to 7 DPI; 0= the day of inoculation or commence of sampling for mares in the control 
group. (b) -7 to 0 (i.e. day of abortion) DFA. There were no significant differences between 
mares in the control group and mares with placentitis (DPI, p=0.87; DFA=0.81). There was 
effect of time for DPI (p=0.002); however, there was no effect on DFA (p=0.27).  There 
were no time group interactions (DPI p=0.83; DFA p=0.61) or group and FFS (p=0.65). 
There were significant three way interactions among FFS, group and time (p=0.02). 
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Normal Parturition Does not Cause Elevation in Serum Amyloid A and Hp in Mares 
 
There were no differences in SAA (p=0.94) and Hp (p=0.98) concentrations in the 
10 days prior to parturition (Fig. 3.5). 
Figure 3.5: Serum amyloid A (SAA, left axis) and haptoglobin (Hp, right axis) 
concentrations 10 days prepartum in seven mares carrying normal pregnancies undergoing 
to uneventful parturition. There were no significant differences across days for SAA 
(p=0.94) or Hp concentrations (p=0.98). 
 
3.5. Discussion 
After experimental induction of ascending placentitis, concentrations of SAA and 
Hp changed rapidly and markedly post inoculation. As a major and positive APP, it is 
expected that SAA will be rapidly elevated after the onset of inflammation (Jacobsen & 
Andersen 2007). Similar to other research models for diseases in mammals (Hulten et al. 
2002, 2003, Dabrowski et al. 2007) concentrations of SAA were significantly elevated 
before detectable changes in Hp and several folds of magnitude in comparison to mares in 
the control group and before experimental induction of placentitis.  A new aspect of our 
study supported by another recent report (Coutinho da Silva et al. 2013), is the fact that 
placentitis induces changes in APP (i.e. SAA and Hp) concentrations at the systemic 
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circulation. Until very recently, equine placentitis was considered a localized disease of the 
pregnant uterus with no systemic involvement.  However, the finding that placentitis 
induces changes in APP (i.e. SAA and Hp) concentrations opens a new field of 
investigation on the inflammatory response in mares with placentitis. In humans, APP (e.g. 
C-reactive protein; CRP) have been focus of numerous publications involving infection of 
the placental and fetal tissues (Wu et al. 2009, Popowski et al. 2011, Lee et al. 2012, 
Ferrazzi et al. 2012). Changes in concentrations of CRP in the systemic circulation of 
women suffering with chorioamnionitis have been demonstrated by several studies (Wu et 
al. 2009, Popowski et al. 2011, Lee et al. 2012, Ferrazzi et al. 2012).  In human medicine, 
CRP is the APP more commonly used to assess risk for premature labor (Smith et al. 2012).  
Inflammatory APP are produced by the liver in all mammals studied to date (Urieli-
Shoval et al. 1998, Jacobsen & Andersen 2007, Chrisman et al. 2008, Berg et al. 2011, 
Leschi et al. 2012). However, transcripts for SAA and Hp were also described in several 
other normal tissues in cattle and horses (Berg et al. 2011) as well as humans (Urieli-Shoval 
et al. 1998).  In the horse, the endometrium presented moderate expression (i.e. defined by 
the authors as >1% of the liver expression) in normal non-pregnant mares (Berg et al. 2011) 
Interestingly, in experimentally induced endometritis using a large inoculum of E. coli (1 
billion cfu) in non-pregnant mares (Christoffersen et al. 2010), the animals presented a 
systemic inflammatory response (i.e. fever, elevated systemic SAA) and increased 
endometrial expression of SAA by 3-12h post inoculation. This study suggested 
upregulation of SAA in the endometrium could result in measurable elevation of systemic 
SAA in mares. In a more recent study by the same authors (Christoffersen et al. 2012), a 
smaller inoculating dose of E. coli (105 cfu) was not associated with systemic signs of 
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endotoxemia or increases in plasma SAA concentrations; however endometrial expression 
of SAA was 10-100 fold higher compared to pre-inoculation expression of SAA. 
Therefore, our findings along with those of Coutinho da Silva et al. (2013) raise a question 
on the origin of SAA and perhaps Hp in mares with placental inflammation. It appears 
likely that the liver may not be the sole source of APP in these mares, but that other tissues 
such as endometrium may contribute to the systemic elevation of SAA and Hp in mares 
with experimentally induced placentitis.  
On a comparative basis, it is worth noting that the epitheliochorial placenta of 
equids allows limited exchange of large molecules between maternal and fetal circulation 
in comparison to the hemochorial placenta of humans. Thus the structural and 
morphofunctional differences between fetal membranes of mares and women may explain 
why infection of the maternal-fetal unit can be life threating in women (Fahey 2008, Tita 
2010) but is rarely so in mares where the disease is restricted to the gravid uterus.  
As observed here and supported in other studies using this experimental model, 
only a single bacterial specie or less commonly two species of bacteria are isolated in 
clinical cases or experimental cases of ascending placentitis (Hong et al. 1993). In the 
present report, Streptococcus equi ssp. zooepidemicus was the single isolate in 80% of the 
experimental mares; however, in the remaining mares, a second bacterial specie was also 
isolated (i.e. Escherichia coli and Actinobacillus equuli). However, in the human clinical 
condition known as chorioamnionitis/funisitis, mixed infection with enteric bacteria 
appears to be a more common clinical presentation (Hillier et al. 1991, Sherman et 
al.1997). 
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In the study by Coutinho da Silva and collaborators (2013), concentration of SAA 
was elevated by four days post experimental induction in all five mares that were 
experimentally induced with ascending placentitis and did not receive treatment after onset 
of clinical signs. This is two days later than the present report in which SAA was already 
significantly elevated from 2 DPI and remained elevated until abortion. Coutinho da Silva 
et al. (2013) used a different immunoassay method to determine the concentrations of SAA, 
used a different bacterial isolate of Streptococcus equi ssp zooepidemicus and their 
inoculating dose was remarkably higher than the one used in our study (10 million cfu 
versus 5 million). Perhaps a higher inoculating dose may explain why mares in the group 
with experimentally induced ascending placentitis that did not receive treatment for 
placentitis aborted ~2 days (Coutinho da Silva et al. 2013) earlier than the average in the 
present report (~9DPI). 
Both Hp and Fb are classified as moderate APP in the horse (i.e. constantly present 
in the blood, and upon inflammation present only a moderate elevation of 1 to 10 times 
baseline), thus it is expected that upon inflammatory insult both molecules will be elevated 
from two to five days post insult in the horse (Jacobsen & Andersen 2006, Cray & Belgrave 
2014). However in the present study Fb was not elevated in mares with experimentally 
induced ascending placentitis but there was an effect of time. Interesting, total WBC was 
higher in control mares at 7 DPI. While we cannot explain the origin of this higher 
concentration of WBC, upon normal foaling no placentae from mares in the control group 
presented evidence of inflammation or other changes that suggest placental lesion. In 
addition, the total WBC in control mares remained within normal ranges (reference 7-12 
x103 WBCs/µL). However, from the sampling period (~280 days of gestation) to normal 
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parturition (~340 days of gestation) in the present report corresponded approximately to a 
2-months period, so changes induced by the sampling could have disappeared. 
Additionally, the origin of the inflammation could have been the body wall or uterine wall. 
Interesting that SAA, a very sensitive marker for inflammation, was not elevated in the 
control group.  This is interesting because FFS had no effect on SAA concentrations, and 
this APP is known to be more sensitive marker for inflammation than Fb and WBC in the 
horse (Belgrave et al. 2013). We did not expect Fb or WBC to be elevated in mares with 
experimentally induced ascending placentitis, based on our experiences with 
spontaneously occurring cases. However, we believe that a controlled study was warranted 
to confirm clinical observations.  
Parturition did not trigger an elevation in SAA or Hp in mares carrying normal 
pregnancies and delivering normal foals. A prior report (Coutinho et al. 2013) suggested 
that parturition induced changes in serum concentrations of SAA in mares carrying normal 
pregnancies and delivering normal foals. These authors (Coutinho et al. 2013) used a 
different assay to measure SAA and the mares were sampled in weekly intervals than the 
more frequent protocol used here. Our findings support the hypothesis that increases in 
SAA and Hp are not associated with parturition, but with placentitis as evidenced by the 
lack of effect of normal parturition. 
In conclusion, SAA and Hp rapidly increase in mares subsequent to experimental 
induction of ascending placentitis and remain elevated until abortion with SAA increasing 
earlier than Hp. Neither Fb nor WBC change in mares with placentitis, therefore are not 
markers for placentitis. There were no detectable changes in the concentrations of SAA 
and Hp in normal mares in the immediate prepartum period. The findings of the present 
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study open a new field of investigation. Elevations of SAA and Hp in mares with 
experimentally induced ascending placentitis suggest that these two APP might be useful, 
but nonspecific, biomarkers for mares with spontaneously occurring placentitis, thus this 
should be tested in prospective controlled designed studies with field cases.  It appears 
likely that SAA and Hp will be useful markers to diagnose field cases of placentitis in 
mares; however, these two APP should be tested prospectively to confirm whether these 
APP are useful biomarkers in spontaneous clinical cases.  
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Chapter 4 
Experimentally-Induced Ascending Placentitis Does not Change Peripheral 
Androgen Concentrations in Mares 
I. F. Canisso1*, B. A. Ball1, A. Esteller-Vico1, N M. Williams2, E L. Squires1, M.H. 
Troedsson1, 
1Reproduction Laboratory, Maxwell H. Gluck Equine Research Center; 2Veterinary 
Diagnostic Laboratory, Department of Veterinary Science, University of Kentucky  
Lexington KY 40546-0099, USA. 
*Submitted to the Equine Veterinary Journal. 
4.1. Summary  
Reasons for performing study: Currently, the diagnosis of ascending placentitis is based 
on clinical signs and transrectal ultrasonography; while advanced stages of placentitis can 
be easily diagnosed, early stages can be missed. Thus additional tools to diagnose 
placentitis are necessary. 
Objectives: To characterize peripheral dehydroepiandrosterone sulphate (DHEA-S) and 
testosterone concentrations in mares carrying normal pregnancies (Study I) and to compare 
plasma concentrations of DHEA-S and testosterone in mares with placentitis and 
gestationally age-matched control mares (Study II). 
Methods: In study I, mares (n=18) had serum samples collected every two weeks from 
100d of gestation to term. In study II, pregnant mares (260-280d of gestation) were 
assigned to a control group (n=17) and to a group with experimentally induced placentitis 
(n=17). Within each group, a subset (n=7) of mares had fetal fluid sampling (FFS) 
performed at 0, 5, 12 days post inoculation (DPI) or until abortion.  Placentitis was induced 
via intracervical inoculation of Streptococcus equi ssp zooepidemicus. Blood was collected 
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at inoculation/commence for control mares (day=0) and daily for 12 DPI or until abortion. 
Concentrations of DHEA-S and testosterone were determined by ELISA.  
Results: In study I, androgen concentrations increased during pregnancy with 
concentrations of DHEA-S peaking by 180 days of gestation. Testosterone concentrations 
were progressively elevated from days 100 to 180 with a plateau until ~240d and a 
progressive decline until 290d of gestation. In study II, mares with experimentally induced 
placentitis aborted within 5-25 DPI (mean 9.4±1.3 days). Concentrations of DHEA-S and 
testosterone were not significantly different between groups, except DHEA-S was 
significantly reduced on the day of abortion for mares in the placentitis group (subset 
having FFS).  
Conclusions: Concentrations of DHEA-S and testosterone were elevated and varied 
through pregnancy; however, neither testosterone nor DHEA-S concentrations in the 
pregnant mares were predictive of impending abortion in mares with experimentally 
induced ascending placentitis.   
Keywords: pregnancy, testosterone, dehydroepiandrosterone, placentitis, abortion, equine 
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4.2. Introduction 
Placentitis has been identified as the major cause of late-term pregnancy loss (i.e. 
abortions, stillbirths and neonatal deaths) in broodmares in central Kentucky (Giles et al. 
1993, Hong et al. 1993, Williams et al. 2004, Troedsson & Zent 2004). Outside North 
America, placentitis has also been reported to be an important cause of pregnancy wastage 
in France (Laugier et al. 2011) and Australia (Carrick et al. 2012).  However, in the United 
Kingdom umbilical cord pathology (e.g. torsion and entrapments) was recognized as the 
leading cause of pregnancy loss in submissions received by a referral laboratory (Smith et 
al. 2003).  Differences in incidences across countries can be explained by surveillance 
systems, methodology to perform the pathologic examination, and true incidence of 
infectious agents.  
Ascending placentitis is commonly associated with bacteria and less commonly 
with fungi; infrequently, mixed bacterial fungal infections have also been observed (Hong 
et al. 1993). Common bacterial isolates associated with the occurrence of ascending 
placentitis are similar to ordinary isolates in endometritis and include Streptococcus equi 
subspecies zooepidemicus, Escherichia coli, Streptococcus equisimilis, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, whereby beta-hemolytic streptococci predominate 
(Giles et al. 1993, Hong et al. 1993, Williams et al. 2004).   
Currently, ascending placentitis is diagnosed based on clinical signs (i.e. vulvar 
discharge, premature udder development and lactation) and transrectal ultrasonography 
(Renaudin et al. 1997, LeBlanc 2010, Troedsson & Macpherson 2011). While transrectal 
ultrasound of the caudal placental pole has been shown to be a useful tool to diagnose and 
manage clinical cases of ascending placentitis (Troedsson & Zent 2004) the technique is 
prone to false positive diagnoses and early stages of the disease can be missed. Additional 
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diagnostic tools for placentitis have the potential to improve the identification of early 
stages of the diseases and may therefore improve the likelihood to deliver a viable foal as 
well as help to avoid unnecessary treatment of normal pregnant mares.  
During pregnancy several estrogens, progestins and androgens are produced in high 
concentrations by the equine fetoplacental unit and are released into the maternal 
circulation (Cox 1975, Raeside et al. 1979, Pashen & Allen 1979, Raeside 2004, Ousey 
2011)  In particular, the hypertrophied fetal gonads of both male and female fetuses secrete 
large quantities of androgens, particularly dehydroepiandrosterone (DHEA, 3β-
hydroxyandrost-5-en-17-one also known as 5-androsten-3β-ol-17-one) and 7-dehydro 
DHEA (3β-hydroxy-5,7-androstadien-17-one) (Raeside et al. 1997).  
 Dehydroepiandrosterone serves as a precursor for classic phenolic estrogens (i.e. 
estrone, estradiol-17β estradiol-17α, and their sulfoconjugates) and 7-dehydro-DHEA 
serves as a precursor for ring B unsaturated estrogens (i.e. equilin, equilenin and their 
hydroxyderivatives 17α-dihydroequilin, 17α-dihydroequilenin, 17β-dihydroequilin, and 
17β-dihydroequilenin) by the equine placenta (Raeside et al. 1979, Pashen & Allen, 1979, 
Bhavnani 1988, Raeside 2004, Ousey 2011). Normally, both precursors are rapidly 
aromatized by the placenta into estrogens; however, some DHEA, particularly the 
sulfoconjugate (DHEA-S) is present in high concentrations in maternal circulation during 
pregnancy in mares (Meinecke & Gips 1990). In addition to DHEA-S, circulating 
testosterone is elevated in plasma of pregnant mares (Silberzahn et al. 1984, Daels et al. 
1996). During early pregnancy, the corpora lutea have been shown to be an important 
source of testosterone (Ginther 1992); however, late in pregnancy this androgen is probable 
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synthesized from DHEA (through androstenedione as an intermediate) and released into 
the maternal circulation (Bhavnani 1988, Raeside et al. 1997, Ousey 2011). 
The fetal gonads produce DHEA and 7-dehydro DHEA from cholesterol and from 
farnesyl pyrophosphate, respectively (Bhavnani 1988, Tait et al. 1985, Raeside 2004). The 
sulfoconjugated form of DHEA predominates in the blood of pregnant mares blood (6:1), 
(Meinecke & Gips 1990) however, in the newborn foal the non-conjugated form 
predominates (i.e. DHEA) (Raeside et al. 1997) Based on immunolabeling and labelled 
precursors studies, DHEA is converted into androstenedione by 3β-hydroxysteroid 
dehydrogenase, and then androstenedione can be converted into estrone by aromatase or 
into testosterone by 17-β hydroxysteroid dehydrogenase (17-β-HSD) (Bhavnani 1988, 
Henderson et al. 1984, Chavatte et al. 1995, Han et al. 1995, Ousey 2011). Estrone can be 
converted into estradiol 17-β by 17-βHSD in the chorioallantois (Ousey 2011). In the mare, 
it is thought that estrone sulfate can be converted into estradiol 17 β sulfate by 17-βHSD 
in the endometrium (Ousey 2011). 
Controlled studies and field investigations have reported that estrogens change in 
mares experiencing pregnancy loss (Kashamn et al. 1988, Douglas 2004). However, there 
are no reports on changes in DHEA-S or testosterone in mares suffering placental disease. 
Since mares experiencing placentitis, both spontaneous (Douglas 2004) and experimentally 
induced (unpublished observations), present remarkable reduction in estrogens 
concentrations, and androgens are products of the fetoplacental unit used as substrate to 
produce estrogens, we hypothesize that placentitis would result in increased concentrations 
of androgens in the maternal plasma. Therefore, the objectives of this study were: (i) to 
describe DHEA-S and testosterone concentrations in mares carrying normal pregnancies; 
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(ii) to compare plasma concentrations of DHEA-S and testosterone in mares with 
experimentally induced placentitis to those in control mares.  
 
4.3. Material and Methods 
Mares were maintained at the Maine Chance Farm University of Kentucky. All the 
experimental protocols were approved by the Institutional Animal Care and Use committee 
at the University of Kentucky (Project #2010-0769). All the animals were kept in paddocks 
and supplemented with hay, grain and water ad libitum along with trace minerals. In study 
I, mares were kept in pastures during the entire experiment and foaling was not attended. 
In study II, immediately pre-abortion or prior to normal parturition; the mares were kept in 
individual stalls (16 x 16 feet) during the night and turned out in pasture during the day.  
 
Study I: Concentrations of DHEA-S and testosterone in mares carrying normal pregnancies  
Animals  
Eighteen light-breed mares were enrolled in this study. The mares were bred with 
fresh extended semen during the breeding season of the northern hemisphere. Ovulation 
was determined by transrectal ultrasonography.  Postpartum placentas and foals were 
examined to assure normality.  
 
Blood Sampling and Immunoassays  
Blood samples were collected every two weeks from 100 days of gestation to term.  
This gestational age was chosen because that is the suggested time that the fetal-placental 
unit starts to be the predominant steroidogenic organ (Ousey 2011). Testosterone is 
elevated starting at 40 to 50 days of pregnancy, and this elevation is mainly associated with 
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the ovarian production of testosterone (Ginther 1992, Daels et al. 1996). Blood was 
collected by jugular venipuncture, allowed to clot, centrifuged at 600 xg for 10 min and 
then serum was harvested and preserved at -20 oC. Determination of DHEA-S and 
testosterone were achieved with specific equine immunoassays. 
Analysis of testosterone was performed in triplicate using a testosterone antibody 
(R156/7 UC-Davis) and testosterone conjugated with horseradish peroxidase and 
testosterone.  The standard curve ranged from 0.02 ng/mL to 10 ng/mL, with a limit of 
detection of 0.021 ng/mL (CV’s; intrassay 9.7% and interassay 17%). The testosterone 
antisera has a high cross-reactivity with only one testosterone metabolite 5 α 
dihydrotestosterone (57%) and low cross reactivity with androstenedione (0.3%) 
(Thompson et al. 2008). The testosterone immunoassay has been previously validated 
against a radio immunoassay (Coat-a-count total testosterone radioimmunoassay; 
PITKTT-8), and chemiluminescence immunoassay (Immulite total testosterone; PILKTW-
12) (unpublished observations).   
Determinations of DHEA-S concentrations were performed in duplicate using a 
DHEA-S antibody (Schwarzenberger et al. 1993) and DHEA-S conjugated with 3-
horseradish peroxidase.  The standard curve ranged from 0.05 ng/mL to 20 ng/ml, with a 
limit of detection of 0.0315 ng/ml (CV’s; intra-assay 6.5% and inter-assay 10.3%). Cross-
reactivity for the DHEA-S antisera has been previous reported (Schwarzenberger et al. 
1993).  Here briefly, DHEA 100%, 5-androsten-3β-ol-17-one 38.2%, 5-androstene -3 β, 17 
β –diol 0.14%, 5-androstene -3,17-dione 6.6%, 4-androstene-3, 17-dione 0.3%, 
testosterone <0.1%β, epiandrosterone 8.8%, androsterone 3.2%, 5 α-diol 1.6%, estrone 
<0.1%.  The DHEA-S antiserum was raised in sheep against 3- β-hydroxy-5-androsten-17-
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one-3 hemisuccinate/BSA. The antiserum was kindly provided by Dr James Raeside and 
has been previously reported for immunoassay of DHEA-S (Raeside et al. 1997, 
Schwarzenberger et al. 1993). The dilution of antiserum was prepared at 1:9000 in sodium 
bicarbonate solution (0.05 M, pH 9.6). Standard solutions were prepared with DHEA-S at 
the concentrations 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 20 ng/ml.  Plates were incubated for two 
hours at room temperature, before being washed with an automated plate washer. Substrate 
solution containing citric acid (0.05 M), ABTS (40mM; 2,2’-azino-bis3-
ethylbenzothiazoline-6-sulphonic acid), and H2O2 (0.5 mM) was added to the plates; 
thereafter, plates were incubated at room temperature for two hours.  Stop solution (i.e. 
0.15 M hydrofluoric acid, 0.006 M NaOH, 1.0 M EDTA) was added at the end of the 
incubation, and reading was carried out by the use of an ELISA microplate reader.  
 
Study II: Concentrations of DHEA-S and testosterone in mares with experimentally 
induced placentitis 
Experimental Design 
Mares of light-breed types carrying normal pregnancies (260-280 days of gestation) 
were assigned to (1) a control group with (n= 17) and (2) a group with experimentally 
induced ascending placentitis (n =17). As part of another study, within each group, 7 mares 
had transabdominal ultrasound guided fetal fluid sampling at 0, 5 and 12 days post 
inoculation (DPI) or until abortion. Similar methodology has been published elsewhere 
(Canisso et al. 2014).  Here briefly, the mare was sedated, placed in stocks and fetal fluids 
samples were collected with transabdominal ultrasound and an echotip spinal needle 
(18Gx6”; 30o short bevel, Chiba-Type spinal needle, couple with a stylet). 
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Experimental Induction of Ascending Placentitis  
Ascending placentitis was induced via intracervical inoculation of Streptococcus 
equi ssp. zooepidemicus. The experimental model for induction of bacterial placentitis in 
the mare was modified from that previously described (LeBlanc et al. 2002). This protocol 
has been successfully used by different laboratories as a reliable and predictable model to 
induce ascending bacterial placentitis in the mare (Morris et al. 2007, Christensen et al. 
2010, Coutinho da Silva et al. 2013).  Sham inoculation of control mares was not performed 
in the present study as this procedure may induce placentitis in an unpredictable manner; 
as noted by previous publications (Christensen et al. 2010, Macpherson et al. 2013, 
Coutinho da Silva et al. 2013) The bacterial inoculum was deposited midway in the cervical 
lumen with a semi-flexible artificial insemination pipette. The inoculum was contained in 
a 0.5-mL straw and was deposited with the use of a stylet. The bacterial strain used was 
isolated from the placenta from a mare diagnosed with spontaneously ascending placentitis 
by the University of Kentucky Veterinary Diagnostic Laboratory.  The bacterial isolate was 
preserved in cryovials containing skim milk at -80oC until use. Prior to inoculation, 
bacterial cultures were prepared and bacterial counts performed in standard fashion using 
blood Agar plates (incubated at 37oC), serial dilution and plating were used to determine 
the number of colony-forming units. The bacterial inoculum (5 million cfu) was suspended 
in 0.5 ml of phosphate-buffered saline. Once inoculation was carried out, a swab was 
obtained from the leftover in the cryovial and cultured in similar conditions to assure that 
the bacteria inoculum was still viable. 
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Blood Sampling and Immunoassays 
Blood samples were obtained immediately before inoculation/initial fetal fluid 
sampling (d=0), and then daily for 12 days DPI or until abortion. Blood was attained by 
jugular venipuncture into heparinized 10-mL tubes. Immediately after collection, the blood 
was centrifuged at 600 xg for 10 min at 5o C. Plasma was harvested and preserved at -20o C 
until further analysis for DHEA-S and testosterone as described in study I. 
Placental and Fetal Pathology 
All aborted fetuses and placentas from inoculated mares and control underwent 
pathologic and microbiological examination as previously described (Hong et al. 1993) at 
the University of Kentucky Veterinary Diagnostic Laboratory.  Here briefly, the placenta 
was laid out and the chorioallantois, amnion, and umbilical cord were examined. Areas 
with no apparent lesions and areas presenting macroscopic lesions were sampled and 
preserved in buffered formalin for further histopathological evaluation. Swabs were 
collected from the chorioallantois and used to perform aerobic bacterial culture (Hong et 
al. 1993). Fetuses were necropsied in routine fashion and internal organs (liver, spleen, 
stomach content, lung, heart, and trachea) were macroscopically examined and sampled 
for histopathologic evaluations and aerobic bacterial culture (Hong et al. 1993). 
 
Statistical Analyses 
All analyses were performed using JMP software. In study I, data were log-
transformed and analysed with a mixed model (mare as random effect and time as a fixed 
effect). Post hoc comparisons were made by Fisher’s protected least significant difference 
(day effect) test.  In study II, data were log-transformed and analysed with a mixed model. 
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Because time of abortion varied from 5 to 25 days, changes in DHEA-S and testosterone 
concentrations were analysed relative to days from abortion (DFA,-8 days to 0). Mare was 
accounted as random effect and group and time (i.e. DFA) were fixed effects.  Fetal fluid 
sampling was nested within group. Two way interactions were also included in the different 
models. Significance was set at p<0.05. Data are presented as mean ± S.E.M. 
 
4.4. Results 
Study I 
All mares had normal gestation lengths (mean 348 ± 2.8 days; range: 328-362 days) 
and delivered normal placentas. Sixteen mares delivered live healthy foals; two mares had 
dystocias and delivered upon obstetrical interventions; one at 328 and another at 339 days 
of gestation. Pathological examination of the fetal membranes and foals concluded that 
dystocia was the cause of the intra-partum death.  There was significant day-effect for both 
androgens (p<0.0001) (Fig. 4.1 & 4.2). Concentrations of DHEA-S peaked by six months 
of gestation (p<0.05) (Fig. 4.1). However, testosterone was progressively elevated from 
days 100 to 180, and then remained elevated until ~240 days of gestation; thereafter a 
progressive decline was observed towards 290 days of gestation. Concentrations of 
testosterone remained constant between ~290 days and term (p>0.05) (Fig. 4.2).  
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Figure. 4.1: Dehydroepiandrosterone sulfate (DHEA-S) concentrations in eighteen light-
breed mares carrying normal pregnancies from ~100 days of gestation to term. There were 
significant differences across sampling days (p<0.0001), with a peak between 175 and 189 
days of gestation (p<0.05). 
 
Figure 4.2: Testosterone concentrations in eighteen light-breed mares carrying normal 
pregnancies from 100 days of gestation to term. There were significant differences across 
sampling days (p<0.0001). Under the conditions of the present study, testosterone did not 
present a distinct peak. However, testosterone was progressively elevated from days 100 
to 180, and then remained plateaued until ~240 days of gestation; thereafter a progressive 
decline was observed towards 290 days of gestation. 
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Study II 
The mean time from inoculation to abortion was 9.4 ± 1.3 days (range: 5-25 DPI) 
for mares with experimentally induced ascending placentitis. One control mare in subgroup 
FFS aborted 8 days after the last sampling; pathological and microbiological examination 
of the placenta and fetus revealed no lesions and culture yielded saprophytic non-
pathogenic bacteria (Table 4.1) and negative virus isolation (data not shown); thus the 
cause of abortion was not determined. One mare in the placentitis group (subgroup without 
FFS) failed to develop placentitis after experimental inoculation; she delivered a normal 
foal and placenta with no microbiological (Table 4.1) or pathological evidence of 
placentitis. These two mares were excluded from the analyses.  Two mares in the group 
with experimentally induced placentitis (one with and another without FFS) did not 
develop placentitis and were re-inoculated 14 days after the first inoculation. Results from 
14 days following the first inoculation were excluded from the analyses for DHEA-S or 
testosterone.  The re-inoculated mare without FFS aborted at 20 DPI and the other re-
inoculated mare with FFS aborted 9 DPI.  
As expected, Streptococcus equi ssp. zooepidemicus was the most prevalent isolate 
from placentas and fetuses from inoculated mares, however, in other fetuses and placentas 
from inoculated mares, Escherichia coli (n=3) and Actinobacillus equuli  (n=1) were also 
cultured in association with the Streptococcus equi ssp. Zooepidemicus (Table 4.1). Except 
for one mare that failed to develop placentitis after experimental inoculation (noted above) 
and the control mare with FFS that aborted, all the remaining mares that aborted with 
experimentally induced ascending placentitis developed gross and histopathologic lesions 
consistent with ascending placentitis (i.e. neutrophilic infiltration in the intervillous spaces, 
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necrosis of chorionic villi, infiltration of mononuclear inflammatory cells in the intervillous 
spaces, villous stroma, chorionic stroma, endothelium and allantois) (Hong et al. 1993) 
(data not shown). All mares in the control group delivered macroscopically and 
microscopically normal placentas. Bacterial culture yielded non-pathogenic saprophytic 
bacteria (Table 4.1).  All but two fetuses from the experimentally induced ascending 
placentitis group were dead at delivery.  These two foals delivered alive (one spontaneously 
and one upon inducted parturition), had clinical evidence of sepsis and were euthanized 
immediately post-delivery. Streptococcus equi ssp. zooepidemicus was isolated in all of 
their internal organs.   
Analyses with the full mixed model for the concentrations of DHEA-S showed no 
differences between groups (p=0.88), or effects of time (DFA p<0.0001), but there were 
interactions between groups and DFA (p<0.0001) and between FFS and DFA (p=0.0001). 
Therefore, the data were re-analyzed in separated mixed models (with mare as random 
effect, group and DFA as fixed effects), for mares having FFS and mares without FFS. 
Comparisons between groups were performed as aforementioned. Concentrations of 
DHEA-S in mares without FFS, revealed no differences between groups (p=0.52), or 
effects of time (DFA p=0.1) or interactions between group and time (Group*DFA p=0.17) 
(Figure 4.3).  However, for the subset of mares having FFS, there were no differences 
between groups (p=0.57), but there were effects of time (DFA p<0.0001), and time by 
group interaction (DFA*group p<0.001). Post hoc comparisons showed that the day of 
abortion was significantly different in mares with experimentally induced ascending 
placentitis (p<0.05) (Figure 4.3).   
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For the testosterone concentrations, there were no significant differences between 
mares in the control group and mares with placentitis (DFA p=0.15) (Fig. 4). There were 
no effects on time (DFA p=0.07) or interactions between group and time (DFA p=0.43) 
(Fig. 4.4). 
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Figure 4.3 Dehydroepiandrosterone sulfate (DHEA-S) concentrations in mares with 
experimentally induced ascending placentitis (n=17) and gestationally age-matched control 
mares carrying normal pregnancies (n=17). Days from abortion (DFA), -8 to 0 (i.e. day of 
abortion) DFA.  Within groups, a subset of 7 mares had fetal fluid sampling (FFS) 
performed at 0, 5 and 12 days post inoculation or until abortion. (A) Represents mares from 
both groups without FFS. There were no groups differences (p=0.52), effects of (DFA 
p=0.10) or interactions between group and time (group*DFA p=0.17). (B) Represents the 
subset of mares from both groups having FFS. There were no group differences (p=0.57). 
However, there were effects of time (DFA p<0.0001), and interaction between time and 
group (group*DFA p<0.001). As denoted by the letters on the figure above, the day of 
abortion was significantly different than the remaining sampling days (p<0.05).   
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Figure. 4.4 Testosterone concentrations in mares with experimentally induced ascending 
placentitis (n=17) and gestationally age-matched control mares carrying normal 
pregnancies (n=17). Days from abortion (DFA), -8 to 0 (i.e. day of abortion) DFA. There 
were no significant differences between mares in the control group and mares with 
placentitis (DFA p=0.15). There were no effects of fetal fluid sampling (FFS p=0.64), or 
effects time (DFA p=0.07) or interactions between group and time (DFA p=0.43) and 
group and time and FFS (p<0.99).  
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Table 4.1: Bacterial culture results from aborted fetuses and placentas from mares in the 
control group and mares with experimentally induced ascending placentitis.  
Organism  Number 
S. equi ssp zooepidemicus 12 
S. equi ssp zooepidemicus & E.coli 3 
S. equi ssp zooepidemicus & Actinobacillus equuli 1 
Non-pathogenic bacteria* 18 
*This represents all mares in the control group and one mare that did not develop placentitis 
after inoculation and that was not re-inoculated. 
 
4.5. Discussion 
 
Because both DHEA-S and testosterone are products of the fetal placental unit, we 
hypothesized that disruption of placental function resulting from experimentally induced 
ascending placentitis would affect the ability of these tissues to metabolize the precursor 
(DHEA) to estrogens and testosterone. However, contrary to our hypothesis, 
concentrations of both androgens examined herein were not different between groups after 
experimental induction of ascending placentitis in mares. Therefore, our findings in mares 
with experimentally induced ascending placentitis suggest that neither androgen can be 
used as a diagnostic marker for spontaneous placentitis; however this has not been critically 
tested.  
The experimental model used to induce ascending placentitis differs from 
spontaneous clinical cases of ascending placentitis, as spontaneous cases tend to be more 
insidious and chronic in comparison with the experimental model, which induces a more 
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acute placentitis. However, we used a smaller inoculating dose (5 million vs. ~10million 
cfu) compared to previous studies (Leblanc et al. 2002, Christensen et al. 2010, Bailey et 
al. 2010, Macpherson et al. 2013, Coutinho da Silva et al. 2013) and mares here aborted 
from 5-25 days after inoculation with an average of ~9.5 days. Furthermore, we did not 
observe acute abortions (i.e. 2-3 days post inoculation) as reported elsewhere. (Coutinho 
da Silva et al. 2013).  Nonetheless, concentrations of both androgens did not vary 
remarkably throughout the experimental days, except DHEA-S which was significantly 
reduced on the day of abortion for mares (subgroup with FFS) with experimentally induced 
ascending placentitis. 
Recent findings from our laboratory appeared to support our hypothesis that 
placentitis affects peripheral androgen concentrations in mares with placentitis; the study 
demonstrated that inhibition of estrogen synthesis using letrozole (a non-steroidal 
aromatase inhibitor) resulted in elevation of DHEA-S and testosterone in plasma of late-
term pregnant mares (unpublished data). We considered that the placental insult prompted 
by placentitis would cause similar effects for both androgens. Unpublished observations 
from our laboratory had shown that mares with experimentally induced ascending 
placentitis present a reduction in estrogens concentrations post-inoculation, therefore it was 
plausible to hypothesize that concentrations of androgens could be elevated in mares with 
placentitis.  Since ascending placentitis only causes partial compromise of the 
chorioallantois (based on pathologic lesions), the remaining unaffected tissues may 
compensate for the affected portion. This could explain why we failed to observe 
differences for both androgens.  
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Mares experiencing pregnancy loss present lower estrogen concentrations in 
comparison to normal mares for the same gestational age (Douglas 2004). It is believed 
that the placental damage would compromise the ability of the placenta to produce 
estrogens, as a consequence we hypothesized that the precursor (DHEA) would accumulate 
in the maternal plasma and as consequence DHEA-S would be also elevated as a 
consequence of increased substrate. Perhaps the mechanism leading to the reduction of 
estrogens in mares with placentitis is related to other unknown mechanisms. Here we 
reported the first controlled study attempting to use androgens, particularly DHEA-S and 
testosterone, as diagnostic markers for mares with placentitis. Previously, a clinical 
descriptive case report had measured DHEA-S and DHEA in eight high risk pregnant 
mares; however, the authors found that neither DHEA-S nor DHEA appeared to be 
particularly useful markers in these mares (Meinecke & Gips 1990). Our findings appear 
to support the clinical observations by Meinecke & Gips (1990).  
In normal pregnant mares, concentrations of both DHEA-S and testosterone varied 
greatly within mares across 100 days of gestation to term. Concentrations of DHEA-S 
peaked by ~180 days of gestation which is similar to a previous report involving five 
pregnant mares (Rance et al. 1978) and slightly before previously reported peak 
concentrations for estrogens (Ginther 1992).The earlier rise in DHEA suggests that the 
equine fetal gonads are synthesizing the precursor (i.e. DHEA) and that the placenta is not 
fully converting DHEA into estrogens. Interestingly, contrary to an earlier report,[19] 
testosterone did not peak, but rather plateaued from approximately 180 -290 days of 
gestation.  The absolute concentrations of testosterone in the current study were about 
three-fold higher than those reported previously (Silberzahan et al. 1984).  Potential 
99 
 
reasons for the disparity in testosterone concentrations in these studies includes differences 
on the assays (ELISA vs RIA) and antibody crossreactivity. The testosterone antibody used 
in this study has a high cross-reactivity with dihydrotestosterone; however, at this point it 
is unknown whether this metabolite of testosterone is present in significant concentrations 
in plasma of mares in the second and third trimester of pregnancy.  
In conclusion, DHEA-S and testosterone were present in high concentrations in 
pregnant mares and varied through day 100 to term. There were no significant differences 
for concentrations of DHEA-S and testosterone between mares with experimentally 
induced ascending placentitis and gestationally age-matched control mares. Based on our 
experimental results we suggest that neither androgen here evaluated in mares with 
experimentally induced ascending placentitis appear to be a useful marker for spontaneous 
placentitis.   
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5.1. Summary  
Reasons for performing study: Placental steroids have been suggested as useful 
diagnostic markers for pregnancy loss in mares; however, there are few controlled studies 
that have examined changes in steroids in mares with placentitis.  
Objectives: To compare plasma concentrations of estradiol 17β, estrone sulfate and 
progestins in mares with placentitis and with gestationally age-matched control mares.   
Methods: Pregnant mares (260-280d of gestation) were allocated to a control group and to 
a group with experimentally induced placentitis. Induction of placentitis was achieved via 
intracervical inoculation of Streptococcus equi ssp zooepidemicus. Plasma was collected 
at inoculation for mares in the placentitis group or commence for control mares (day=0), 
and then daily until abortion or for 12 days post inoculation (DPI). Concentrations of 
estrone sulfate and progestins were determined by ELISA, whereas estradiol 17β was 
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determined by a chemiluminescence immunoassay.  Data were analyzed by mixed models, 
for DPI and for days from abortion (DFA) for the different steroids.  
Results: Mares with experimentally induced placentitis aborted within 5-25 DPI. There 
were significant effects of time (DPI, p<0.0001; DFA p=0.0008) and time by group 
interactions (DPI or DFA p<0.001) for the concentrations of estradiol 17-β. Concentrations 
of estradiol 17-β were significantly reduced at 4 DPI and at - 2 DFA (p<0.05). Analyses of 
estrone sulfate revealed effects of time (DPI p<0.003; DFA p=0.01) and time by group 
interactions (DPI p=0.002; DFA p<0.0001).  Estrone sulfate concentrations were 
significantly reduced 6 and 7 DPI and on the day of abortion (0 DFA) for mares with 
experimentally induced placentitis. There were no effects of time (DPI p=0.72; DFA 
p=0.76) or time by group interactions (DPI*group p=0.99; DFA*group p=0.54) on 
progestin concentrations.  
Conclusions: Concentrations of estrogens but not progestins changed significantly in 
mares with experimentally induced ascending placentitis. Prospectively controlled studies 
are warranted to evaluate whether estrogens are useful markers for spontaneous placentitis. 
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5.2. Introduction 
Placentitis is an important cause of pregnancy wastage in broodmares (Giles et al. 
1993, Williams et al. 2004). Currently, diagnosis of placentitis is based upon 
ultrasonography and clinical signs (i.e. premature lactation and/or vulvar discharge) 
(Troedsson & Macpherson 2011). Transrectal ultrasonography of the cervical pole of the 
placenta (Renaudin et al. 1997) has been shown to be a useful tool to confirm and to 
manage clinical ascending placentitis (Troedsson & Zent 2004). However, data on 
sensitivity and specificity are scant. Clinical signs vary and may only be detected in 
advanced stages of placentitis (Troedsson & Macpherson 2011); thus, development of new 
diagnostic tests for placentitis will potentially enhance veterinary care for pregnant mares. 
The endocrine fetoplacental unit synthesizes and metabolizes steroids (i.e. 
progestins, androgens, and estrogens) (Cox 1975, Pashen & Allen 1979, Raeside 2004), 
which are responsible for pregnancy maintenance and for preparation of the mare for 
parturition (Cox 1975, Pashen & Allen 1979, Raeside 2004, Ousey 2011). The fetal adrenal 
gland plays a role in endocrine support of pregnancy as an important source of substrate 
(i.e. pregnenolone) for the placental production of progestins (Ousey 2011). The fetal 
adrenal gland expresses P450 side chain cleavage (P450scc) that converts cholesterol to 
pregnenolone (Chavattee et al. 1995, Han et al. 1995, Ousey 2011, Weng et al. 2007). 
Pregnenolone is then metabolized to progesterone by the action of 3β-hydroxysteroid 
dehydrogenase (3β-HSD) in the equine placenta (Chavattee et al. 1995, Han et al. 1995, 
Ousey 2011). Under, normal conditions, progesterone is rapidly converted into 5α-
dihydroprogesterone (5α-DHP; 5α-pregnane,3,20-dione) by the action of a 5α reductase 
present in the equine placenta and endometrium (Ousey et al. 2003, Ousey 2011), and 
5αDHP may be further converted into 20α-hydroxy-5α-pregnan-3-one (20α5P) by 20 α-
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reductase expressed in the placenta (Ousey et al. 2003, Ousey 2011). Progestins can be 
sub-classified as pregnenes and 5α pregnanes. Pregnenes include pregnenolone, 
progesterone and 5-pregnene-3β,20β–diol (P5ββ) (Ousey et al. 2003); 5α-pregnanes 
include 5α-DHP, 3β5P, 20α-5P, ββdiol, 5-pregnene-3β,20α–diol (βαdiol) (Ousey et al. 
2003); however, 5αDHP, 20α5P, and βα-diol predominate (Chavatte et al. 1997). 
During pregnancy, the hypertrophied fetal gonads of both male and female fetuses 
produce large quantities of androgens, particularly dehydroepiandrosterone (DHEA) and 
7-dehydro DHEA from cholesterol and from farnesyl pyrophosphate, respectively [12-
14,17].  Classic phenolic estrogens (i.e. estrone, estradiol-17β estradiol-17α, and their 
sulfoconjugates) are synthesized from DHEA (Raeside 2004). . Ring B unsaturated 
estrogens (i.e. equilin, equilenin and their hydroxyderivatives 17α-dihydroequilin, 17α-
dihydroequilenin, 17β-dihydroequilin, and 17β-dihydroequilenin) are produced from 7-
dehydro-DHEA by the equine placenta (Cox 1975, Raeside et al. 1979, Pashen & Allen 
1979, Raeside, Ousey 2011). Immunolabeling studies of the chorioallantois and labelled 
precursor studies suggested that DHEA is converted into androstenedione by 3β-HSD and 
that androstenedione can be converted into estrone by aromatase or into testosterone by 
17-β hydroxysteroid dehydrogenase (17-β-HSD) (Tait et al. 1985, Bhavnani 1988, 
Chavattee et al. 1995, Raeside 2004, Ousey 2011). In turn, estrone can be converted into 
estradiol 17-β by 17-βHSD in the chorioallantois (Raeside 2004, Ousey 2011). It is thought 
that estrone sulfate can be converted into estradiol 17 β sulfate by 17-βHSD in the 
endometrium (Ousey 2011). The key role of the placenta in steroidogenesis during equine 
pregnancy suggests that pathologic conditions of the fetoplacental unit will compromise 
the ability of different steroids to be metabolized and released in the maternal circulation. 
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Abnormalities of pregnancy may alter the normal profile of placental steroids and 
serial determinations of peripheral steroids in the pregnant mare have been suggested as 
useful diagnostic markers for placentitis (Kashman et al. 1988, Rossdale et al. 1991, 
Douglas 2004, Ousey et al. 2005). Mares with placental pathology may have increased 
plasma concentrations of progestins as a result of fetal stress (Douglas 2004, Ousey et al. 
2005, Ousey 2011). Estrone sulfate has been suggested to be a useful marker for fetal well-
being during early pregnancy (Kashman et al. 1988); however, studies involving estrone 
sulfate in advanced pregnancy are scant (Kashman et al. 1988, Ousey et al. 1987). To our 
knowledge, there are no controlled studies assessing estrone sulfate in mares experiencing 
placentitis, despite its frequent use to assess fetal well-being. Field studies carried by a 
commercial laboratory reported that mares at risk for abortion had significantly lower “total 
estrogen” (unreported cross-reactivity) concentrations than mares that maintained 
pregnancy (Douglas 2004). Controlled studies are warranted to confirm field observations 
about estrogens and progestins and to assess whether estrone sulfate is a useful marker for 
placentitis. Therefore, we hypothesized that experimentally induced placentitis will be 
associated with the reduction of estrogens and increase in progestin concentrations. The 
objective of the current study was to compare plasma concentrations of progestins, 
estradiol 17β, and estrone sulfate in mares with experimentally induced ascending 
placentitis and gestationally aged-matched control mares carrying normal pregnancies. 
 
 
 
 
105 
 
5.3. Material and Methods 
Animal Husbandry  
Horse mares enrolled in these experiments were maintained at the Maine Chance 
Farm. All the experimental protocols were approved by the Institutional Animal Care and 
Use Committee at the University of Kentucky. All mares were kept in paddocks and 
supplemented with hay, grain and water ad libitum along with trace minerals. Upon 
imminent abortion or normal parturition, mares were kept in individual stalls (16 x 16 feet) 
during the night and turned out in pasture throughout the day.  
Experimental Design & Induction of Ascending Placentitis  
Mares carrying normal pregnancies (260-280 days of gestation) were assigned to 
(1) a control group and to (2) a group with experimentally induced ascending placentitis. 
As part of another study, within each group, a subset of mares had fetal fluid sampling 
(FFS) performed at 0, 5 and 12 days post inoculation (DPI) or until abortion. Similar 
methodology has been described elsewhere (Paccamonti et al. 1995) and has been slightly 
modified (Canisso et al. 2014). Briefly, the mare was sedated, placed in stocks and fetal 
fluids were collected with transabdominal ultrasound and an echotip spinal needle 
(18G×6”; 30o short bevel, Chiba-Type spinal needle, with stylet, Echo Block PTC Havel’s 
Cincinnati, OH, USA) (Canisso et al. 2014). 
Ascending placentitis was induced via intracervical inoculation of Streptococcus 
equi ssp. zooepidemicus. The experimental model for induction of bacterial placentitis in 
the mare was modified from that previously described (LeBlanc et al. 2002) and has been 
successfully used by different laboratories as a reliable and predictable model to induce 
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ascending bacterial placentitis in the mare (Coutinho da Silva et al. 2013, Morris et al. 
2007).  Sham inoculation of control mares was not performed in the present study as this 
procedure may induce placentitis in an unpredictable manner; as noted by previous 
publications.  The bacterial inoculum was deposited midway intracervically with the usage 
of a semi-flexible artificial insemination pipette. The inoculum was contained in a 0.5-mL 
straw and was deposited with the use of a stylet. The bacterial strain used was isolated from 
a placenta from a mare diagnosed with spontaneously ascending placentitis by the 
Veterinary Diagnostic Laboratory at the University of Kentucky.  The bacterial isolate was 
preserved in cryovials containing skim milk at -80oC until use.  Prior to inoculation, 
bacterial cultures were prepared and bacterial counts performed in standard fashion using 
blood Agar plates (incubated at 37oC), serial dilution and plating were used to determine 
the number of colony-forming units. The bacterial inoculum, containing 5 million colony 
forming units (cfu), was suspended in 0.5 ml of phosphate buffered saline. Once 
inoculation was carried out, a swab was obtained from the leftover in the cryovial and 
cultured in similar conditions to assure that the bacteria inoculum was still viable. 
Transrectal Ultrasonography 
Before the beginning of the experiment, mares underwent transrectal 
ultrasonography to assess the caudal placental pole to assure that all mares were carrying 
normal pregnancies. Three measurements of the combined thickness of uterus and placenta 
(CTUP) were taken and compared with previously established normal ranges (Renaudin et 
al. 1997). All mares had CTUP measures within previously reported normal ranges and 
presented normal ultrasonography appearance of the caudal pole of the placenta (data not 
shown); therefore all mares were enrolled in this study.  Thereafter, all mares had 
107 
 
transrectal ultrasonography performed every other day for 12 days or until abortion to 
follow ultrasonographic changes in inoculated mares and to confirm the lack of changes in 
mares in the control group. Particularly, we assessed changes that are highly indicative of 
placentitis including placental separation and fluid accumulation between the uterus and 
chorioallantois. It was out of the scope of this study to compare or associate 
ultrasonographic findings with steroid concentrations. A previous publication using a 
different progestin assay had addressed these associations (Morris et al. 2007).  
Determination of Estradiol 17β, Estrone sulfate and Progestins Concentrations  
Blood samples were obtained immediately before inoculation/initial FFS (d=0), and 
then daily for 12 days or until abortion. Blood was attained by jugular venipuncture into 
heparinized 10-mL tubes. Immediately after collection, the blood was centrifuged at 600 
xg for 10 min at 5o C. Plasma was harvested and preserved at -20o C until further analysis. 
Estradiol 17β concentrations were determined in 17 mares in the control group and 
14 mares in the group with experimentally induced ascending placentitis. As part of another 
study, FFS was performed in a subset of 7 mares in the control group and 5 mares in the 
placentitis group. Concentrations of estradiol 17β were determined by chemiluminescent 
immunoassay (Estradiol, Immulite 1000, Siemens; intra-assay CVs were 1.2-1.4%; 
interassay CVs were 2-3.15%). The detection range for this assay varies from 20 to 2,000 
pg/mL with an analytical sensitivity of 15 pg/mL. According to the manufacturer, the cross 
reactivity for this assay is non-significant for most adrenal and reproductive steroids (the 
reader is referred to kit’s manual, for more information), thus the highest reported cross 
reactivity was 2.09% with estrone.   
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Concentrations of estrone sulfate were measured in 28 mares, with 14 in each 
group. As part of another study, FFS was performed in a subset of 7 mares in the control 
group and 6 mares in the placentitis group. Estrone sulfate was determined (in triplicate) 
using a competitive immunoassay previously validated for horses (Stabenfeldt et al. 1991, 
Carneiro et al. 1998). The standard curve ranged from 0.05 ng/mL to 20 ng/mL with a limit 
of detection of 0.05 ng/well (intra-assays CV of 10.2% and inter-assay CV of 16.6%). The 
reported cross-reactivity of the polyclonal antibody (R583) used for this assay are estrone-
3-sulphate (100%), estrone-3-glucorinide (70%), estrone (269%), and estradiol-17β (9.8%) 
(Stabenfeldt et al. 1991).  
Progestin concentrations were determined in 14 mares in the control group and 14 
mares in the group with experimentally induced ascending placentitis. As part of another 
study, FFS was performed in a subset of 6 mares in the control group and 7 mares in the 
placentitis group. Progestins concentrations were determined (in duplicate) by the use of a 
competitive immunoassay (Munro & Stabenfeldt 1984).  Cross-reactivity for this antisera 
was reported in the initial description as 11α-hydroxyprogesterone 21.4%, 17 α-
hydroxyprogesterone 0.25%, 20α-hydroxyprogesterone 0.32%, 20β-hydroxyprogestone 
2.38%, 5 α-DHP 29.5%, estradiol 17β 0.02%, cortisol 0.02%, androstenedione 0.07%, and 
testosterone 0.03% (Munro & Stabenfeldt 1984). The standard curve ranged from 0.05 
ng/mL to 20 ng/mL, with a limit of detection of 0.25 ng/well (intra-assays CV of 15.4% 
and inter-assay CV of 18.5%). 
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Placental and Fetal Pathology 
Placentas from control and inoculated mares, and all aborted fetuses underwent 
complete pathological (macroscopic and histopathologic examination) and microbiological 
evaluation (Hong et al. 1993).  Here briefly, the placenta was laid out and the 
chorioallantois, amnion, and umbilical cord were examined. Areas with no apparent lesions 
and areas presenting macroscopic lesions were sampled and preserved in buffered formalin 
for further histopathologic evaluation. Swabs were collected from the chorioallantois and 
used to perform aerobic bacterial culture (Hong et al. 1993). Fetuses were necropsied in 
routine fashion and internal organs (liver, spleen, stomach content, lung, heart, and trachea) 
were macroscopically examined and sampled for histopathologic evaluations and aerobic 
bacterial culture (Hong et al. 1993). 
Statistical Analyses  
All the data analyses were carried out with JMP 10 (SAS Institute, Cary NC, USA). 
Concentrations of estradiol 17β, estrone sulfate and progestins were analyzed relative to 
days post-inoculation (DPI, 0 to 7 days) as well as relative to days from abortion (DFA,-8 
days to 0) in separate mixed models. Mare was accounted as random effect, and treatment 
and time (DPI or DFA) were fixed effects. Fetal fluid sampling was nested within group. 
As we were interested in evaluating the acute changes in steroids concentrations following 
inoculation, the data were analyzed for changes up to 7 DPI. On the other hand, as the 
interval from inoculation to abortion was variable, we examined the changes in steroids in 
the eight days prior to abortion.  Two and three way interactions were also included in the 
different models for DPI and DFA. Since there were no effects of FFS, data were combined 
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within groups for further analyses.  Prior to analyses, the data were log transformed as 
necessary. Post-hoc comparisons across days were analyzed by Fisher’s Least Significant 
Difference Test. Data are presented as mean ± S.E.M.  Correlations between estradiol 17  
and estrone sulfate were determined by pairwise comparisons. 
 
5.3. Results 
Mares with experimentally induced placentitis aborted between 5 and 25 DPI. 
Three mares that were inoculated failed to develop placentitis after a single inoculation. 
One mare with experimentally induced placentitis (subgroup without FFS) did not develop 
placentitis; she delivered a normal foal and a placenta with no pathological or 
microbiological evidence of placentitis, this mare was excluded from the analyses. Two 
mares in the group with experimentally induced placentitis (one with and another without 
FFS) did not develop placentitis and were re-inoculated 14 days after the first inoculation. 
The mare without FFS aborted 20 days after re-inoculation and the other mare with FFS 
aborted 9 days after re-inoculation. The first 14 days following the first inoculation in these 
two were re-inoculated mare were excluded from the analyses. 
As expected and noted in a parallel publication, Streptococcus equi ssp. 
zooepidemicus was the predominant bacterial isolate, however E. coli was also isolated in 
association with Streptococcus equi ssp. zooepidemicus. All inoculated mares, but one 
mare, developed ultrasonographic changes consistent with ascending placentitis (i.e. 
placental separation, fluid accumulation between uterus and the chorioallantois). All mares 
in the control group presented normal ultrasonographic findings (data not shown). With the 
exception of one mare that failed to develop placentitis after experimental induction (noted 
above) and the control mare with FFS that aborted, all the remaining mares that aborted 
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with experimentally induced ascending placentitis developed gross and histopathologic 
lesions consistent with ascending placentitis (Hong et al. 1993) (data not shown). All mares 
in the control group delivered macroscopically and microscopically normal placentas. 
Bacterial culture yielded non-pathogenic saprophytic bacteria (data not shown).   
There were significant effects of time (DPI, p<0.0001; DFA p=0.0008) and time by 
group interactions (DPI or DFA p<0.001) for the concentrations of estradiol 17-β (Figure 
1). Post hoc comparisons revealed that concentrations of estradiol 17-β was significantly 
reduced 4 DPI and - 2 DFA (p<0.05). Analyses of estrone sulfate revealed effects of time 
(DPI p<0.003; DFA p=0.01) and time by group interactions (DPI p=0.002; DFA 
p<0.0001).  Estrone sulfate concentrations were significantly reduced 6 and 7 DPI and in 
the day of abortion (0 DFA) for mares with experimentally induced ascending placentitis 
(Figure 2). For the progestin concentrations, there were no effects of time (DPI p=0.72; 
DFA p=0.76) or time by group interactions (DPI*group p=0.99; DFA*group p=0.54) 
(Figure 3). Estradiol 17 and estrone sulfate concentrations were moderately correlated 
(r=0.34, p=0.001).  
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Figure 5.1. Estradiol 17-β concentrations in mares with experimentally induced ascending 
placentitis (n=14) and gestationally age-matched control mares carrying normal 
pregnancies (n=17). The average time from inoculation to abortion was 7.8 days (range 5-
14 days). (A) Represents 0 (i.e. day of inoculation/commence of sampling for control 
mares) to 7 days post inoculation (DPI). (B) Represents samples for days from abortion 
(DFA) -8 to 0 (i.e. day of abortion). There were significant effects of time (DPI, p<0.0001; 
DFA p=0.0008) and time by group interactions (DPI or DFA p<0.001). Post hoc 
comparisons revealed that concentrations of estradiol 17-β was significantly reduced 4 DPI 
and - 2 DFA (p<0.05). *Within day denotes significant difference (p<0.05) between 
groups.  
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Figure 5.2: Estrone sulfate concentrations in mares with experimentally induced ascending 
placentitis (n=14) and gestationally age-matched control mares carrying normal 
pregnancies (n=14). The average time from inoculation to abortion was 9.4 days (5-25 
days). (A) Represents 0 (i.e. day of inoculation/commence of sampling for control mares) 
to 7 days post inoculation (DPI). B) Represents samples for days from abortion (DFA) -8 
to 0 (i.e. day of abortion). There were effects of time (DPI p<0.003; DFA p=0.01) and time 
by group interactions (DPI p=0.002; DFA p<0.0001).  Estrone sulfate concentrations were 
significantly reduced 6 and 7 DPI and on the day of abortion (0 DFA) (p<0.05). *Within 
day denotes significant statistical difference p<0.05.  
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Figure 5.3: Progestin concentrations in mares with experimentally induced ascending 
placentitis (n=14) and gestationally age-matched control mares carrying normal 
pregnancies (n=14). The average time from inoculation to abortion was 9.4 days (range 5-
25 days) (A) Represents 0 (i.e. day of inoculation/commence of sampling for control 
mares) to 7 days post inoculation (DPI). B) Represents samples for days from abortion 
(DFA) -8 to 0 (i.e. day of abortion). There were no effects of time (DPI p=0.72; DFA 
p=0.76) or time by group interactions (DPI*group p=0.99; DFA*group p=0.54) for the 
concentrations of progestins.  
 
5.5 Discussion 
 
Although peripheral estrogens in the mare have been suggested as a possible marker 
for fetoplacental well-being for many years (Kashman et al. 1988), this is the first report 
to demonstrate time-dependent changes in estrogen concentrations subsequent to 
experimentally induced, ascending placentitis in mares.  Approximately, 99% of the 
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estradiol 17β in pregnant mares is present as a sulfoconjugate; however, the remaining 1% 
is present in the maternal circulation as estradiol 17β (Ginther 1992). Here, we 
demonstrated that free estradiol 17 β was significantly reduced following experimental 
induction of placentitis, therefore, this steroid may be a useful diagnostic marker for 
placentitis in mares with spontaneous disease. Interestingly, estrone sulfate, a commonly 
used hormone to monitor the fetal wellbeing, was only reduced several days after 
inoculation/or close to abortion. This suggest that this marker only changes in advanced 
stages of placentitis, but also may reflect the long half-life of this hormone in maternal 
plasma which may limit its clinical applications.  Concentrations of estradiol 17 β and 
estrone sulfate presented low correlations, this lack of associations can be explained by the 
different half-lives, as sulfoconjugated steroids are thought to have longer half-lives.  
Prior studies have reported changes in estrone sulfate concentrations relative to 
early fetal loss in the mare; however, the experimental induction of pregnancy loss in these 
mares involved acute induction of fetal death or luteolysis which have very different effects 
on placental function than the induction of ascending placentitis in the current study 
(Kashman et al. 1988, Stabenfeldt et al. 1991). Santschi et al. (1991) examined changes in 
estrone sulfate concentrations in pregnant mares with a variety of medical and surgical 
conditions and concluded that estrone sulfate concentrations in late gestation frequently 
overlapped with those of normal pregnancy. In contrast, Douglas (2004) reported 
significantly lower “total serum estrogen” concentrations in mares that aborted with 
placentitis than mares that delivered live foals during the interval between 150 and 280 
days of gestation.  In Douglas’ study (2004), estrogens were determined using an assay for 
17α estradiol, thus limited direct comparisons can be drawn.   
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It is surprising that progestin concentrations did not change in mares with 
experimentally induced placentitis in the current study. In a previous study, significant 
differences in progestin concentrations were reported following placentitis (Morris et al. 
2007). In mares with experimental placentitis, it was found that chronic placentitis (defined 
by the authors as mares aborting >7 days after inoculatiuon) was associated with increased 
plasma progestin concentrations (Morris et al. 2007). Conversely, mares that developed 
acute placentitis and abortion soon after infection experienced a rapid drop in plasma 
progestin concentrations (Morris et al. 2007). The authors suggested that measurement of 
repeated samples of plasma progestin concentrations in mares with placentitis might be a 
useful method to identify mares that may abort or deliver prematurely, especially if 
combined with transrectal ultrasonography. In the present study, we did not analyze 
changes in progestin concentrations based upon interval to abortion, but rather examined 
changes in concentrations for progestins for all mares based upon days from abortion. In 
the current study, there were no significant changes in plasma progestin concentrations in 
mares aborting with experimentally induced placentitis.  In another report with seven 
spontaneous cases of placentitis, gas chromatography-mass spectrophotometry analyses 
revealed changes in different progestins which appeared to be elevated (i.e. P4, P5,3β5P, 
P5ββ, ββ-diol, βα-diol, 5α-DHP, 20α5P, 20β-OH) (Ousey et al. 2007). Since the mares in 
that report were not sampled at regular and similar intervals, additional studies should be 
carried with mares sampled at regular intervals and gestationally age-matched control 
mares should be also sampled. It is also worth noting that the antibody used in our study 
for determination of progestin concentrations was different than the antibody used by 
Morris et al. (2007). As noted before, the antibody used in the present study (Munro & 
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Stabenfeldt 1984) cross-reacts with 5α-DHP in ~30%; however, the assay used by Morris 
et al. (200), the authors reported that their assay cross-reacted with 5α-DHP 10%. It is 
possible that differences in cross-reactivity can explain the discrepant results between 
Morris et al. (2007) and our findings.  
In conclusion, estrogens but not progestins changed following experimental 
induction of placentitis in mares. Estradiol 17β concentrations changed rapidly in plasma 
of mares with experimentally induced ascending placentitis, contrary to estrone sulfate 
which changed only close to abortion. Concentrations of estradiol 17β and estrone sulfate 
are only moderately correlated. Our observations with experimental cases of ascending 
placentitis should be expanded to prospectively controlled field studies to confirm the 
usefulness of estradiol 17β as a diagnostic maker for placental disease in the mare.  
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Chapter 6 
Alpha-fetoprotein is Present in the Equine Fetal Fluids and is Increased in Plasma 
of Mares with Experimentally Induced Ascending Placentitis 
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6.1. Summary 
The objectives of this study were to: (i) determine alpha-fetoprotein (AFP) concentrations 
in fetal fluids (FF), (ii) compare plasma concentrations of AFP in mares with placentitis 
(n=17) and gestationally age-matched control mares (n=17), and (iii) use cytology of the 
FF to determine its origin. Fetal fluid sampling (FFS, n=7/group) was performed at 0, 5 
and 12 days post inoculation (DPI) or until abortion. Plasma was harvested daily for 12 
days or until abortion.  Placentitis was induced via intracervical inoculation of 
Streptococcus equi ssp. zooepidemicus. Proteins present in the FF were resolved by 1D-
SDS-PAGE. Immunoblotting was used to detect the presence of AFP in fetal fluids. 
Concentrations of AFP in FF and plasma were determined with a chemiluminescence 
immunoassay. Mixed models for DPI, and for days from abortion (DFA) were used to 
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analyze plasma concentrations of AFP. A protein band ~68 kDa consistent with the AFP 
size was present in all samples. Immunoblotting for AFP revealed a single protein (~68 
kDa) in all samples. Concentrations of AFP in FF appeared higher than those in maternal 
plasma.  There were effects of time (DPI p<0.0001; DFA p=0.0002) and time-by-group 
interactions (DPI*Group p<0.06; Group*DFA p<0.001). Amniotic fluid was found to be 
rich in epithelial cells; however, allantoic fluid was acellular. This study confirmed that 
AFP is present in the FF of mares during the third trimester of pregnancy. Cytology can be 
used to identify the origin of the FF. Experimentally induced placentitis was associated 
with an elevation in plasma concentrations of AFP. 
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6.2. Introduction 
 
Ascending placentitis, an importance cause of pregnancy wastage, is the most 
prevalent type of placentitis in mares (Hong et al. 1993); three other less common 
morphologic forms have been recognized (i.e. focal mucoid, hematogenous, and 
multifocal) (Williams et al. 2004). Ascending placentitis can be caused by fungal or 
bacterial agents with bacteria being responsible for about 90% of clinical cases (Hong et 
al. 1993). Bacterial agents commonly associated with the occurrence of ascending 
placentitis include Streptococcus equi subspecies zooepidemicus (S. zooepidemicus), 
Escherichia coli (E. coli), Klebsiella pneumoniae, and Pseudomonas aeruginosa, although 
beta-hemolytic streptococci predominate (Hong et al. 1993, Giles et al. 1993, Williams et 
al. 2004).  
Currently the diagnosis of ascending placentitis is based on clinical signs (i.e. 
premature mammary gland development ± streaming milk, and vulvar discharge) and 
transrectal ultrasonography of the caudal pole of the placenta (Troedsson & Macpherson, 
2011).  Although ultrasonography of the placenta has been shown to be a useful tool for 
the clinical diagnosis of ascending placentitis (Troedsson & Zent 2004), information on the 
sensitivity and specificity of the technique is limited.  Furthermore, early stages of 
placentitis may not be detected with transrectal ultrasonography. Therefore, new diagnostic 
markers are needed for early diagnosis and to avoid unnecessary treatment of normal 
pregnant mares.  
To date several markers have been investigated in mares experiencing pregnancy 
losses. Among these markers, steroids produced by the fetoplacental unit have been the 
focus of the majority of the reports (Rossdale et al. 1991, Douglas 2004, Ousey et al. 2005, 
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Morris et al. 2007).  Relaxin, a placental specific hormone has also been investigated in 
high risk pregnant mares (Ryan et al. 2009); however, the lack of a commercially available 
equine assay precludes the use of relaxin. Lately, inflammatory acute phase proteins, 
particularly serum amyloid A and haptoglobin have also been investigated (Canisso et al. 
2014a); however, it is unclear whether these inflammatory proteins are useful markers for 
spontaneous cases of placentitis.   
Different diagnostic markers have been identified in amniotic fluid of women with 
chorioamnionitis. Some of these markers are also present in blood and have been used as 
diagnostic tools for pathologic conditions of the placenta and fetus (Gravett et al. 2004, 
Ruetschi et al. 2005, Romero et al. 2008, Buhimschi & Buhimschi 2012). However, in 
comparison to humans, the physiology and pathology of the fetal fluids in domestic 
mammals, particularly in the horse, is poorly understood. In horses, studies have been 
conducted primarily to examine the the presence of certain enzymes also present in other 
body systems as well as quantification of electrolyte composition (Schmidt et al. 1991, 
Williams et al. 1993, Holdstock et al. 1995, Paccamonti et al. 1995, Lyle et al. 2006, 
Zanella et al. 2013, Finger et al. 2014). A more detailed study of protein composition of 
equine fetal fluids would potentially allow the identification of proteins that are highly 
expressed in the fetal fluids, and possibly also present in blood.  
Data from other domestic mammals suggested that alpha-fetoprotein (AFP) is a 
major protein present in the allantoic and amniotic fluids (Okano et al. 1977, Smith et al. 
1979, Luft et al. 1984, Deutsch 1991); Alpha-fetoprotein is a member of the albuminoid 
superfamily, the other protein members of this superfamily are vitamin D binding protein, 
alpha-albumin, and afamin (Lichenstein et al. 1994, Mizejewski 1995). In mammalian 
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fetuses, among other functions, AFP is associated with estrogen-binding (allowing 
development of GnRH surge center in females), anti-oxidative activities (through binding 
of heavy metals), and immunoregulation (Peck et al. 1978, Mizejewski 1995, Gabant et al. 
2002, De Mees et al. 2006). In horses, AFP is highly expressed during early pregnancy by 
the conceptus (Simpson et al. 2000). Although there are no reports of AFP concentrations 
associated with equine fetal fluids later in gestation, it seems likely that AFP continues to 
be a major protein present during the later stages of equine gestation. Cytologic 
preparations of the equine fetal fluids have been suggested to be a useful method to identify 
the type of fetal fluid (i.e. allantoic or amniotic) (Lyle et al. 2006), however, we were 
unable to find any report describing the cytology appearance of these fluids. Therefore, we 
were interested to confirm whether AFP is present in the fetal fluids of mares during the 
third trimester of pregnancy and whether this protein can be measured in plasma of the 
pregnant mare, and whether concentrations of this molecule change followed experimental 
induction of placentitis. The objectives of this study were to: (i) describe AFP 
concentration in the equine fetal fluids, (ii) compare the concentrations of alpha-fetoprotein 
in plasma of mares with experimentally induced placentitis and gestationally age-matched 
control mares, and (iii) use cytological preparations of the fetal fluids to determine its 
origin. 
6.3. Material and methods 
Animal Husbandry  
Mares were maintained at the Maine Chance Farm, Department of Veterinary 
Science, University of Kentucky, Lexington, KY. The Institutional Animal Care and Use 
Committee at the University of Kentucky approved all the experimental protocols (Project 
#2010-0769). All the mares were kept in paddocks and supplemented with hay, grain and 
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water ad libitum along with trace minerals. Immediately prior to normal parturition or pre-
abortion; the mares were kept in individual stalls (16 × 16 feet) during the night and turned 
out on pasture during the day.  
Study Design 
Mares carrying normal pregnancies (260-280 days of gestation) were assigned to 
(1) a control group with (n=7) or without (n=10) trans-abdominal ultrasound-guided fetal 
fluid sampling (FFS) and (2) a treatment group with experimentally induced ascending 
placentitis with (n =7) or without FFS (n=10). Fetal fluid sampling was performed at 0, 5 
and 12 days post inoculation (DPI) or until abortion. Similar methodology has been 
previously described elsewhere (Paccamonti et al., 1995) and slightly modified by us 
(Canisso et al., 2014b). Briefly, the mare was sedated, placed in stocks and fetal fluids were 
collected with transabdominal ultrasound and an echotip spinal needle (18G×6”; 30o short 
bevel, Chiba-Type spinal needle, with stylet, Echo Block PTC Havel’s Cincinnati, OH, 
USA) (Canisso et al. 2014b).  Blood samples were obtained immediately before 
inoculation/initial FFS (d=0) and then daily for 12 days or until abortion.  
Immediately after collection, aliquots of fetal fluids were frozen in liquid nitrogen 
and preserved at -80oC until further analyses. To confirm the origin of each sample, an 
aliquot was submitted to the Veterinary Diagnostic Laboratory at the University of 
Kentucky (UKVDL) for determination of creatinine, calcium, sodium and chloride as 
previously described (Holdstock et al. 1995; Paccamonti et al. 1995). Amniotic fluid has 
low creatinine concentrations and relatively high chloride concentrations, whereas 
allantoic fluid has high creatinine concentrations and low calcium concentrations 
(Paccamonti et al. 1995). Data for creatinine and electrolyte concentrations are presented 
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in the supporting information. In addition, cytologic examination of all fetal fluid samples 
was performed. The slides were prepared by standard cytospin technique and stained by 
Diff-Quick. All fetal fluid samples were submitted for routine aerobic bacterial culture at 
the UKVDL. 
Blood was collected daily from inoculation until 12 DPI or abortion. Blood was 
attained by jugular venipuncture into heparinized 10-mL tubes. Immediately after 
collection, the blood was centrifuged at 600×g for 10 min at 5o C. Plasma was harvested 
and preserved at -20o C until further analysis. 
Experimental Induction of Ascending Placentitis  
Placentitis was induced via intracervical inoculation of S. zooepidemicus. The 
experimental model for induction of bacterial placentitis in the mare was modified (Canisso 
et al. 2014a) from that previously described (Mays et al. 2002; LeBlanc et al. 2002).  The 
bacterial inoculum was deposited midway intracervically with a semi-flexible artificial 
insemination pipette. The inoculum was contained in a 0.5-mL straw was deposited with 
the use of a stylet (Canisso et al. 2014a). The bacterial strain used was isolated from the 
placenta of a mare diagnosed with spontaneously ascending placentitis by the UKVDL.  
The bacterial isolate was preserved in cryovials containing skim milk at -80oC until use. 
Prior to inoculation, bacterial cultures were prepared and bacterial counts performed in 
standard fashion using blood-agar plates (incubated at 37oC) with serial dilution and plating 
to determine the number of colony-forming units. The bacterial inoculum was suspended 
in 0.5 ml of phosphate-buffered saline. Once inoculation was carried out, a swab was 
obtained from the remaining sample in the cryovial and cultured in similar conditions to 
assure that the bacteria in the inoculum remained viable. 
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Placental and Fetal Pathology 
Placentas from control and inoculated mares, and all aborted fetuses underwent 
complete pathological (macroscopic and histopathologic examination) and microbiological 
evaluation (Hong et al. 1993). Briefly, the placenta was laid out and the chorioallantois, 
amnion, and umbilical cord were examined. Areas with no apparent lesions and areas 
presenting macroscopic lesions were sampled and preserved in buffered formalin for 
further histopathologic evaluation. Swabs were collected from the chorioallantois and used 
to perform aerobic bacterial culture (Hong et al. 1993). Fetuses were necropsied in routine 
fashion and internal organs (liver, spleen, stomach content, lung, heart, and trachea) were 
macroscopically examined and sampled for histopathologic evaluations and aerobic 
bacterial culture (Hong et al. 1993). 
Electrophoresis 
Total protein concentration of fetal fluids was determined with the Coomassie 
Protein Assay Kit (Thermo Scientific, Waltham, MA, USA) according to the 
manufacturer’s instructions. Samples (10 µg total protein) were diluted (1:1 v/v) with 
Laemmli sample buffer (Bio-Rad Laboratories, Hercules, CA) and incubated at 95°C for 4 
min followed by electrophoresis on 4-20% SDS polyacrylamide gels (Mini-PROTEAN 
TGXTM Precast Polyacrylamide Gel, Bio-Rad Laboratories, Hercules, CA, USA).  The gels 
were run with a running buffer (Tris-Glycine 0.1% SDS) at 200V for 45 min. All gels were 
stained with Coomassie blue (0.05%, w/v) and subsequently de-stained with methanol 
(20%) and glacial acetic acid (10%). Images were obtained using an automatic reader (Cell 
& Biosciences, San Andreas, CA, USA).  
Immunoblotting Alpha-fetoprotein 
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To confirm the specificity of the AFP antibody, western blotting was performed 
using fetal fluid samples. Samples (10 µg total protein) were diluted with Laemmli sample 
buffer (BioRad, Hercules, CA, USA) and incubated at 95°C for 4 min followed by 
electrophoresis on 10% SDS polyacrylamide gels. After electrophoresis, proteins were 
transferred to 0.2 µm nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA, 
USA) using a wet electroblotting apparatus (Bio-Rad Laboratories, Hercules, CA, USA). 
Membranes were incubated for 1 h in 1×PBS with 0.05% Tween (1×PBS-T) with 5% non-
fat dry milk and 3% BSA to block non-specific binding followed by incubation with goat 
anti-human AFP polyclonal antibody (1:1,000, Santa Cruz Biotechnology Inc., Dallas, TX, 
USA) diluted in 1×PBS-T with 0.3% BSA for 2 h at room temperature. Following several 
wash steps with 1×PBS-T, binding of primary antibody was detected using horseradish 
peroxidase (HRP)-conjugated rabbit anti-goat IgG (1:5,000, R&D Systems, Minneapolis, 
MN, USA) and SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, 
Waltham, MA, USA). Images were visualized using an automatic analyzer (Cell & 
Biosciences, San Andreas, CA, USA). Dilutional parallelism (10 µg-1 µg) was confirmed 
with fetal fluid samples and equine fetal sera samples (data not shown).  Plasma samples 
of pregnant mares (n=3), non-pregnant mares (n=3), and geldings (n=4) were 
immunoblotted, and AFP was not detected in plasma of these animals (data not shown).   
 
 
Determination of Alpha-fetoprotein Concentrations 
Concentrations of AFP in fetal fluids and plasma were measured with a 
heterologous commercial immunoassay (AFP Siemens Healthcare Diagnostics Tarrytown, 
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NY, USA) on a chemiluminescence platform (Immulite® 1000 platform; Siemens 
Healthcare Diagnostics Tarrytown, NY, USA). This assay has a range of 0.2 to 300 units 
of AFP, samples above the upper detection limit were diluted automatically by entering the 
dilution ratio in the platform with the diluent that accompanies the commercial kit.  Since 
AFP is a glycoprotein of the albuminoid superfamily (i.e. closely related to albumin) 
(Deutsch 1991), we examined whether the AFP immunoassay would recognize equine 
albumin (i.e. the major plasma protein in horses). Plasma samples of geldings (n=4), equine 
fetuses (n=3; 300 d gestational age, thought to have high concentrations of AFP), pregnant 
mares in the second and third trimester (n=5) and non-pregnant mares (n=3) were assayed 
for AFP. According to the manufacturer, conversion of units/mL to ng/mL of human AFP 
is accomplished with a correction factor of 1.21. 
Statistical Analyses  
All the data analyses were carried out with JMP 10 (SAS Institute, Cary, NC, USA). 
Plasma concentrations of AFP were analyzed using a mixed model for days from abortion 
(DFA, -7 to 0), with time being treated as a continuous variable, mare as a random effect, 
and group as a fixed effect. Plasma concentrations of AFP were also analyzed using a 
mixed model for days post inoculation (DPI, days 0, 5, 6 and 7).  Two way interactions 
were examined between fixed and continuous effects in both models. In both models, FFS 
did not significantly affect (P > 0.05) plasma AFP concentrations, and data from both 
subsets (i.e. mares having FFS) were combined within groups for further analyses. Post 
hoc comparisons for DPI were performed with Tukey’s HSD test. 
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6.4. Results 
 
Mares with experimentally induced ascending placentitis aborted on average 9.4 ± 
1.3 DPI (range 5 to 25 days). One mare in the control group (subgroup FFS) aborted 8 days 
after the last FFS; placental and fetal examination revealed no pathologic lesions and 
culture yielded saprophytic non-pathogenic bacteria and negative virus isolation (data not 
shown).  Therefore, the cause of abortion in this mare was not determined.  Three mares 
(17.6% of the mares that were inoculated) failed to develop placentitis after a single 
inoculation. One of these mares (subgroup without FFS) was not re-inoculated, a normal 
foal was delivered, and there was no evidence of placentitis. The two other mares (one with 
and another without FFS) that failed to develop placentitis were re-inoculated 14 days after 
the first inoculation. One mare (subgroup without FFS) aborted 20 days after re-
inoculation, whereas the other mare (subgroup with FFS) aborted 9 days after re-
inoculation. The mare that was not re-inoculated (treatment group) and the control mare 
that aborted were excluded from the analyses.  Similarly, the first 14 days of samples for 
the two re-inoculated mares were excluded from the analyses.  
Twelve fetuses and placentas from inoculated mares had S. zooepidemicus as the 
sole isolate; E. coli was cultured in association with S. zooepidemicus in 3 fetuses and 
placentas from inoculated mares. One fetus and its accompanying placenta had 
Actinobacillus equuli isolated in association with S. zooepidemicus. With the exception of 
the mare that failed to develop placentitis after experimental induction (above) and the 
control mare with FFS that aborted, all mares that aborted developed gross and 
histopathologic lesions consistent with ascending placentitis (Hong et al. 1993) (data not 
shown). All mares in the control group delivered macroscopically, histologically and 
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microbiologically (i.e. non-pathogenic saprophytic bacteria) normal placentas (data not 
shown).   
Fourteen fetuses from aborting mares in the group with experimentally induced 
placentitis were nonviable at delivery. Two foals were delivered alive, one foal was 
delivered alive after spontaneous delivery, and one foal was delivered upon induction of 
parturition due to sepsis in its dam. Both of these foals had clinical evidence of sepsis and 
were euthanized immediately post-delivery.  
Except one mare that had positive bacterial culture at 5 DPI, none of the mares in 
the control group or the group with experimentally induced ascending placentitis presented 
positive bacterial culture of the fetal fluids. As expected, S. zooepidemicus was isolated in 
the amniotic fluid of this mare. 
Several protein bands of different molecular weights were present in both allantoic 
and amniotic fluids (Fig.6.1). A protein band consistent (~68 kDa) with alpha-fetoprotein 
(AFP) was present in all samples. Two other protein bands were present in most samples 
(i.e. ~250 kDa, 43/44 samples; ~200 kDa, 39/44 samples).  To confirm the identity of the 
68-kDa protein, immunoblotting for AFP was performed in all samples (Fig. 6.2). A single 
band consistent with AFP was present in all samples of both allantoic and amniotic fluid.  
As expected, concentrations of AFP were below the limits of detection for the 
immunoassay (0.2 units/ml) for geldings and non-pregnant mares, there appear no apparent 
crossreactivity with albumin. As predicted, equine fetuses presented high concentrations 
of AFP in plasma (ranging from 600 to >1200 units/mL). The manufacturer states that the 
assay is not accurate for samples with concentrations above 600 units/mL; despite possible 
dilution, samples obtained from equine fetuses can be interpreted as having very high 
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concentrations of AFP.  As part of the validation of this assay, we examined the 
concentrations of AFP (units/mL) during the last five months of gestation, the results were: 
7th (0.8 ±0.1), 8th (0.5 ±0.05), 9th (0.4±0.03), 10th (0.3 ±0.02) and 11th (0.6 ± 0.2) months 
of gestation (n = 5 mares). Based upon this biological validation, it appears that the 
heterologous human AFP recognized this protein in plasma of pregnant mares, fetal fluids, 
and in equine fetal plasma.  The AFP immunoassay confirmed the presence of AFP in all 
fetal fluid samples from mares with experimentally induced ascending placentitis and 
gestationally age-matched control mares (Table 6.1). Analyses of maternal plasma 
concentrations of AFP relative to DPI demonstrated no effect of group (p=0.73); however, 
there were effects of time (DPI, p<0.0001) and a time-by-group interaction (DPI*Group 
p<0.06) (Fig.3). Post hoc comparisons across days and groups showed that AFP 
concentrations at 7 DPI were significantly higher in mares with experimentally induced 
placentitis when compared to controls (p<0.05) (Fig 6.3). For the analyses of maternal 
plasma AFP relative to DFA, there were effects of group (p<0.0001), time (DFA p=0.0002) 
and a group by time interaction (Group*DFA p<0.001) (Fig 6.4).  
Upon cytological examination of the amniotic fluid, we observed that this fluid is 
rich in epithelial cells, and that scant debris is present surrounding these cells, contrarily, 
the allantoic fluid is acellular and remarkable amorphous material was observed (Fig 6.5). 
There were no apparent differences between mares in the control group and mares with 
experimentally induced ascending placentitis, except for one mare that presented numerous 
bacterial colonies surrounding the epithelial cells in the amniotic fluid (Fig 6.5).  
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Figure.6.1: Representative one-dimensional SDS-PAGE of allantoic and amniotic fluids, 
in mares with experimentally induced ascending placentitis and gestationally age-matched 
control mares at 0 (D0), 5 (D5) and 12 (D12) days post-inoculation. Day 0 was defined as 
the day of inoculation, or commencement of sampling for mares in the control group. L: 
represents the molecular weight makers.  Mare 1: 0-12 represent allantoic samples; Mare 
2: 0-5 amniotic samples; Mare 3 & 4: represent allantoic samples. Several proteins were 
present in these samples; however, one protein band (68 kDa) was consistently present in 
all samples. 
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Figure 6.2: Immunoblotting for alpha-fetoprotein (AFP) in allantoic and amniotic fluids of 
mares with experimentally induced ascending placentitis and gestationally age-matched 
control mares. Fetal fluid samples were collected at days 0, 5 and 12. Day 0 was defined 
as the inoculation day for mares in the placentitis group and commencement of sampling 
for mares in the control group.  A single immunoreactive protein (~68kDa) was detected 
with AFP in all samples of both types of fetal fluids.  All the bands in the figure above 
represent serial sampling from 3 mares.  
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Figure. 6.3. Alpha fetoprotein (AFP) concentrations in plasma of mares carrying normal 
pregnancies and mares with experimentally induced ascending placentitis for 0, 5, 6 and 7 
days post inoculation (DPI). There were no group differences (p=0.73). There were effects 
of time (DPI, p<0.0001) and a time-by-group interaction (DPI*Group; p<0.06). Post hoc 
comparisons across days and groups showed that AFP concentrations at 7 DPI were 
significantly higher in mares with experimentally induced placentitis compared to controls 
(p<0.05). To convert units/mL to ng/mL, multiply units/ml by a correction factor of 1.21. 
*Within days different letters denotes significant statistical differences (p<0.05). 
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Figure 6.4: Alpha fetoprotein (AFP) concentrations in plasma of mares carrying normal 
pregnancies and mares with experimentally induced ascending placentitis for days from 
abortion (DFA, -7 to 0). There were effects of group (p<0.0001), time (DFA p=0.0002) 
and a group-by-time interaction (Group*DFA p<0.001). 
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Figure 6.5. Representative cytological preparations of the fetal fluids in mares with 
experimentally induced ascending placentitis and gestationally age-matched control mares. 
These slides were prepared by cytospin and stained by Diff-Quick. A & B represents the 
allantoic fluid of a control mare at 0 and 5 DPI; C &D represents the amniotic fluid at 0 
and 5 DPI; E & F Represents the allantoic fluid at 0 and 5 DPI in mares with experimentally 
induced placentitis; G & H represents the amniotic fluid at 0 and 5 DPI. The amniotic fluid 
was rich in epithelial type cells and presented relative scant debris among cells; allantoic 
fluid was acellular, and remarkable amorphous material was observed.  There were no 
apparent differences between mares in the control group and mares with experimentally 
induced ascending placentitis, except for one mare (represented in G & H above), note 
numerous bacterial colonies surrounding the epithelial cells (H), Streptococcus equi 
subspecies zooepidemicus was cultured from this mare (contained in the circle). (Scale bars 
= 25µm). 
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Table 6.1: Concentration of alpha-fetoprotein (AFP) (units/mL) in the allantoic and 
amniotic fluids of mares with experimentally induced ascending placentitis and 
gestationally age-matched control mares at days 0, 5 and 12 post-inoculation (DPI).  Day 
0 was defined as the day of inoculation or the commencement of sampling for mares in the 
control group. Numbers in parentheses represent number of samples assayed.  Data are 
expressed as Mean ± SEM.  
 
To convert units/mL to ng/mL, multiply units/mL by a correction factor of 1.21. 
 
  
 Day 0 Day 5 Day 12 
Fluid 
type 
Control Placentitis Control Placentiti
s 
Control  Placentiti
s 
Allanto
ic 
120.6±14.3(
5)  
107.6±18.6(
5) 
100±12(
6) 
168±39.2(
5) 
110 
±14.5(4)  
166±73.8(
2) 
Amniot
ic 
111 ± 5.6(2) 196(1) 65.5(1) 385±148(
3) 
260±201(
3) 
__ 
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6.5. Discussion 
 
To our knowledge, this is the first study to confirm the presence of AFP in the 
allantoic and amniotic fluids of mares during the third trimester of pregnancy.  However, 
this finding was not surprising, as studies in other mammals had long shown that this 
protein is present in the fetal fluids throughout pregnancy (Okano et al. 1977, Smith et al. 
1979, Luft et al. 1984, Deutsch 1991). Previously, in the horse, indications that AFP was 
present in the fetal fluids late in pregnancy came from a study conducted with slaughter 
specimens (Zanella 2008), whereby the author sampled mares across pregnancy and based 
on fetal measurements, the gestational age was estimated. Upon electrophoresis, using 1D-
SDS-PAGE, the author observed a protein band consistent with AFP, in all fetal fluids 
samples (Zanella 2008).  
In the present study, AFP was elevated in plasma of mares with experimentally 
induced ascending placentitis. This increase may be due to up regulation and/or an 
increased vascular permeability across the placenta. For either mechanism, this finding 
provides a new area of investigation, as we confirmed that AFP, a protein produced by the 
fetus (and present in the fetal fluids), can be detected in the maternal circulation and that 
disease (i.e. placentitis) can increase the concentration of AFP in the maternal circulation. 
It is highly suggestive, that similar to AFP, other fetal proteins might cross the placenta 
upon normal and pathological conditions. 
Despite the extensive use of AFP in human medicine as a marker for placental and 
fetal heath for several years, apparently, this is the first study to report AFP in mares with 
experimentally induced placentitis. Recent studies in human medicine have shown the 
importance of AFP as a prognosticator of neonatal infection (for review, Buhimschi & 
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Buhimschi 2012). Although AFP is elevated in plasma of mares with experimentally 
induced placentitis, it remains to be determined if similar elevations of AFP concentrations 
in plasma occur in mares with spontaneous placentitis.  It is worth to note, that AFP was 
elevated in the later course of the disease, perhaps this protein may have limited application 
as early marker for placentitis, but it may have clinical utility as later marker for placentitis 
(i.e. chronic stage of placentitis), thus, probable it may be a useful prognosticator for 
placentitis since it changed late stages of disease.  
Contrary to our results, a study in pregnant cows experimentally infected with 
Aspergillus fumigatus, Sarcocystis cruzi or Campylobacter fetus failed to demonstrate 
elevation of AFP in association with placentitis induced by these infectious agents (Baetz 
et al. 1981). Biological differences between species and pathogeneses of these diseases in 
cattle and horses, may explain the contrasting findings. It is worth-noting, that cows may 
take several days to expel a dead fetus; however, in mares this is not usually common.  
Differences between the assays with regards to sensitivity may also explain the contrasting 
results. 
In a clinical trial involving a large group of commercial mares, Sorensen and 
collaborators (1990) developed an assay for a molecule termed “equine feto-protein”.  
From that report, it is unclear whether this protein is AFP or if it is some other molecule 
derived from the fetoplacental unit.  If “equine feto-protein” is similar to AFP, their 
findings concur with ours that placentitis induces changes in peripheral concentrations of 
AFP.  Unfortunately, the authors did not report the absolute concentrations derived in the 
study, under the allegation that the assay was under revision for patent protection.  
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Therefore, we cannot compare absolute concentrations if indeed, they measured the same 
molecule.  
As previously suggested, but not shown by the authors (Lyle et al. 2006), the 
cytological appearance of these fluids are distinct enough that amniotic and allantoic fluid 
can be easily differentiated from one another, thus creatinine and electrolytes measures can 
be replaced by the cytological examination. An interesting aspect of cytology of the fetal 
fluids is the fact that only one mare had detectable bacteria, none of the remaining mares 
had evidence of bacterial colonies; aerobic bacterial culture confirmed the presence of the 
bacteria. However, it is worth-noting that amniotic fluid represented the minority of 
samples in the present study; it is possible that more mares would have presented positive 
bacterial cultures of the fetal fluids if more amniotic samples were harvested in the present 
study.  
Since we performed several bacterial cultures in the allantoic fluid, and none of the 
samples yielded positive bacterial cultures, despite severe placentitis, we suggest that 
during spontaneous infection (i.e. the bacteria infecting the cervical pole of the placenta), 
bacteria likely gain access to the fetus through the umbilical cord. It seems very logical to 
us that if bacteria would gain access to the fetus through the allantoic fluid, we would have 
seen evidence of this infection (i.e. positive bacterial culture of the allantoic fluid). On the 
other hand, positive culture of the amniotic fluid may suggest that the fetus was first 
infected, and then respiratory and gastrointestinal secretions of bacteria into the amniotic 
fluid may happen as a secondary event to the fetal infection, rather than a primary event. 
Therefore, we suggest that infection of allantoic fluid may not play an important role in the 
mechanism leading to the fetal infection. 
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In conclusion, AFP is present in all fetal fluid samples and is increased in plasma 
of mares with experimentally induced ascending placentitis, either due to upregulation 
and/or increased vascular permeability across the placenta. Cytological preparations of the 
fetal fluids can be used to identify its origin. It appears that infection of the allantoic fluid 
may not play an important role in the mechanism leading to the fetal infection. Although, 
experimentally induced placentitis was associated with an elevation in plasma 
concentrations of AFP.  
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7.1. Summary 
Little is known about the protein composition of equine fetal fluids. The objectives 
of this study were to (i) describe the normal protein composition of the amniotic and 
allantoic fluids of mares at 300d of gestation, and (ii) compare the protein composition of 
the allantoic fluid before and after experimental induction of ascending placentitis. In study 
I, three mares carrying normal pregnancies were euthanized at 300 d of gestation and fetal 
fluids were collected and preserved at -80oC until further analyses. In study II, three control 
mares and three mares with experimentally induced ascending placentitis had allantoic 
fluid collected by transabdominal, ultrasound-guided puncture. Fetal fluids were analyzed 
with a high-throughput proteomic technique (LC-MS/MS) to characterize the protein 
composition of fetal fluids in late-term mares carrying normal pregnancies and allantoic 
fluids from mares with experimentally induced placentitis. Approximately 100 proteins 
were present in both allantoic and amniotic fluids. Three proteins (i.e. lactoferrin, serum 
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transferrin, alpha-1-proteinase were present in allantoic samples and were elevated at least 
two fold in mares with experimentally induced ascending placentitis. It remains to be 
determined how these changes in fetal fluid proteins are related to ascending placentitis 
and whether they have any diagnostic application for placental disease in the mare. 
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7.2. Introduction 
Ascending placentitis is an important cause of abortion in mares, its diagnosis is 
based on clinical signs (vulvar discharge and premature mammary gland development ± 
milk streaming) and transrectal ultrasonography (Troedsson & Macpherson 2011). The 
clinical signs and associated ultrasonographic changes (e.g. placental separation) are 
variable and may only be present in advanced stages of disease; therefore, early diagnosis 
would potentially improve the likelihood of a delivery of a viable foal.  Recently, our 
laboratory has been focused on developing new diagnostic tests for equine placentitis. 
Several markers have been investigated in experimental cases and some appear to be useful 
tools to detect experimentally induced placentitis. Among these markers, acute phase 
proteins, particularly serum amyloid A, appear to be a sensitive but nonspecific marker for 
placentitis (Canisso et al. 2012, Canisso et al. 2014).   
In the horse, little is known about the protein composition of fetal fluids (Williams 
et al. 1993, Paccamonti et al. 1995, Zanella 2008, Zanella et al. 2013). However, in human 
medicine, amniotic fluid has been the focus of numerous reports (Ruetschi et al. 2005, 
Buhimschi et al. 2008, Romero et al. 2008 Buhimschi &Buhimschi 2012). Two  
dimensional gels and LC/MS have been used to identify proteins in the amniotic fluid  of 
humans (Romero et al. 2008 Buhimschi &Buhimschi 2012, Tambor et al. 2012, Tambor 
et al. 2013) .To date, studies conducted with horses were carried out to examine the 
electrolyte composition or to investigate the presence of specific proteins present in other 
body systems (Paccamonti et al. 1995, Holdstock et al. 1995, Zanella et al. 2013, Canisso 
et al. 2014). The protein composition of the equine fetal fluids has received limited 
attention either during normal pregnancy (Zanella 2008) or during pathologic conditions 
(Finger et al. 2014).   Proteomic analyses applied to study the protein composition of the 
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equine fetal fluids in earlier studies (Zanella 2008, Finger et al. 2014) provided only limited 
identity of protein composition; therefore a high-throughput proteomic technique would 
allow more definitive identification of proteins in equine fetal fluids. 
In the recent years, high-throughput proteomics techniques have been used to 
identify new diagnostic markers in the amniotic fluid of women experiencing 
chorioamnionitis or to identify fetal defects (for review, Klein et al. 2014). The application 
of a high-throughput proteomic technique such as liquid chromatographic mass 
spectrometry (LC-MS) associated with bioinformatics tools provides an opportunity to 
identify proteins that have not yet been described in equine fetal fluids . We hypothesize 
that the protein composition of the amniotic fluid differs from that of allantoic fluid and 
that ascending placentitis alters the protein composition of the allantoic fluid. The 
objectives of this study were to (i) describe and compare the protein composition of 
amniotic and allantoic fluids of mares carrying normal pregnancies at 300d gestation (ii), 
and to compare the protein composition of allantoic fluid before and after experimental 
induction of ascending placentitis in normal and control mares. 
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7.3. Material and methods 
Clinically healthy adult horse mares were enrolled in these experiments. Mares 
were maintained at the Maine Chance Farm, Department of Veterinary Science, University 
of Kentucky, Lexington, KY, USA. All the experimental protocols were approved by the 
Institutional Animal Use and Care committee at the University of Kentucky (Project 
#2010-0769). All the animals were kept in paddocks and supplemented with hay, grain and 
water ad libitum along with trace minerals. Immediately pre-abortion or prior to normal 
parturition the mares were kept in individual stalls (16 x 16 feet) during the night and turned 
out in pasture during the day.  
Study I:  Protein composition of amniotic and allantoic fluids in mares carrying normal 
pregnancies in the third trimester of pregnancy 
Allantoic and amniotic fluids from mares (n=3) carrying normal singleton 
pregnancies, were collected after euthanasia at 300 days of gestation. Within approximately 
20 minutes postmortem, samples were harvested through direct access of both fetal 
compartments (i.e. allantoic and amniotic) and frozen immediately.  A syringe was used to 
collect aliquots of the fetal fluids, aliquots of 2 mL were loaded into cryovials and samples 
were immersed in liquid nitrogen. From liquid nitrogen, samples were stored at -80oC until 
further analyses.  
Immediately before analyses, samples were slowly thawed on ice. A fixed volume 
of 10 µl of fetal fluid was submitted to vacuum centrifugation for 3 minutes at 38oC to 
concentrate the final volume of protein. Samples (5 µL) were diluted (1:1 v/v) with 
Laemmli sample buffer (Bio-Rad Laboratories, Hercules, CA) and incubated at 95°C for 4 
min followed by electrophoresis on 10% SDS polyacrylamide gels (Mini-PROTEAN 
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TGXTM Precast Polyacrylamide Gel, Bio-Rad Laboratories, Hercules, CA, USA).  The gels 
were run with Tris-Glycine 0.1% SDS at 200V for 20 min. All gels were briefly stained 
with Coomassie blue (0.05%, w/v) and subsequently de-stained with methanol (20%) and 
glacial acetic acid (10%). Images were obtained using an automatic reader (Cell & 
Biosciences, San Andreas, CA, USA).  
After destaining, proteins were analyzed at the laboratory of Protein Analyses 
(Department of Molecular and Cellular Biochemistry, University of Kentucky) where 
proteins were excised from the gel and digested with trypsin. Peptides resultant from this 
digestion were analyzed by tandem LC-MS. Peptides obtained with from the LC-MS 
analyses were analyzed by an ion trap mass analyzer (Orbitrap®) (Zubarev & Makarov 
2013). Resulting spectra were submitted for a MASCOT search sequence for similarity 
against other mammalian proteins present in the SwissProt database (excluding humans, 
rats and mice). Proteins present were identified by uniprot entries (www.uniprot).  
Study II: Protein composition of the allantoic fluid in mares carrying normal pregnancies 
and mares with experimentally inducedascending placentitis 
Allantoic fluid samples from six mares carrying normal pregnancies (265-280 days 
of gestation) were used in this study. Three mares were non-inoculated controls and three 
mares had experimentally induced ascending placentitis.  As noted in a parallel publication, 
ascending placentitis was induced via intra-cervical inoculation of Streptococcus equi 
subspecies zooepidemicus (Canisso et al. 2014a).  Allantoic fluid was obtained by 
transabdominal ultrasound guided puncture at 0 and 5 days post inoculation/commence of 
the study for control mares (Canisso et al. 2014b). 
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To assure that control mares had normal pregnancies and to confirm that 
experimentally inoculated mares developed placentitis, all placentas were submitted for 
routine histopathologic examination (Hong et al. 1993).  All mares with experimentally 
induced ascending placentitis had inflammatory necrotic changes consistent with bacterial 
placentitis and Streptococcus equi subspecies zooepidemicus was the single isolate in the 
placenta and aborted fetuses. All mares in the control group delivered normal foals and 
placentas.  
Only descriptive analyses were used to characterize proteins present in the amniotic 
and allantoic fluids of normal mares. In study II, paired t-tests were used to compare 
abundance of proteins present in allantoic fluid samples from mares at Days 0 and 5, and 
unpaired t-tests were used to compare abundance of proteins across groups. Protein 
abundance was based upon spectral count (Zhu et al. 2010). Significance was set at p<0.05 
7.4. Results 
Based upon non-redudante sequences, a total of 37 proteins were identified in the 
amniotic fluid (Table 7.1) and 59 proteins were identified in the allantoic fluid of mares 
carrying normal pregnancies at 300 days of gestation (Table 7.2). Most of the proteins 
described are secretory proteins, structural proteins. The list of all proteins including ion 
scores are listed in the appendices (D).  For study II, a total of eight proteins were present 
in all allantoic fluid samples (Table 7.2), and among these eight proteins, lactotransferrin, 
serotransferrin and alpha-1-antiproteinase were increased at least two-fold from 0 to 5 days 
post inoculation in allantoic fluid from mares with experimentally induced ascending 
placentitis (p<0.05) and remained unchanged in control samples. Furthermore, 
lactotransferrin, serotransferrin and alpha-1-antiproteinase were significantly increased in 
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allantoic fluid at day 5 post inoculation in mares with experimentally induced placentitis 
compared to control (p<0.05) (Table 7.3). 
Table 7.1: Proteins identified in amniotic fluid samples from normal mares at 300d 
gestation based upon LC-MS-MS.  
Proteins Proteins 
Serum albumin  Alpha-1B-glycoprotein  
Fibronectin  Glycoprotein hormones alpha chain  
Apolipoprotein  Actin-related protein 3  
Gelsolin  Stress-70 protein, mitochondrial  
Alpha-fetoprotein  Angiotensinogen  
Keratin, type II cytoskeletal 1 Apolipoprotein D  
Keratin, type II cytoskeletal 5 Angiotensin-converting enzyme 2 
Keratin, type II cytoskeletal 7 Decorin  
Keratin, type I cytoskeletal 10 Apolipoprotein E  
Keratin, type II cytoskeletal 75 Surfeit locus protein 6  
Alpha-2-macroglobulin Lactase-phlorizin hydrolase  
Lactotransferrin  Proteasome subunit beta type-8  
Lumican  Type III iodothyronine deiodinase  
Coatomer subunit beta  Alpha-1-antiproteinase 2  
Hemoglobin subunit beta  Clusterin  
Alpha-1-antiproteinase  Melanotransferrin  
Major allergen Equine chromosome 1  Uteroglobin  
Serotransferrin  Transmembrane protein 198  
Phosphatidylinositol 3-kinase regulatory subunit gamma   
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Table 7.2: Proteins identified in allantoic fluid samples from normal mares at 300d 
gestation based upon LC-MS-MS.  
Proteins  
Serum albumin Peptidase inhibitor 16  
Fibronectin  Cationic trypsin  
Hemoglobin  Actin, alpha skeletal muscle  
Alpha-fetoprotein Inter-alpha-trypsin inhibitor  
Serotransferrin  Cadherin-2 
Alpha-1-antiproteinase  Regulator of G-protein signaling 
Annexin A1  Thrombospondin-1  
Keratin, type II cytoskeletal 5  G-protein coupled receptor  
Keratin, type II cytoskeletal 75 Ubiquitin-40S ribosomal protein S27a  
Keratin, type II cytoskeletal 7  Polyubiquitin-B  
Calsequestrin-2  Secretogranin-1  
Keratin, type II cytoskeletal 79  Phytanoyl-CoA dioxygenase, peroxisomal  
LYR motif-containing protein 7  Glycerate kinase  
Amyloid beta A4 protein  Hemoglobin fetal subunit beta 
CD44 antigen O Tenascin  
Insulin-like growth factor-binding protein Peptidase inhibitor  
Alpha-1B-glycoprotein  Alpha-1-antitrypsin  
Keratin, type I cytoskeletal 10  Cationic trypsin  
Ezrin  Calsequestrin-2  
Moesin  SPARC  
Radixin  Inter-alpha-trypsin inhibitor  
SPARC LYR motif-containing protein 7  
G-protein coupled receptor  G-protein coupled receptor  
14-3-3 protein zeta/delta  Uroplakin-1b  
Coatomer subunit beta' 14-3-3 protein zeta/delta  
Actin-related protein  Surfeit locus protein 6  
Keratin, type II cytoskeletal 1 Metalloproteinase inhibitor 2  
Metalloproteinase inhibitor 2  SCO-spondin  
Collagen alpha-2 (IV) chain  Major allergen Equ chromosome 1 
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Table 7.3: List of proteins present in the allantoic fluid of mares carrying normal 
pregnancies and mares with experimentally induced placentitis based upon LC-MS-MS.  
Proteins 
Lactotransferrin  
Hemoglobin  
Inter-alphatrypsin inhibitor 
Serotransferrin 
Serum albumin  
Alpha-1-antiproteinase  
Alpha-fetoprotein  
Fibronectin 
 
 
7.5. Discussion 
 
To the authors’ knowledge, this is the first report using high-throughput protein 
sequencing to study the protein composition of fetal fluids in mares with normal 
pregnancies and in mares with experimentally induced placentitis.  Several proteins were 
newly identified both in the allantoic and amniotic fluids. Our findings may guide future 
research aiming to investigate the physiology of the fetal fluids and potential role of 
proteins in the fetal maturation. Since several proteins were newly known to be present in 
equine fetal fluids, investigators can use other techniques to quantify specific proteins 
described by us.  
Interestingly, most of the proteins detected in equine fetal fluids are similar to the 
proteins present in the maternal plasma. It should be noted that the type of placentation in 
the horse limits exchange of large molecules, therefore, proteins present in the fetal fluids 
are likely originated in the fetus, and for instance some proteins like keratin could originate 
from fetal skin. It is worthnoting that some molecules present in the fetal fluids are released 
into the maternal circulation (e.g. alpha-fetoprotein) and that placentitis increases its 
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concentration in maternal plasma, probably related to increased permeability (Chapter 6). 
In the present study, three secretory proteins (i.e. serum transferrin, lactotransferrin and 
alpha-antiproteinase) were increased at least two-fold in the allantoic fluid of mares with 
experimentally induced placentitis. It is uncertain whether the increase in these proteins 
observed here can be used to assess fetal well-being. The increase in these three plasma 
proteins in the fetal fluids suggest that the increased permeability may have occurred. 
Interestingly, lactoferrin has anti-bacteriostatic capabilities (Kolm et al. 2006). Since 
lactoferrin is produced and secreted by the endometrium and is increased in endometritis 
(Kolm et al. 2006), increase secretion of this enzyme in the fetal fluids may reflect the 
presence of endometrititis-associated with placentitis. It is unknown whether placentitis is 
associated with increased secretion of lactotransferrin in the fetal fluids, although this 
hypothesis should be tested. Serum transferrin is responsible for ion transport, in human 
medicine genetic defects have been associated with excessive and absent congenital serum 
transferrin (Bartnikas 2012), in equine medicine, the role of serum transferrin in equine 
placentitis is unknown.  
Proteomic studies in humans demonstrated that amniotic fluid presented more than 
800 types of proteins (Cho et al. 2007). However, in our study about 100 proteins were 
found to be present. Reasons for that discrepancy can be associated with biological 
variations, different methodology and the current data base available for proteins of equine 
origin. In the present study, we use 1-dimensional electrophoresis to separate the 
electrolytes known to be present in the fetal fluids (Paccamonti et al. 1995). It is possible 
that some proteins that were overabundant in the samples precluded identification of less 
abundant proteins. Alternative methods to isolate proteins, such as protein precipitation 
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could have been used to remove electrolytes and then concentrate proteins for LC/MS. 
Application of different methods would likely result in different outcomes; however, it was 
outside the scope of this study to compare different methods.  
Alpha-1-antiproteinase is an acute phase protein. It which acts as an anti-
inflammatory protein, which is increased several-fold upon inflammation (Kolarich et al. 
2006, Ahsan et al. 2014). It is believe that this protein has protective effects against several 
lytic proteins secreted by neutrophils.  In human medicine, the levels of alpha-1-
antiproteinase in plasma have been used as a diagnostic and prognostic tool for 
keratoconjunctivitis (Ahsan et al. 2014). In horses, this protein has been described but its 
role in placentitis is unknown. Because this protein was elevated in fetal fluids in mares 
with experimentally induced placentitis, and because it is an acute phase protein, alpha-1-
antiproteinase inhibitor should be evaluated as a possible biomarker for equine placentitis.   
Protein composition of the fetal fluids has been the focus of numerous publications 
in human medicine, however, these fetal fluids have received limited attention in equine 
reproductive medicine, particularly in mares with placentitis. In the present study, protein 
composition of the fetal fluids, determined by high-throughput proteomic techniques (i.e. 
LC-MS-MS) identified several proteins in the amniotic and allantoic fluids of mares 
carrying normal pregnancies. In addition, we demonstrated several proteins that were 
previously undescribed in the allantoic fluids of mares with placentitis. Further ongoing 
evaluations may determine whether the any of the three proteins found to be elevated in 
the allantoic fluid are also elevated in plasma. It remains to be determined whether the 
increase is related to protein extravasation or to increased production of these proteins or 
whether these proteins are of fetal or maternal origin.  For either mechanism, our results in 
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both studies open a new field of investigation regarding diagnostic markers present in the 
fetal fluids that may be increased or reduced in maternal plasma.  
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Chapter 8 
General Conclusion and Future Directions 
 
Bacterial placentitis is an important cause of pregnancy loss in mares. Two types 
of placentitis were examined in this dissertation: ascending and nocardioform placentitis.  
Both types of placentitis occur late in pregnancy, and acute-chronic inflammatory lesions 
are present upon delivery/abortion. Acute infections of the gravid equine uterus during 
mid-gestation are commonly associated with fulminant bacterial infection of the fetus with 
minimal or no lesions present in the placenta, this type of infection is unnoticed and 
invariably result in abortion. On the other hand chronic infections of the placenta occurring 
from the mid to late term are associated with acute-chronic lesions present in the placenta.  
Ascending placentitis and nocardioform placentitis manifest as chronic insidious 
infections.  
Despite the fact that the first diagnosis of nocardioform was made three decades 
ago, little is known about the pathogenesis of nocardioform placentitis. Until now, all our 
knowledge about nocardioform placentitis in mares results from epidemiological 
observations carried out by the University of Kentucky Veterinary Diagnostic Laboratory.  
Lack of a research model to experimentally induce nocardioform placentitis has limited 
our understanding of the disease.  Since nocardioform lesions are located at the base of the 
uterine horn and body, it has been speculated that the bacteria gain access to uterus during 
breeding or other gynecological interventions; however, inoculation of mares with C. equi 
after artificial insemination did not result in nocardioform placentitis. In addition, 
endometrial swabs collected from commercial Thoroughbred mares immediately before or 
after mating did not provide evidence or suggest that nocardioform placentitis is 
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transmitted during mating. Furthermore, oral, respiratory, and intravenous inoculation of 
C. equi did not result in clinical nocardioform placentitis. These findings demonstrated that 
the simple presence of C. equi was not sufficient to induce disease. This may indicate that 
other unidentified factors may play a role in disease pathogenesis. Alternative routes of 
inoculation (e.g. ocular), using different bacterial isolates and species of microorganisms, 
different doses and intervals of inoculation should be tested.  
The second and major component of this dissertation involved the identification of 
diagnostic markers for placentitis. Because ascending bacterial placentitis is readily and 
predictably induced using existing experimental models, this type of placentitis was used 
to identify diagnostic markers for placentitis in maternal plasma and fetal fluids.  Currently, 
the diagnosis of ascending placentitis is based on transrectal ultrasonography and clinical 
signs. Often clinical signs and associated ultrasonographic changes are only present in 
well-advanced stages of placentitis, thus there is a real need to investigate new markers for 
placentitis.  In the present dissertation, three main fields were explored to identify new 
markers for bacterial placentitis as follows: acute phase inflammatory proteins, steroid 
hormones produced by the fetal placental unit, and protein composition of the fetal fluids.  
Of the three acute phase proteins investigated, serum amyloid A and haptoglobin 
but not fibrinogen increased remarkably in association with experimentally induced 
ascending placentitis. Until very recently, placentitis was thought to be a disease of the 
equine pregnant uterus without detectable inflammatory changes in maternal plasma. The 
anecdotal suggested lack of changes in WBC cells and fibrinogen in maternal plasma, as 
these two are the most widely used means to evaluate inflammation in the horse.  Indeed, 
our experimental findings here confirmed that placentitis was not associated with changes 
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in WBC and fibrinogen. The findings that serum amyloid A and haptoglobin are elevated 
in maternal plasma raise the question of the origin of this elevation. It is likely that this 
detectable increase in maternal plasma has some involvement of the endometrium, since 
experimentally induced endometritis using a high inoculating dose was associated with 
systemic elevation in serum amyloid A. It is likely that other inflammatory markers change 
in mares with placentitis, thus further investigation in this particular field may enhance our 
knowledge about placentitis and may allow us to identify new markers for placentitis.  
Steroids produced by the fetoplacental unit including androgens, estrogens and 
progestins were investigated in the present dissertation. The use of fetoplacental unit 
steroids as markers for placental health are not necessary a novel idea, however, we 
investigated steroids (i.e. testosterone, estrone sulfate, DHEA-S, and estradiol 17β) that 
have not been investigated yet in mares with placentitis.  Androgens appear to be poor 
marker for experimentally induced ascending placentitis. On the other hand, concentration 
of estradiol 17β and estrone sulfate were reduced in mares with experimentally induced 
placentitis. Estrone sulfate has been suggested for years to be a good marker to assess fetal-
wellbeing; however, until now it has not been evaluated in mares with placentitis. Mares 
with experimentally induced placentitis presented reduced concentrations of estrone sulfate 
close to abortion, and this probably limits the use of this molecule as a biomarker for 
placentitis in mares. On the other hand, estradiol 17β was reduced in mares with 
experimentally induced placentitis, and this molecule appears to be a good potential marker 
for placentitis in mares.   
Protein composition of the fetal fluids has been the focus of numerous publications 
in human medicine; however, analysis of fetal fluids has received limited attention in 
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equine reproductive medicine. In the present dissertation, different methods were used to 
study the protein composition of the fetal fluids. In the first study, alpha-fetoprotein was 
characterized as a major protein present in the equine fetal fluids, and this protein was 
elevated in plasma of mares with placentitis. In a second study, conducted to evaluate the 
protein composition of the fetal fluids, using a high-throughput proteomic technique (i.e. 
LC-MS-MS) several new proteins were discovered in the amniotic and allantoic fluids of 
mares carrying normal pregnancies. In addition, for the first time using a LC-MS-MS, we 
demonstrated several proteins that were unknown to be present in the allantoic fluids of 
mares with placentitis. Further ongoing evaluations, may determine whether some of these 
newly discovered proteins are elevated in allantoic fluid. In the first study involving protein 
composition of the fetal fluids, we demonstrated that alpha-fetoprotein, a protein originated 
in the fetoplacental unit is released in the maternal circulation, and that placentitis increases 
its concentrations. It remains to be determined whether the increase is related to protein 
extravasation or to increased production of this molecule.  For either mechanism, our 
results in both studies open a new field of investigation regarding diagnostic markers 
present in the fetal fluids that may be increased or reduced in maternal plasma.  
In the present dissertation, an experimental model to induce ascending bacterial 
placentitis was used to identify new diagnostic markers for this disease; however, further 
studies should be carried to investigate whether the diagnostic markers for experimentally 
induced placentitis are useful markers for spontaneous placentitis. 
 
Copyright © Igor Frederico Canisso 2014 
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Appendices  
Appendice A: 
The information listed in the present manuscript has been included as 
supplementary material in the manuscripts generated out of this dissertation. 
Study I: Breeding Management 
 
The mares were examined 3 to 4 times per week by transrectal palpation and 
ultrasonography (coupled with a linear transducer 5 MHz Titan® Sonosite Bothell, WA, 
USA) until a preovulatory follicle (i.e. ≥35 mm, presence of endometrial edema) was 
detected. If needed, mares were given prostaglandin F2α (7.5 mg, IM, Pfizer Animal 
Health, USA) to induce estrus.  The mares were bred with fresh extended semen using a 
commercial extender (Equi-Pro®, Minitube of America, Verona, WI, USA) without 
antibiotics.’ 
Once mares had a preovulatory follicle, they were bred with ≥ 500 million 
progressive motile sperm with pooled semen from three fertile stallions.  A single dose of 
human chorionic gonadotropin (i.e. 2,500 units, Intervet/Schering-Plough Animal Health 
New York, NY USA) was given intravenously to induce ovulation.  If the mare did not 
ovulate by 48 h after the first breeding, she was re-bred every 48 h until an ovulation was 
detected.  
At 24 h post breeding, each mare received an intrauterine inoculation of C. equi (1 
x 104 cfu in 1mL of skimmed milk). The inoculum was deposited into the uterine body 
through the use of a commercial (Minitube of America, Verona, WI, USA) semi-flexible 
AI pipette containing a stylet for deposition. Each inoculum was cultured to confirm 
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viability of the bacterial agent. At 24h post inoculation, each mare had an endometrial swab 
collected for PCR testing for C. equi [Reference 7].  The mares were re-checked by 
transrectal palpation and ultrasonography every 48 h until ovulation was detected. The 
mares accumulating intrauterine fluid received oxytocin injections twice daily (20 iu; IM, 
Bimeda Animal Health, Oakbrook Terrace, IL, USA) until fluid accumulation was not 
detectable with ultrasound.  
 
Study II 
Bacterial culture 
 
The culture was prepared on blood agar plates, and incubated at 37oC for at least 3 
days in aerobic culture. Pure culture of C. equi was confirmed using the characteristic 
pungent/soil odor, hard colonies, dark field examinations, gram staining and PCR analysis 
[References:7,14]. Briefly, 20-30 colonies were picked, suspended in 2 ml of Mueller 
Hinton Broth (with cation adjusted) in Magna lyser Green Beads Tubes (Roche 
Diagnostics, Indianapolis). To break hard C. equi colonies, suspension was homogenized 
using a commercial bead-beating system (Roche Diagnostic, Indianapolis) at the speed of 
7,000 rpm for 30 sec. The homogenate was centrifuged at 12000 rpm for 3 min, and then 
the cell pellet was washed 3 times with PBS.  The final pellet was resuspended in PBS and 
kept on refrigerated. This final suspension was then 10 fold-serial diluted and plated on 
agar plates. Cell numbers were counted, cfu was calculated and inoculation was performed 
next day. Since approximately 30% of the bacterial cells become dead by next day by this 
procedure (unpublished data, Erol), inoculum (cfu) was adjusted accordingly to make 109 
viable Crossiella. equi. 
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Appendice B 
 
 
Figure 3.1 (A & B): Serum amyloid A (SAA) and haptoglobin (Hp) concentrations in a 
control mare excluded from the statistical analyses. During the entire sampling period the 
concentrations of SAA (<20mg/L) and Hp (<2.7 mg/mL) remained within normal ranges. 
Transabdominal guided fetal fluid sampling was performed at days 0, 5 and 12. She aborted 
8 days after the last fetal fluid sampling. Pathological and microbiological examination of 
the placenta and fetus revealed no lesions and culture yielded saprophytic non-pathogenic 
bacteria and negative virus isolation; thus the cause of abortion was not determined. 
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 Figure 3.2 (A &B): Serum amyloid A (SAA) and haptoglobin (Hp) concentrations in a 
mare that failed to develop placentitis after experimental induction of placentitis. This mare 
was excluded from the statistical analyses. During the entire sampling period the 
concentrations of SAA (<20mg/L) and Hp (<2.7 mg/mL) remained within normal ranges. 
This mare was not re-inoculated.  At parturition, there was no evidence of placentitis. This 
mare belonged to the subgroup without fetal fluid sampling. The mare delivered a normal 
foal and placenta with no pathological or microbiological evidence of placentitis. 
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 Figure 3 (A & B): Serum amyloid A (SAA) and haptoglobin (Hp) concentrations in a mare 
that failed to develop placentitis after experimental induction of ascending placentitis. 
During the first two weeks follow to inoculation concentrations of of SAA (<20mg/L) and 
Hp (<2.7 mg/mL) remained close to normal ranges. Transabdominal guided fetal fluid 
sampling was not performed at any time on this mare. There were no signs of placentitis 
upon ultrasonographic examination. This mare was re-inoculated two weeks after the first 
attempt. Data for SAA and Hp concentrations in the first two weeks were excluded from 
statistical analyses. After re-inoculation this mare developed signs of placentitis and 
aborted 20 days after re-inoculation. 
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 Figure 4 (A & B): Serum amyloid A (SAA) and haptoglobin (Hp) concentrations in a mare 
after experimental induction of ascending placentitis. Transabdominal guided fetal fluid 
sampling was performed at days 0, 5 and 12. SAA concentrations remained slightly 
elevated normal ranges upt across all days (i.e. <20mg/L). Concentrations of Hp remained 
within normal ranges across all days (i.e. < 2.7 mg/mL). This mare failed to develop 
placentitis; there were no signs of placentitis upon ultrasonographic examination. Data for 
SAA and Hp concentrations in the first two weeks post the inoculation were excluded from 
statistical analyses. The mare was re-inoculated 14 days post inoculation, developed signs 
of placentitis and aborted 9 days post-re-inoculation. 
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 Figure 3.5: Serum amyloid (SAA), haptoglobin (Hp), fibrinogen (Fb) concentrations and 
white blood cell counts (WBC) in a control mare subgroup with fetal fluid sampling. This 
mare developed extensive cellulitis at the Viborg’s triangle secondary to venipuncture, thus 
she was excluded from the analysis. Concentrations of SAA, Hp, Fb and WBC were 
elevated once the mare developed the condition. The mare delivered a health foal and 
normal placenta at 330 days of gestation.  
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Table 3.1: Separation of the chorioallantois from the endometrium near the cervical star in 
mares (n = 14) with experimentally induced ascending placentitis.  The placenta was 
examined by transrectal ultrasonography performed every other day from inoculation until 
abortion.  
 
As noted in the manuscript, three mares did not develop placentitis (data not included in 
the table above). During the first 14 days post inoculation none of these three mares 
developed areas of placental separation. Two of the mares were re-inoculated 14 days 
following the first inoculation; both mares were detected to have areas placental of 
separation by 5-6 days post inoculation, one mare aborted 3 days later, another mare 
aborted 14 days. 
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Appendice C 
Table 1: Proteins present in the amniotic fluid in 1 or 2 samples. The entries on the left 
column represent the accession number on uniprot.  
Protein 
identification   Comon name (Species) 
P49822 Serum albumin (Canis familiaris) 
P02062 Hemoglobin subunit beta (Equus caballus) 
P38029 Alpha-1-antiproteinase (Equus caballus) 
Q95182 Major allergen Equ c 1 (Equus caballus) 
P24627 Lactotransferrin (Bos taurus) 
P09571 Serotransferrin (Sus scrofa) 
P34955 Alpha-1-antiproteinase (Bos taurus) 
P12725 Alpha-1-antiproteinase (Ovis aries) 
P23035 Alpha-1-antiproteinase (Oryctolagus cuniculus) 
O46404 Phosphatidylinositol 3-kinase regulatory subunit gamma (Bos taurus) 
Q2KJF1 Alpha-1B-glycoprotein (Bos taurus) 
P35605 Coatomer subunit beta' (Bos taurus) 
P01219 Glycoprotein hormones alpha chain (Sus scrofa)  
P61157 Actin-related protein 3 (Bos taurus) 
Q6EIY9 Keratin, type II cytoskeletal 1 (Canis familiaris) 
P85295 Serum albumin (Fragments) (Capra hircus) 
Q3ZCH0 Stress-70 protein, mitochondrial (Bos taurus)  
Q95182 Major allergen Equ c 1 (Equus caballus) 
P20757 Angiotensinogen (Ovis aries) 
Q29477 Lactotransferrin (Capra hircus) 
Q32KY0 Apolipoprotein D (Bos taurus) 
P37153 Apolipoprotein D (Oryctolagus cuniculus) 
Q56H28 Angiotensin-converting enzyme 2 (Felis catus) 
Q58DD0 Angiotensin-converting enzyme 2 (Bos taurus) 
Q56NL1 Angiotensin-converting enzyme 2 (Paguma larvata) 
Q29443 Serotransferrin (Bos taurus) 
Q28888 Decorin (Oryctolagus cuniculus)  
Q7M2U7 Apolipoprotein E (Zalophus californianus)  
P18649 Apolipoprotein E (Canis familiaris) 
Q03247 Apolipoprotein E (Bos taurus) 
P18287 Apolipoprotein E (Oryctolagus cuniculus) 
Q0VCY3 Surfeit locus protein 6 (Bos taurus) 
P09849 Lactase-phlorizin hydrolase (Oryctolagus cuniculus) 
Q3T112 Proteasome subunit beta type-8 (Bos taurus) 
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Q5W416 Proteasome subunit beta type-8 (Canis familiaris) 
Q29576 Proteasome subunit beta type-8 (Fragment) (Sus scrofa) 
Q5I3B1 Type III iodothyronine deiodinase (Bos taurus) 
Q6QN11 Type III iodothyronine deiodinase (Sus scrofa) 
Q6DN07 Type III iodothyronine deiodinase (Ovis aries) 
P38029 Alpha-1-antiproteinase 2 (Equus caballus) 
  Fibronectin (Bos taurus) 
P14632 Lactotransferrin (Bos taurus)  
Q29482 Clusterin (Equus caballus) 
P14632 Lactotransferrin (Sus scrofa) 
O97490 Melanotransferrin (Oryctolagus cuniculus) 
Q6EIZ0 Keratin, type I cytoskeletal 10 (Canis familiaris) 
Q8MKG2 Uteroglobin (Equus caballus) 
  Serotransferrin (Sus scrofa) 
  Keratin, type II cytoskeletal 1 (Canis familiaris) 
  Alpha-1B-glycoprotein (Bos taurus) 
Q08E36 Transmembrane protein 198 (Bos taurus) 
P18649 Apolipoprotein E (Canis familiaris) 
Q03247 Apolipoprotein E (Bos taurus) 
Q3SZ57 Alpha-fetoprotein (Bos taurus) 
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